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Abstract 
Due to its extreme lactation strategy the tammar wallaby (Macropus eugenii) provides unique 
opportunities to understand the local control of mammary epithelial cell function. The 
tammar lactation is characterised by a relatively short gestation period (phase 1) leading to 
the birth of a fetus –like young followed by a long lactation divided into three phases (2A, 2B 
and 3). At parturition only organ systems necessary for birth and immediate survival out of 
the uterus are functional. Quite intriguingly, despite its altricial state the neonate is able to 
locate one of the four available teats and attach for the first 100 days post-partum implying 
that the olfactory system is one of the earliest organ systems to develop.  However the 
neonate is not capable of immune response and relies heavily on the mother’s capacity to 
progressively produce milk of profoundly different composition in each of the lactation 
phases in order to meet the specific immunological and nutritional needs at different stages of 
development.  Although there is evidence to show that nursing tammars deliver immune 
factors through milk to the neonate, prior to the bactericidal activity assays reported in this 
study no antimicrobial activity had been demonstrated for any of the putative defence 
molecules. The current study examines how the level of cathelicidins, a family of 
antimicrobial proteins secreted in milk, progressively changes during lactation in relation to 
the potential microbial challenge of both the pouch young and the mammary gland of the 
mother. 
 Interestingly the lactating wallaby is capable of asynchronous concurrent lactation (ACL) in 
which the mother produces phase 2A milk from one mammary gland and phase 3 milk from 
an adjacent mammary gland concurrently in order to simultaneously feed the pouch young 
and an older sibling that has moved out of the pouch and started foraging.  While phase 2A 
(P2A) milk is dilute and rich in oligosaccharides, phase 3 (P3) milk is concentrated and low 
in carbohydrates but rich in protein and lipid. Since the secretion of different milks from the 
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two mammary glands happens while the glands are under an identical systemic control, 
understanding the mechanisms regulating ACL has the potential to reveal factors within the 
mammary gland that control mammary epithelial function. The study investigates the role of 
the extracellular matrix (ECM) in the regulation of ACL and further examines the specific 
effect of ECM on the expression of individual milk protein genes with a focus on 
cathelicidin. 
 Using RTPCR we observed temporal regulation of cathelicidins through differential splicing 
synchronised with the need to protect the mother’s mammary gland and the neonate from 
possible infections. MaeuCath1 was found to be differentially spliced into two variants, 
MaeCath1a and Maeucath1b. MaeuCath1a consists of all the cathelicidin exons including the 
antimicrobial region and is highly expressed in early lactation and at involution, periods 
representing highest vulnerability of both the mother’s mammary gland and the neonate to 
pathogenic infections. MaeuCath1b has the antimicrobial region spliced out and is expressed 
predominantly in mid to late lactation when milk production and therefore mammary cell 
proliferation is at its peak. The study showed for the first time that MaeuCath1b has a 
proliferative effect on wallaby mammary epithelial cells (WallMECs).  The study also 
showed that treatment of cells with mammary ECM from different phases of lactation 
reproduces the cathelicidin expression profile observed in mammary tissues from the 
respective phases. For instance treatment of WallMECs from P2A with ECM from P2B and 
P3 significantly decreased MaeuCath1a expression while treatment with P2A and involuting 
ECM increased its expression. Notably the study showed that treatment of WallMECs from 
an earlier phase of lactation with ECM from a later phase of lactation causes the cells to 
change their phenotype to the later phase.  
 Collectively this study has shown for the first time that lactation-phase specific changes in 
mammary ECM may be needed to direct ACL and the secretion of bioactives that regulate 
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mammary gland function and provide immunological and developmental signals to the pouch 
young.   
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Literature Review 
1.0 Introduction 
The class Mammalia consists of an extremely diverse group of animals but they are all 
characterised by the production of milk to provide nutrition for the young. There are nearly 
5000 species of mammals divided into three subclasses including the monotremes, marsupials 
and eutherians, (Sharman 1970, Tyndale-Biscoe, Hearn et al. 1974, Lefevre, Sharp et al. 
2010). A distinctive feature of mammals is that although they occupy extremely diverse 
habitats, both terrestrial and marine, they maintain a constant body temperature thereby 
placing a significant demand on both the young and the adult to develop appropriate adaptive 
mechanisms which may include the consumption of high energy foods, hibernation (Terrien, 
Perret et al. 2011) and growth of hair among numerous others.  
Notably, the diversity in the habitats also implies that each mammal is challenged by unique 
predatory or pathogenic challenges to which they have to adapt.   For the mammalian neonate 
adaptation to the environment is packaged in the extremely divergent reproductive and 
lactation strategies observed across all the subclasses. Adaptive mechanisms that are common 
to all the three subclasses of mammals include the mother synchronising  parturition with 
favourable environmental conditions and producing energy-rich milk (Conaway 1971). The 
following is a brief account of the various mammalian reproductive and lactation strategies: 
1.1 Reproduction and lactation in monotremes 
Monotremes belong to the order Monotremata and consist of 2 families, Ornithorhynchidae, 
the duck-billed platypus and Tachyglossidae which includes echdnas.  A characteristic 
feature of the monotremes is that they are the only extant mammals in which the females lay 
eggs instead of giving birth. The egg is covered with a porous leathery shell which is capable 
of absorbing nutrients from the mother’s circulatory system (Behringer, Eakin et al. 2006) 
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during gestation and by the time it is laid it already has an embryo with well defined somites 
(Behringer, Eakin et al. 2006).  
The female reproductive system and the eggs of monotremes closely resemble the reptilian 
and avian eggs but clear differences emerge in their gestation and incubation periods 
(Dawson 1983). Monotremes have longer gestation periods than extra-uterine incubations 
whereas birds and reptiles tend to have very short periods between development of the egg in 
the ovary and laying, but have extended periods of incubation. For instance while the 
platypus egg remains in the uterus for 28 days and hatches after ten days of extra-uterine 
incubation, in the chicken the egg is laid within 1 day of production in the ovary but has to 
incubate externally for 21 days before hatching (Dawson 1983).  
There are some differences in the incubation and nursing habits among the monotremes. In 
the platypus, the egg is laid in a burrow on the side of the stream where the platypus lives and 
the young is hatched in an altricial state and is nursed by the mother which produces milk 
through pores in the abdominal skin (Holland and Jackson 2002). A major difference between 
the platypus and the echidna is that the latter has a pouch into which the egg is laid and 
incubated. Upon hatching, the young echidna remains in the pouch where it obtains milk 
from two areolae which are located on the anterior wall of the pouch (Holland and Jackson 
2002).   
1.2 Reproduction and lactation in eutherians 
Unlike monotremes all eutherians are viviparous and in the majority of them the young is 
highly precocious when it is born, often requiring the mother’s nursing and protection only in 
the first few hours post-partum. A distinguishing feature of eutherian reproduction is that 
unlike monotremes and marsupials whose zygote derives nutrition from the yolk during the 
early phases of embryogenesis, the eutherian oocyte is very small, does not have a yolk and 
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therefore the developing embryo relies entirely on nutrition through the placenta. This is 
consistent with their classification as placental mammals (Rothchild 2003).  Relative to 
marsupials and monotremes the eutherians give birth to well developed young. The eutherian 
reproductive cycle consists of hormonally-regulated development of the mammary gland, 
followed by pregnancy, varied lengths of gestation, parturition and lactation which varies in 
duration from species to species (Clutton-Brock and Harvey 1978).  The duration of gestation 
in both eutherians and marsupials is thought to be dependent on body size of the mother and 
the degree of development of the neonate at parturition hence the larger mammals have 
relatively longer gestations than the smaller sized mammals (Huggett and Widdas 1951).  
Similarly the mammals that give birth to morphologically and physiologically well developed 
young have longer pregnancies than those that give birth to poorly developed young (Rowlands 
1973, Lombardi 1998).  
Exceptions to this rule include cetaceans, hystricomorphs and the primates. Despite being 
among the largest mammals, cetaceans have a disproportionately short gestation - the blue 
whale (Balaenoptera musculus) is by far the largest extant mammal, weighing up to 180 
metric tons and has a gestation that is only 1 to 3 months longer than that of  the human 
(Lefevre, Sharp et al.). In contrast the hystricomorphs which include the relatively diminutive 
guinea pigs and chinchilla rats give birth to precocious neonates after a relatively long 
gestation. The chinchilla for instance weighs only 500g but has a gestation of 111days 
(Busso, Ponzio et al. , Weir 1973, Kuroiwa and Imamichi 1977). Primates similarly have a 
higher gestation to weight ratio than expected but unlike hystricomorphs, their young are less 
precocious and depend on maternal nursing for extended periods. 
Whatever the species-specific mode of reproductive adaptation, eutherian neonates enjoy the 
benefit of longer gestations including predator evasion, reduced energy expenditure due to 
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transfer of the burden of thermo-regulation to the mother and a buffered physiochemical 
environment (Lombardi 1998).  
Eutherian lactation is very diverse between species in regard to the timing of milk secretion 
(pre or post- partum), mammary gland morphology and frequency of suckling. Interspecies 
differences in milk composition are also evident (Medhammar, Wijesinha-Bettoni et al. 
2011). At mid lactation for instance human milk consists of 0.8% protein compared to 10.6% 
in the domestic cat. Conversely carbohydrate content in human milk is 6.8% (Coppa, 
Gabrielli et al. 1993) compared to 3.7% in cat milk.  However, the only major variation in the 
composition of eutherian milk occurs at the transition from the colostrum phase when the 
milk is concentrated (Saint, Smith et al. 1984) and rich in antibodies and antimicrobial 
proteins (Zablocka, Janusz et al. 2001), to the more dilute mature milk phase. 
In humans mammary preparation for lactation starts at the onset of pregnancy but hormone-
controlled development of milk ducts becomes evident 24 weeks after pregnancy. In the lead 
up to parturition the human mammary gland starts producing the immunoglobulin-rich 
colostrum which constitutes the first line of passive immunity conferred to the baby by the 
mother. However, before parturition production of mature milk is restricted by the presence 
of progesterone in circulation and is only initiated after birth when the level of progesterone 
declines, partly due to the ejection of the placenta (Conly, Morrison et al. 1970, Cregan, 
Mitoulas et al. 2002).  
1.3 Reproduction and lactation in marsupials 
The extreme divergence in mammalian reproduction and lactation is crystallised in the 
differences between marsupial and eutherian lactation. Compared to eutherians, marsupials 
have short gestation periods usually (lasting 26 days in tammar wallaby) (Tyndale-Biscoe, 
Hearn et al. 1974). The birth of the marsupial young happens briefly after gastrulation  
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allowing for  limited pre-parturition organogenesis (Behringer, Eakin et al. 2006) and 
therefore only organs crucial for survival peripartum are developed when the young is born 
(Basden, Cooper et al. 1997, Old and Deane 2000). A major difference between eutherians 
and macropodid marsupials is that in the eutherians pregnancy must precede lactation 
whereas in marsupials the hormonal milieu during oestrus is sufficient to initiate lactation so 
long as a suckling stimulus is provided (Sharman and Galaby 1964, Findlay 1982). 
Additionally the four mammary glands of macropodid marsupials differentiate independently 
of each other and two adjacent mammary glands can produce milk of different composition 
simultaneously (Griffiths, McIntosh et al. 1972, Green, Newgrain et al. 1980, Findlay 1982, 
Nicholas 1988, Khalil, Digby et al. 2008).   
Another distinguishing feature between  marsupial and eutherian lactation is the timing of the 
mammary proliferation phase. In eutherians mammary proliferation ceases in the early post-
partum period when peak lactation is attained and in some species even before parturition. 
For example, in mice, rats and rabbits cell proliferation continues upto 7 days post-parturition 
(Cowie, Forsyth et al. 1980). In contrast, in macropodid marsupials mammary growth 
(mediated by mitotic proliferation) appears to continue through the latter phases of lactation. 
However this sustained increase in the size of mammary gland has been a subject of debate 
(Tyndale-Biscoe 1987) as it was initially thought to be caused purely by the hypertrophic 
distension of mammary alveoli due to increased milk secretion (O'Donoghue 1911, Tyndale-
Biscoe 1987). Later studies by Stewart, F. (Stewart 1984) however showed that mitotic cell 
division as well as hypertrophic distension contribute to the increase in mammary size during 
late lactation. Stewart measured DNA concentration in tammar wallaby mammary glands at 
days 140 and 240 lactation and found that although the volume of the mammary gland  at day 
240 was much higher than day 140, the DNA concentration was unchanged implying that 
there was a marked increase in cell numbers during peak lactation.   
  
7 
 
Due to their relatively short gestation, marsupial neonates are deprived of the advantages of 
long embryo retention including the transfer of the cost of thermo-regulation to the mother 
and the benefits of the pathogen-sequestered environment of the placenta, both of which are 
enjoyed by eutherian neonates (Lombardi 1998). Consequently the marsupials make a 
significantly higher investment than eutherians in postnatal development during lactation. 
Not surprisingly, while the composition of eutherian milk remains constant after the 
colostrum phase (Schmidt 1971, Jenness 1974), marsupials progressively alter the milk 
composition throughout lactation in order to meet the developmental and nutritional needs of 
the young (Green, Newgrain et al. 1980, Nicholas, Hartmann et al. 1981, Nicholas 1988, 
Nicholas, Fisher et al. 2001, Trott, Simpson et al. 2003, Lefevre, Digby et al. 2007, Khalil, 
Digby et al. 2008, Kwek, Iongh et al. 2009). 
1.4 Lactation in wallaby 
Tammar lactation is divided into four phases (figure 1). The gestation phase (P1) lasts 
approximately 26 days culminating in the birth of a fetus-like young (Renfree 1981, Tyndale-
Biscoe 1987, van Oorschot and Cooper 1988). During P1 all the four mammary glands 
undergo progressive lobulo-alveolar development, gradually replacing the connective tissue 
with glandular tissue (Findlay 1982). Phase 2A (P2A) starts at parturition when the neonate,  
although extremely altricial, has motile capability and crawls from the cloaca to one of the 
four teats to which it attaches permanently for approximately 100 days post-partum (Tyndale-
Biscoe 1987, Nicholas 1988, Old and Deane 2000, Behringer, Eakin et al. 2006, Brennan, 
Sharp et al. 2007). Once the pouch young starts sucking, the other three mammary glands 
regress and become quiescent (Daly, Digby et al. 2007). During P2A the mother produces 
relatively small volumes of dilute milk that is rich in carbohydrates but low in protein and 
lipid (Nicholas 1988, Hendry, Simpson et al. 1998, Trott, Simpson et al. 2003) (figure 1). A 
notable feature of neonatal development during P2A is that the growth and development of 
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the brain occurs at a remarkably high rate compared to other organs (Renfree, Holt et al. 
1982).  
Phase 2B (P2B) commences 100-120 days post-partum and continues for approximately 100 
days during which the neonate remains in the pouch but relinquishes the teat and only re-
attaches to suck (Hendry, Simpson et al. 1998, Trott, Simpson et al. 2003). Similar to P2A the 
milk produced during P2B is dilute and high in carbohydrates but low in protein and lipids. 
Unlike P2A however, neonatal brain growth slows down during P2B (Renfree, Holt et al. 
1982) and instead the development of organ systems required for survival outside the pouch 
is accelerated. For instance at around day 140 post-partum the eyes open thereby enabling 
vision, by day 160 the PY can stand on its own and by day 180 the thyroid gland is functional 
and therefore neonatal thermoregulation is possible (Renfree, Holt et al. 1982).    
At the onset of phase 3 (P3), the neonate ventures out of the pouch and feeds on herbage, 
only returning to the pouch infrequently to suckle. During P3 the mammary gland enlarges 
significantly (Bird, Hendry et al. 1994), producing large amounts of concentrated milk that is 
rich in protein and lipid but low in carbohydrates (Tyndale-Biscoe 1987, Nicholas, Simpson 
et al. 1997, Hendry, Simpson et al. 1998, Trott, Simpson et al. 2003). P3 also represents the 
period of most dramatic change in morphology and growth of the young including the switch 
from ectothermic to endothermic regulation of body temperature (Nicholas 1988, Nicholas, 
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Simpson et al. 1997, Richardson, Aldred et al. 2002). 
 
Figure 1. 
 
Progressive changes in milk production, milk composition and growth of the young during 
the three phases of the lactation cycle in the tammar wallaby (Nicholas, Simpson et al. 1997, 
Brennan, Sharp et al. 2007). 
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Table 1: Comparison of milk protein, fat and carbohydrate content in mammals 
 
Protein (g) Fat (g) Carbohydrate (g) Energy (kcal) 
Cow 3.2a 3.7 a 4.6 a 66 a 
Human 1.1 a 4.2 a 7 a 72 a 
Water Buffalo 4.1 a 9 a 4.8 a 118 a 
Goat 2.9 a 3.8 a 4.7 a 67 a 
Donkey 1.9 a 0.6 a 6.1 a 38 a 
Elephant 4 a 5 a 5.3 a 85 a 
Monkey, rhesus 1.6 a 4 a 7 a 73 a 
Mouse 9 a 13.1 a 3 a 171 a 
Whale 10.9 a 42.3 a 1.3 a 443 a 
Seal 10.2 a 49.4 a 0.1 a 502 a 
Tammar 
wallaby (P2A) 4
b 15c 12 c 238 c 
Tammar 
wallaby (P3) 13
b 26 c 3.5 c 333 c 
 
a:  Webb, B.H., A.H. Johnson and J.A. Alford. 1974. Fundamentals of Dairy Chemistry. 
Second Ed. AVI Publishing Co., Westport, CT., Chap. 1. 
b: B. Green, K. Newgrain and J. Merchant, Aust. J. Bioi. Sci., 1980, 33, 35-42 
c: Robert KA, Braun S (2012). PLoS ONE 7(11): e51099. Doi:10.1371/journal.pone. 
0051099 
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1.4.1 Carbohydrates 
Similar to eutherian milk (Kunz, Rudloff et al. 2000), the main carbohydrate in tammar milk 
at parturition is lactose (Green, Newgrain et al. 1980). However at around day 6 postpartum 
and for the rest of P2A and P2B lactose becomes less prominent and is replaced by complex 
oligosaccharides in the form of galactosyllactoses, [Gal(β-3)]nGal(β-4)Glu,which at this 
stage of lactation constitute  as high as 50% of the total solids in tammar milk (Green, 
Newgrain et al. 1980, Nicholas 1988, Menzies and Nicholas 2007). The large increase in 
oligosaccharides is attributable to the increased expression of the genes for the anabolic 
enzymes such as β-1,3 galactosyltransferase (3βGalT) and β-1,4 galactosyltransferase 
(4βGalT) which catalyse the transfer of galactose to lactose (Messer and Green 1979, Messer 
and Nicholas 1991, Menzies and Nicholas 2007). It has been suggested that prior to day 6 
postpartum the gut of the PY may not have started secreting the enzymes needed to digest the 
oligosaccharides hence the mother secretes milk that is rich in lactose instead of 
oligosaccharides (Messer and Green 1979, Messer and Nicholas 1991). Presumably once the 
neonate’s gastro-intestinal system acquires the ability to metabolise the complex sugars, the 
mother starts secreting milk that is high in oligosaccharides thereby delivering high energy 
milk to the PY without increasing its osmolarity (Messer and Elliott 1987). 
Marking the transition from phase 2B to P3 there is a drastic decrease in total hexose in 
tammar milk (Messer and Green 1979, Green, Griffiths et al. 1983, Nicholas 1988). 
Additionally the level of complex oligosaccharides decreases significantly, coincident with 
increased activity of UDP-galactose hydrolase (Messer and Nicholas 1991) and instead the 
major carbohydrates are the monosaccharides glucose and galactose (Messer and Green 1979, 
Green, Griffiths et al. 1983). By this time the neonate will have acquired an adult-like kidney 
function and is able to metabolise concentrated milk of high osmolarity. 
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1.4.2 Lipids 
The lipid content in tammar milk is represented mainly by triacylglycerols (Green, Griffiths 
et al. 1983, Kwek, Wijesundera et al. 2007) but the fatty acyl content is temporally regulated. 
During P2A palmitic acid (C16:0) is the predominant fatty acid in milk triacylglycerols but its 
level decreases by day 70 of lactation coincident with an increase in oleic acid (C18:1). 
Observations from an in-vitro model using mammary explants from days 20-24 pregnant 
wallabies showed that although mammary epithelial cells can synthesize lipid when media is 
supplemented with insulin alone, secretion of lipid into the lumen can only happen when 
prolactin is included (Kwek, Wijesundera et al. 2007) suggesting that lipid content in milk is 
under hormonal control. Further, in this explant model, in the absence of prolactin the cells 
secreted more oleic acid than palmitic acid but on addition of prolactin, palmitic acid was the 
predominant fatty acid. Since palmitic acid is a constituent fatty acid of a major surfactant 
(R.V. Baudinette 1988) in the lung, its synthesis in P2A may suggest that it is required in the 
development of the respiratory system. Similarly, oleic acid, a precursor of nervonic acid 
which is required for the formation of myelin (Sargent, Coupland et al. 1994) may be crucial 
in brain development of the neonate (Kwek, Wijesundera et al. 2007).  
1.4.3 Protein – phase specific markers and their possible roles 
All the four major milk proteins β-lactoglobulin, α-lactalbumin, α-casein and β-casein are 
present in tammar milk at parturition (Trott, Simpson et al. 2003, Joss, Molloy et al. 2009) 
and remain throughout lactation. However at the onset of P3 the expression of the β-
lactoglobulin and β-casein genes increases significantly while the expression of α-
lactalbumin and α-casein genes remains unaffected (Bird, Hendry et al. 1994). A noteworthy 
feature of P2A is that at parturition the activity of beta-1,3 galactosyltransferase (3βGalT) an 
enzyme that catalyses the formation of oligosaccharides is undetectable but its activity 
increases six-fold by day 10 post-partum and its activity is dependent on the sucking stimulus 
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of the neonate. A similar enzyme beta-1,4 galactosyltransferase is detectable on d1L but its 
activity also increases 3-fold by day 10 post-partum (Menzies and Nicholas 2007). Since the 
expression of 3βGalT has been shown to be inducible by lactogenic hormones in mammary 
explants extracted from pregnant wallabies, the increase in milk oligosaccharides is likely to 
be regulated by hormones and factors intrinsic to the mammary gland (Menzies and Nicholas 
2007). The switch to P3 signals a decline in 3βGalT and up-regulation of UDP-galactose 
hydrolase which hydrolyses UDP-galactose thereby inhibiting the formation of 
oligosaccharides (Messer and Nicholas 1991).  
1.5 Phase specific markers of tammar lactation 
1.5.1 Phase 2A 
In addition to the differential expression of the enzymes involved in oligosaccharide 
metabolism, each of the three post-parturition phases of tammar lactation is characterised by 
the expression of phase-specific proteins (Nicholas 1988, Nicholas, Simpson et al. 1997, 
Trott, Wilson et al. 2002, Trott, Simpson et al. 2003, Menzies and Nicholas 2007) (figure 2). 
P2A is characterised by the expression of the gene for the early lactation protein (tELP) 
(Simpson, Shaw et al. 1998, Trott, Simpson et al. 2003, Khalil, Digby et al. 2008), P2B by 
the expression the gene for the whey acidic protein (tWAP) (Simpson, Ranganathan et al. 
2000, Nicholas, Fisher et al. 2001) and P3 by the expression of the gene for the Late lactation 
protein (LLP-B) (Trott, Wilson et al. 2002, Trott, Simpson et al. 2003).   
The 18kDa tELP is a member of the Kunitz family of protease inhibitors and shares 37% 
homology with the bovine colostrum trypsin inhibitor (Simpson, Shaw et al. 1998, Pharo, De 
Leo et al. 2012). The expression of tELP stops when the PY relinquishes the teat for the first 
time and switches from being permanently attached to the teat to intermittent re-attachment 
for feeding (Simpson, Shaw et al. 1998). Although the physiological role of tELP still 
remains unclear, it has been suggested that its expression in early lactation is a safeguard 
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against proteolytic degradation of immunoglobulins (Ig) in the milk (Simpson, Shaw et al. 
1998). A relationship indeed exists between both bovine (Pineiro, Brock et al. 1978) and 
porcine (Jensen and Pedersen 1979) colostrum trypsin inhibitor and the Ig content of milk 
suggesting that tELP may play an immunological role when the PY is most vulnerable to 
infection. 
1.5.2 Phase 2B 
Once the PY relinquishes the teat the expression of the gene for the whey acidic protein 
(tWAP), a member of the four-disulphide core (4-DSC) domain family of proteins 
commences and remains up-regulated until the PY vacates the pouch (figure 2). The gene for 
tWAP consists of three 4-DSC’s instead of two 4-DSC’s found in eutherians (Nicholas, 
Simpson et al. 1997, Simpson, Ranganathan et al. 2000, Demmer, Stasiuk et al. 2001, 
Nicholas, Fisher et al. 2001). Similar to tELP, tWAP is a putative protease inhibitor but its 
predicted active site has no similarity with the active sites of known protease inhibitors 
(Simpson, Ranganathan et al. 2000).  
Since tWAP is a multi-domain protein it is feasible that it plays various roles in lactation and 
a three dimensional model of tWAP has indeed shown that its three 4-DSC’s have no 
molecular interaction with each other and are likely to act autonomously (Simpson, 
Ranganathan et al. 2000). Since the expression of the tWAP gene is at its peak when the PY 
starts developing fur and coincides with an increase in the milk content of sulphur-rich amino 
acids (Renfree, Meier et al. 1981, Simpson, Ranganathan et al. 2000) which have been 
associated with hair growth, it has been suggested that tWAP may be necessary for hair 
growth. Cell proliferation assays performed by measuring DNA synthesis and the expression 
level of cell-cycle regulators cyclin-D1 and CDK4 in mouse mammary cells (HC11) and 
wallaby mammary epithelial cells (WallMECs) have shown that domain III (DIII) of tWAP 
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enhances cell proliferation (Topcic, Auguste et al. 2009). These findings are particularly 
significant because peak tWAP secretion in milk occurs between d172L and d202L 
(Simpson, Ranganathan et al. 2000) when the mammary starts enlarging in the lead up to the 
exit of the neonate from the pouch and its subsequent consumption of large volumes of milk 
(Nicholas, Simpson et al. 1997). More recently, domain II of WFDC2, another 4-DSC family 
member was found to have antimicrobial activity against Staphylococcus aureus, a known 
agent of mastitis but no such activity against Enterococcus faecalis, a commensal of the gut, 
leading to the suggestion that it provides antimicrobial protection to the mother’s mammary 
gland while preserving the balance of the gut microflora (Watt, Sharp et al. 2012).  
1.5.3 Phase 3 
Overlapping with the expression of tWAP (figure 2) from around 26 weeks post partum is 
another developmentally regulated protein, the late lactation protein-A (LLP-A) which bears 
similarity to the lipocalin family of proteins (Trott, Wilson et al. 2002). Although it is well 
established that protein content, especially whey proteins increases dramatically at the onset 
of P3 (Green, Newgrain et al. 1980) it is intriguing that close to half of that increase is 
contributed by LLP-A which reaches a peak concentration of 26g/l between 36 and 40 weeks 
post partum (Nicholas, Messer et al. 1987). The timing of the secretion of LLP-A in milk 
with the shift from a purely milk diet to a combination of milk and herbage by the PY its 
relatively high concentration in milk suggests that LLP-A could play an anti-toxin role or a 
simple dietary role.  
LLP-A shares 48% amino acid homology with another lipocalin-like protein, the late 
lactation protein (LLP-B) whose secretion in milk is detectable from d200L and remains until 
weaning (Trott, Wilson et al. 2002). Both LLP-A and LLP-B have been shown to be 
regulated by the hormones cortisol, insulin and prolactin (Trott, Wilson et al. 2002, Trott, 
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Adams et al. 2005) and can only be expressed in mature alveoli (Trott, Wilson et al. 2002). 
Given their prominence in marsupial milk (Nicholas, Messer et al. 1987, Trott, Wilson et al. 
2002, Trott, Simpson et al. 2003) and absence in eutherian milk these proteins are likely to 
play roles other than nutrition that are unique to marsupial lactation and therefore a need 
exists to investigate their role in neonatal development. 
 
 
Figure 2. 
Differential expression of the major milk proteins during tammar lactation (Nicholas, K.) 
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1.6 Immunological molecules  
At parturition tammar PY have no functional immune system and only acquire adult-like 
immune mechanisms in late P2B when they are about to exit the pouch (Deane 1988, Basden, 
Cooper et al. 1997, Baker, Belov et al. 2005). The PY is therefore dependent on the delivery 
of immune factors through the milk for protection against pathogens which exist in the pouch 
(Old and Deane 1998) and the wallaby habitat. Accordingly, two periods of immune transfer 
from the mother to the neonate characterised by a dramatic increase in the expression of 
immunoglobulin genes in the mammary gland have been observed in tammar (Daly, Digby et 
al. 2007). The first period of increased expression of Ig’s occurs a few hours after parturition 
while the second one occurs just prior to the first exit of the pouch by the neonate, the two 
periods of greatest vulnerability to pathogens by the PY. Importantly, not only are all the 
major Ig’s including IgA, IgG, IgM, IgE, Igκ and Igλ upregulated but also the chemokine 
CCL28 which facilitates epithelial uptake of IgA (Wilson and Butcher 2004) and the IgG 
receptor FcRn (Adamski, King et al. 2000, Western, Eckery et al. 2003) Similar periods have 
been reported in another marsupial, the brushtail possum (Trichsurus vulpecula) (Adamski 
and Demmer 1999, Adamski and Demmer 2000, Adamski, King et al. 2000).  
Notably, although immune transfers are well known in eutherians, they only happen in the 
colostrum phase after which the gastrointestinal epithelium closes and becomes impervious to 
Ig’s (Morris 1964, Kolb 2002). In contrast marsupial neonates including the tammar PY are 
capable of immunoglobulin absorption across the gastro-intestinal barrier throughout 
lactation (Yadav 1971, Daly, Digby et al. 2007). The tammar lactation model therefore 
presents unique opportunities to understand the role of passive immunity in neonatal 
development.  
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1.7 Anti-microbial and developmental proteins 
Using a complex set of proteomics tools including the matrix assisted laser desorption 
ionisation mass spectrometry (MALDI MS) and de novo peptide sequencing, a mix of 
proteins associated with various functions including antimicrobial defence, growth and 
development have been identified in milk (Joss, Molloy et al. 2009). The study by Joss et al 
identified lactoferrin, complement B protein, haptocorrin, amphiphysin and the myeloid 
cathelicidin among other proteins, all of which were developmentally regulated. Lactoferrin 
and cathelicidin are well known antimicrobial proteins while haptocorrin has also been shown 
to have bactriocidal activity against E.coli (Adkins and Lonnerdal 2003) and all of them were 
expressed in P2A and P2B (Joss, Molloy et al. 2009). Amphiphysin which plays a role in 
endocytosis (Butler, David et al. 1997) was found in d172L – d250L milk while complement 
B protein which plays a role in pathogen opsonisation (Peters, Ambrus et al. 1988) was 
detected in P2B.  
1.7.1 Cathelicidins 
Cathelicidins are a well studied family of antimicrobial proteins found in a wide variety of 
vertebrates (Zanetti, Gennaro et al. 1995, Boman 1998, Hancock and Lehrer 1998, Lehrer and 
Ganz 1999, Zasloff 2002). Together with many other cationic amphiphilic peptides 
collectively known as host-defense peptides (Hancock, Brown et al. 2006, Nijnik and 
Hancock 2009), cathelicidins represent a significant constituent of innate immunity in 
mammals and display a remarkably broad spectrum anti-pathogenic activity, a single 
cathelicidin often showing activity against bacteria, fungi and viruses (Ramanathan, Davis et 
al. 2002). 
The generic primary structure of cathelicidins includes four exons (Gudmundsson, 
Magnusson et al. 1995, Zhao, Ganz et al. 1995, Gudmundsson and Agerberth 1999), the first 
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three of which consist of the 22-35 amino acid N-terminal signal peptide and the cathelin-like 
region which covers 90-115 amino acids (Yang, Biragyn et al. 2004). The fourth exon 
consists of the variable C-terminal anti-microbial domain preceded at its N-terminal by a 
species-specific protease cleavage site (Zanetti, Litteri et al. 1991, Gudmundsson, Agerberth 
et al. 1996). Due to the variability in the amino acid composition of the antimicrobial region 
of cathelicidins their structural conformation also varies between species, often existing in α-
helical (Hirata, Shimomura et al. 1994), extended α-helical (Cabiaux, Agerberth et al. 1994) 
and β-sheet conformations (Fahrner, Dieckmann et al. 1996). All cathelicidins however share 
a net positive charge of 2-9 and a high percentage of hydrophobic residues. This mix of 
cationic and hydrophobic residues confers amphipathic properties to cathelicidins upon which 
their antimicrobial activity is dependent (Hancock and Lehrer 1998, Zasloff 2002). Although 
the mechanism by which cathelicidins kill their targets is not very well understood, its 
consensual that amphipathic interactions with pathogen membranes play a major role 
(Hancock and Lehrer 1998).  
In tammar seven cathelicidin genes MaeuCath1-7 have been identified and found to posses 
the generic cathelicidin features including the signal peptide, a middle cathelin-like region, a 
valyl130 elastase cleavage site (Zanetti 2004) and a hydrophobic C-terminus (Daly, Digby et 
al. 2007, Lefevre, Digby et al. 2007). The putative antimicrobial region of all the MeauCaths 
was rich in arginine and lysine, accounting for 38.9% and 22.9% of the amino acid residues 
in MaeuCath1 and MaeuCath3 respectively, implying that they are likely to form a strongly 
amphipathic interaction with membranes.  
Although cathelicidins are mostly associated with neutrophils where they are stored in 
granules (Ramanathan, Davis et al. 2002), constitutive expression of cathelicidin genes has 
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been reported in various mammalian tissues including kidney, liver and lymphoid organs 
(Bals, Wang et al. 1998, Wu, Zhang et al. 1999) where they perform different functions.  
The sequence heterogeneity of the antimicrobial domain between species has been proposed 
to be an adaptation to the extremely diverse pathogenic challenge for the various host 
animals. This point of view gains credence from the tendency in mammals to have more than 
one cathelicidin gene (Castiglioni, Scocchi et al. 1996, Wu, Zhang et al. 1999, Daly, Digby et 
al. 2007, Wang, Wong et al. 2011), each presumably targeting different microbes.  There is 
increasing evidence however to show that apart from their antimicrobial role, cathelicidins 
play significant physiological roles in mammals (Yang, Biragyn et al. 2004). Cathelicidins 
have been shown to play chemotactic roles (Huang, Ross et al. 1997, Agerberth, Charo et al. 
2000), neutralise endotoxins (Golec 2007), enhance re-epithelialisation of dermal wounds 
(Yang, Biragyn et al. 2004) and modulate angiogenesis (Li, Post et al. 2000).   
One of the earliest developmental pointers to the role of cathelicidins in neonatal 
antimicrobial defence is the presence of cathelicidins in vernix caseosa, the lipid-rich 
substance that covers a new-born baby and which is thought to have antimicrobial properties 
(Haubrich 2003, Tollin, Bergsson et al. 2005, Visscher, Narendran et al. 2005). In tammar 
one cathelicidin gene, MaeuCath1 has been shown to be expressed in the spleen, liver, skin, 
bone marrow, thymus and gut of the pouch young (Daly, Digby et al. 2007, Lefevre, Digby et 
al. 2007) and the adult mammary gland (Lefevre, Digby et al. 2007, Khalil, Digby et al. 
2008). The secretion of cathelicidins in milk (Joss, Molloy et al. 2009) therefore must raise 
questions as to whether milk performs multiple roles in the young and perhaps the mammary 
environment of the mother.  
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Figure 3. 
Generic primary structure of cathelicidins and known domain functions.  The variable region 
is not drawn to scale (Yang, Biragyn et al. 2004) 
1.8 Hormonal control of lactation 
Both the development and function of the mammary gland in all mammals is under hormonal 
control, the only major difference between species being the requirement of the individual 
hormones in the various phases of mammary development and function (Topper and Freeman 
1980). There is consensus that from embryonic mammary development up to and including 
lactogenesis, different combinations of the hormones  insulin (I), progesterone (pg), 17-β-
estradiol (E2), androgen, cortisol, thyroid hormones (T3 and T4), growth hormone (GH), 
choriomammotropin and prolactin (P) must be present (Topper and Freeman 1980) .  
1.8.1 Progesterone 
Progesterone has been associated with the overt differentiation of the mammary epithelium  
in early pregnancy that is necessary for alveolar growth. Studies in pubertal mice showed that 
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progesterone may initiate differentiation by sensitizing epithelial cells to insulin (Topper and 
Freeman 1980) which in addition to its metabolic regulatory role is required for mammary 
epithelial cell differentiation. Progesterone is well known for its role as a negative modulator 
of lactogenesis in several mammalian species since its circulating levels remain high during 
pregnancy but decline sharply at parturition when secretion of milk is initiated (Kuhn 1977, 
Topper and Freeman 1980, Nicholas, Simpson et al. 1997). However, this role remains a 
subject of dispute since the administration of progesterone after the induction of lactation 
neither diminishes lactation nor down-regulates the expression of individual milk proteins 
(Topper and Freeman 1980, Nicholas and Tyndale-Biscoe 1985). In eutherians, this 
diminished response of the lactating mammary gland to progesterone treatment has been 
attributed to decreased expression of the progesterone receptor (PR) during lactation (Topper 
and Freeman 1980, Shyamala, Schneider et al. 1990) but it is not clear whether PR expression 
affects marsupial lactation in a similar way.  Further, in a rat explant culture progesterone 
appeared to have prolactational properties, inducing the expression of alpha-lactalbumin in 
explants from virgin mammary glands (Nicholas, Sankaran et al. 1981). Whether or not 
progesterone inhibits lactation, at least it is evident that while it is physiologically relevant 
during pregnancy, it becomes redundant during lactation and its synthesis either stops or it is 
rapidly converted to 20α-hydroxyprogesterone (Ray, Averill et al. 1955, Wiest, Kidwell et al. 
1968, de la Llosa-Hermier, Leboulleux et al. 1983, Farina, Ribeiro et al. 2004). 
1.8.2 Prolactin 
Prolactin is the only hormone without which lactation cannot proceed whether in-vivo or in-
vitro in most mammalian species (Topper and Freeman 1980, Nicholas and Tyndale-Biscoe 
1985, Cregan, Mitoulas et al. 2002). Although the combination of cortisol, insulin and 
prolactin has been shown to be required for lactogenesis in vivo (Bird, Hendry et al. 1994) 
experiments using wallaby mammary explants showed that accumulation of the milk protein 
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α-lactalbumin can be achieved in-vitro in the absence of extraneous insulin and cortisol as 
long as prolactin was available at physiological concentrations (Nicholas and Tyndale-Biscoe 
1985). Intriguingly, in the wallaby the level of prolactin does not change significantly 
peripartum (K. R. Nicholas 1995) raising questions of whether the endocrine system only 
triggers lactogenesis but sustained lactation requires both hormones and autocrine factors 
intrinsic to the mammary gland. Indeed factors apart from the endocrine system, including 
the sucking stimulus provided by the neonate and endocrine-independent maternal control 
have been investigated (Bird, Hendry et al. 1994, Nicholas, Simpson et al. 1997, Hendry, 
Simpson et al. 1998).  
1.8.3 Estradiol  
Immediately before parturition, the circulating concentration of eastradiol (E2) increases 
(Yoshinaga, Hawkins et al. 1969, Hori, Ide et al. 1970, Horikoshi and Wiest 1970) leading to 
the suggestion that E2 may play a role in post parturition MEC proliferation in preparation for 
milk production. In tammar, 8-12hr postpartum there is an increase in circulating E2 
presumably in order to initiate ovulation (Tyndale-Biscoe, Hinds et al. 1983, Harder, Hinds et 
al. 1985). Similar to progesterone however, the role of E2 in mammary function may be 
limited to pre-parturition morphogenesis and MEC differentiation since ovariectomy does not 
have a profound effect on lactation in a variety of species (ref). Treatment of pubertal mice 
with a combination of growth hormone (GH) and E2 has indeed been shown to enhance 
ductal morphogenesis. 
1.8.4 Growth Hormone  
Growth hormone (GH) has been reported to promote the development and functional 
differentiation of mammary tissue during the lactation cycle of mammals of all classes 
(Forsyth 1986). In lactating  women GH  promotes galactopoiesis (Milsom, Breier et al. 
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1992) and in mice it has been shown to stimulate lobulo-alveolar growth in anterior pituitary-
ablated mice suggesting that GH may play a supplementary role to pituitary hormones in 
mammary morphogenesis.  
1.8.5 Insulin in lactation 
The array of target organs and tissues on which insulin exerts its regulatory effects includes 
the majority of mammalian tissues, the most studied among them being the skeletal muscle 
where insulin stimulates glucose up-take and metabolism and the adipose tissue where it 
plays a role in lipid metabolism (Dent, Lavoinne et al. 1990). In the mammary gland, studies 
have shown that the expression of milk protein genes by epithelial cells responds to insulin 
depending on the stage of the lactation cycle. In mice, MEC’s from virgin animals are 
insensitive to insulin but during pregnancy they get sensitized and remain responsive 
throughout lactation. Upon milk stasis they revert to their insensitive state (Oka, Perry et al. 
1974) thereby highlighting the significance of insulin signalling in milk synthesis. Studies on 
tammar mammary explant cultures of tissues from late gestation showed that in order for the 
tissue to express the full complement of milk proteins insulin must be supplied (K. R. 
Nicholas 1995). Interestingly the responsiveness of mammary epithelial cells to insulin 
appears to be independent of insulin receptors since no significant difference has been 
observed in the capacity to bind insulin between cells from virgin and pregnant animals 
(Topper and Freeman 1980) implying that the effect of insulin may be mediated by post-
receptor mechanisms.  
1.8.6 Cortisol 
Although cortisol is required for optimal ductal branching in the virgin state and inter-ductal 
alveolar formation during pregnancy, both these activities have been shown to proceed albeit 
not optimally in the absence of the hormone (Topper and Freeman 1980). In the mouse, 
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cortisol has been shown to enhance the formation of the rough endoplasmic reticulum (RER). 
In the wallaby, the lactogenic effect of prolactin seems to be dependent on cortisol and 
insulin and a combination of the three hormones is required for the expression of the full 
complement of milk proteins (Renfree 1984, Nicholas, Simpson et al. 1997). Just like insulin, 
no significant change in circulating cortisol has been shown to accompany the post-
parturition increase in milk production.  
1.8.7 Placental lactogen 
Similar to prolactin and growth hormone, placental lactogen (PL) is a protein hormone, 
secreted during pregnancy, that stimulates mammary development and mammary functional 
differentiation and regulates the metabolic activity of the mother during pregnancy and 
lactation. However, unlike prolactin and growth hormone, PL appears to be very selectively 
expressed across mammalian species since bioassay and radioreceptor based detection 
systems failed to identify PL in several species including horses, armadillos, pigs, dogs, 
rabbits and the shrews (Forsyth 1986).  
Although in humans and other eutherian species PL has been shown to functionally mimic 
prolactin (Josimovich, Atwood et al. 1963, Handwerger and Freemark 1987) and may play a 
crucial role in galactopoiesis, it is unlikely that PL plays similar roles in marsupial lactation 
since mammary gland development and milk secretion appear to proceed normally in the 
absence of pregnancy (Tyndale-Biscoe 1987). 
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Figure 4. 
Schematic diagram showing endocrine regulation of mammary gland development (Brisken C , 
O’Malley B Cold Spring Harb Perspect Biol 2010;2:a00317) 
 
1.9 Asynchronous concurrent lactation 
An intriguing feature of tammar lactation and other macropodid marsupials is that the nursing 
mother is capable of what is known as asynchronous concurrent lactation (Tyndale-Biscoe 
1987, Nicholas 1988, K. R. Nicholas C.J.W 1995, Nicholas, Simpson et al. 1997). At any one 
time during lactation the wallaby can have a dormant blastocyst and at the same time initiate 
two concurrent lactations from adjacent mammary glands in order to feed a newly born 
young and an older sibling at heel simultaneously (Hendry, Simpson et al. 1998). The pouch 
young feeds on P2A milk produced in the smaller mammary gland while the older sibling 
feeds on  P3 milk secreted in the much larger mammary gland (Nicholas 1988). Several 
mechanisms have been suggested for ACL all of which agree that the mammary glands 
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function independently of each other (Nicholas, Simpson et al. 1997, Trott, Simpson et al. 
2003).  
A study in the agile wallaby (Macropus agilis) (Lincoln and Renfree 1981) showed 
differences in sensitivity to oxytocin between the two mammary glands, the P2 mammary 
gland being more sensitive than the P3 mammary gland. This study therefore suggested that 
while the P2 mammary gland is able to respond to mild sucking stimulus of the PY, the P3 
gland needs more aggressive sucking provided by the young at heel in order to secrete milk 
thereby explaining why the larger gland does not produce milk continuously despite the 
perpetual stimulation of the other gland by the permanently attached PY. The study in 
M.agilis therefore concluded that ACL is regulated by the sucking of the young. Later studies 
however revealed that ACL not only involves differences in milk volumes but also significant 
differences in the milk composition of the two mammary glands (Lincoln and Renfree 1981, 
Nicholas 1988). Further a study in which the intensity of the sucking stimulus was kept 
constant by repeatedly  (every 14 days) fostering 60 day old PY for up to 56 days revealed 
that the sucking pattern of the young had no effect on milk composition and that the suckled 
mammary glands progressed to later phase phenotype independent of the sucking stimulus 
(Trott, Simpson et al. 2003).    
Whatever the mechanism, gaining insight into the regulation of ACL has a great potential in 
improving our understanding of factors intrinsic to the mammary gland which regulate 
mammary epithelial cell function and lactation. Because of the established roles of the 
extracellular matrix (ECM) in the mammary gland, this study investigates the potential role 
of the ECM in regulation ACL. 
1.10 The extracellular matrix 
The extracellular matrix (ECM) is the complex mesh of proteins that constitute the 
substratum on which cells rest (Bissell and Barcellos-Hoff 1987). Secreted by various cell 
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types including fibroblasts, adipocytes, endothelial, myoepithelial and epithelial cells 
(Jalkanen, Rapraeger et al. 1988, Ekblom, Lonai et al. 2003, Kalluri 2003), the ECM has been 
viewed as an extension of the cell into its environment and a conduit through which structural 
and biochemical signals are relayed (Bissell and Barcellos-Hoff 1987).     
Since it was first demonstrated that mammary epithelial cells cultured on salivary 
mesenchyme underwent morphological changes to resemble the salivary gland (Kratochwil 
1969, Kratochwil 1971) a large body of evidence has accumulated to show that the stromal 
environment and particularly ECM regulates the function of tissue specific cells of various 
organs including the mammary gland.  For instance it was discovered that when 
mesenchymal stem cells were cultured on matrices which mimic the stiffness of brain, muscle 
and bone they differentiate into neuronal, myoblast, and osteoblast lineages respectively 
implying that lineage determination may be dependent on the substratum on which the cells 
attach (Engler, Sen et al. 2006). Similarly, in the mouse model milk protein gene expression 
is induced when MECs are cultured on floating collagen gels whose elasticity is comparable 
to the stiffness of the mammary gland but not attached collagen gels which are significantly 
stiffer (Lee, Parry et al. 1984, Alcaraz, Xu et al. 2008) -  mouse  β-casein is expressed in cells 
growing on floating collagen gel and fixed Engelbreth-Holm-Swarm (EHS) matrices but the 
WAP gene does not express (Lin, Dempsey et al. 1995). In contrast  Type IV collagen and 
fibronectin have no effect on beta-casein expression and heparan sulfate proteoglycan, 
increased transcription of the β-casein gene but did not induce secretion of the protein (Li, 
Aggeler et al. 1987).  
Against the backdrop of these observations and evidence gained from various in-vitro 
mammary epithelial cultures Bissel et al have proposed a dynamic and reciprocal relationship 
between epithelial cells and the ECM. Thus, when a cell comes in contact with ECM, 
biomechanical and biochemical signals are transduced through ECM receptors on the surface 
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of the cell to the nucleus resulting in dramatic re-organisation of the cytoskeleton and 
chromatin structures (Xu, Boudreau et al. 2009). This cascade of signalling events leads to 
changes in gene expression patterns in the epithelial cell resulting in the secretion of new 
molecules into the ECM thereby altering the biochemical and biophysical properties of the 
ECM, in effect initiating another signalling cycle (Bissell, Hall et al. 1982, Bissell and 
Aggeler 1987, Xu, Boudreau et al. 2009).  
ECM constituent proteins are differentially expressed according to the reproductive state and 
co-regulated with the matrix metalloproteases (MMP’s) which degrade the ECM and the 
tissue inhibitors of metalloproteases (TIMP’s) which inhibit the MMP’s (Schedin, Mitrenga 
et al. 2004) and have collectively been associated with histogenic  functions including, 
mammary gland morphogenesis, pubertal ductal branching, lobulo-alveolar formation, 
lactation and involution (Bissell, Hall et al. 1982, Schedin, Mitrenga et al. 2004). More 
specifically ECM proteins have been associated with basal/apical polarity of epithelial cells 
(Paszek, Zahir et al. 2005) and differentiation of mesenchymal stem cells (Engler, Sen et al. 
2006), apoptosis, cell survival and proliferation (Butcher, Alliston et al. 2009, Provenzano, 
Inman et al. 2009). In the developing mouse mammary gland, individual ECM proteins are 
expressed at specific sites. For example glycosaminoglycans (GAGs) are predominantly 
expressed on the basal surface of the end bud, while chondroitin sulfate is most abundant in 
the non-proliferating end bud flank (Silberstein and Daniel 1982). In the cap region where 
active proliferation is required for penetration during ductal branching,  hyaluronate is the 
predominant ECM protein (Williams and Daniel 1983). 
 Apart from the major ECM proteins including, laminins, fibronectin, collagens, nidogens and 
tenascins, the ECM is rich in growth factors which are found cross-linked with ECM proteins 
by transglutaminases (Nunes, Gleizes et al. 1997). Similarly cytokines are found in the ECM 
where they are linked to ECM proteins via glycosaminoglycans (GAG’s) and either get 
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released or remain bound depending on ECM stiffness and degradation of ECM by MMP’s 
(Discher, Mooney et al. 2009). It is therefore foreseeable that ECM proteins, MMP’s and 
TIMP’s together, locally regulate mammary function through pathways involving growth 
factors and cytokine signalling among other mechanisms.  
In this study the role of the ECM in local regulation of milk protein gene expression and 
ultimately ACL was examined. The study hypothesized that treating mammary epithelial 
cells extracted from tissues in an earlier phase of lactation with ECM from later phases of 
lactation would change the milk protein gene expression profile of the cells to resemble the 
phase from which the ECM was extracted. Similarly ECM extracted from earlier phase 
tissues would de-differentiate later phase cells to adopt the phenotype of the earlier phase. 
The change in phenotype from one phase to another is determined by measuring the level of 
expression of the genes for the phase specific markers, tELP, tWAP and tLLP and comparing 
with the gene for major milk protein β-casein. The study further hypothesizes that the ECM 
plays a secondary role in the innate immunity of the mammary gland by regulating the 
expression of cathelicidin genes. To test this hypothesis WallMEC’s from P2A and P2B were 
cultured on ECM from various phases of lactation and cathelicidin expression determined by 
RT-PCR.  
1.11 Unique opportunities presented by wallaby lactation 
Since the phase specific changes in milk composition are accompanied by profound 
developmental and morphological changes in the neonate, tammar lactation presents unique 
opportunities to understand the role of individual milk biomolecules in specific facets of 
neonatal development. For instance since the most prominent delivery of oligosaccharides 
through tammar milk occurs during the period of greatest brain growth (Green, Newgrain et 
al. 1980, Nicholas 1988, Menzies and Nicholas 2007), it is feasible that they play a role in 
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neonatal brain development. Indeed there is increasing evidence suggesting that 
oligosaccharides found in human milk may enhance neonatal brain development and perform 
antimicrobial roles among other functions (Bode and Jantscher-Krenn 2012, Jantscher-Krenn 
and Bode 2012, Jantscher-Krenn, Lauwaet et al. 2012). Similarly the switch from palmitate to 
oleate as the major fatty acid at the transition from phase 2A to 2B may suggest that oleic 
acid may be required in developmental changes observed in P2B including vision and hair 
growth (Renfree, Holt et al. 1982).  
1.12 Objectives 
Main Objective: To investigate the role of the extracellular matrix in mammary epithelial 
cell function and delivery of domain-specific bioactive proteins (cathelicidins) through 
wallaby milk    
Specific objectives:  
1. To investigate the temporal regulation of mammary cathelicidins 
2. To investigate the antimicrobial properties of milk cathelicidins 
3. To investigate the role of cathelicidins in mammary epithelial function 
4. To investigate the role of ECM in local control of milk composition 
5. To investigate the role of ECM in cathelicidin gene expression 
1.13 The overarching hypothesis  
 
The temporal changes in wallaby milk protein gene expression are mediated by progressive 
changes in the composition of the mammary extracellular matrix through enhanced 
responsiveness of mammary epithelial cells to lactogenic hormones.    
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2.1.1 Abstract 
Cathelicidins secreted in milk may be central to autocrine feedback in the mammary gland for 
optimal development in addition to conferring innate immunity to both the mammary gland 
and the neonate. This study exploits the unique reproductive strategy of the tammar wallaby 
model to analyse differential splicing of cathelicidin genes and to evaluate the bactericidal 
activity and effect of the protein on mammary epithelial cell proliferation. Two linear 
peptides, Con73 and Con218, derived from the heterogeneous carboxyl end of cathelicidin 
transcripts, MaeuCath1 and MaeuCath7 respectively, were evaluated for antimicrobial 
activity. Both Con73 and Con218 significantly inhibited the growth of Staphylococcus 
aureus, Pseudomonas aureginosa, Enterococcus faecalis and Salmonella enterica. In 
addition both MaeuCath1 and MaeuCath7 stimulated proliferation of primary tammar 
wallaby mammary epithelial cells (WallMEC). Lactation-phase specific alternate spliced 
transcripts were determined for MaeuCath1 showing utilisation of both antimicrobial and 
proliferative functions are required by the mammary gland and the suckled young. The study 
has shown for the first time that temporal regulation of milk cathelicidins may be crucial in 
antimicrobial protection of the mammary gland and suckled young and mammary cell 
proliferation.   
 
Key words: cathelicidin, tammar wallaby, mammary epithelial cells, cell proliferation, 
antimicrobial, lactation 
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2.1.2 Introduction 
Evidence is now emerging to show that milk not only provides appropriate nutrition for the 
young but also plays a significant role in the development of the mammary gland (Nicholas, 
Simpson et al. 1997). Major milk proteins, whey acidic protein (WAP) and alpha-lactalbumin 
for instance have been shown to enhance mammary epithelial cell proliferation (Topcic, 
Auguste et al. 2009) and initiate apoptosis in mammary cells (Sharp, Lefevre et al. 2008) 
respectively.   In this study we use the unique reproductive strategy of the marsupial, tammar 
wallaby (Macropus eugenii) to investigate the role of mammary-derived cathelicidins 
MaeuCath1 and MaeuCath7 and their derivative peptides Con73 and Con218, respectively in 
lactation.  
Relative to eutherians, marsupials including wallabies have a short gestation period, leading 
to the birth of an altricial neonate. The tammar lactation cycle consists of one pre-parturition 
phase (phase 1) and three post-parturition phases (2A, 2B and 3) during which there is 
significant remodelling of the mother’s mammary gland, changes in milk composition, and 
development of the neonate from a foetus-like form to adult-like anatomy (Nicholas 1988, 
Bird, Hendry et al. 1994, Nicholas, Simpson et al. 1997, Brennan, Sharp et al. 2007). During 
phase 2A which lasts up to 110 days post-partum, the neonate is permanently attached to the 
teat and feeds on milk which is low in protein and fat but high in carbohydrates (Nicholas, 
Simpson et al. 1997). Phase 2B consists of days 100-200 post-partum when the pouch young 
detaches from the teat and only reattaches to feed. Phase 3 commences approximately 200 
days post-partum and is characterised by secretion of high volumes of milk that is rich in 
protein and fat but low in carbohydrates (Nicholas 1988, Nicholas, Simpson et al. 1997). 
Development of the respiratory, cardio-vascular and adaptive immune systems in the tammar 
neonate occurs during lactation and therefore the milk must provide bioactives for immediate 
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nutritional and immunological demands and to act as signals for development (Basden, 
Cooper et al. 1997).  
A number of genes, including cathelicidins, encode antimicrobial peptides that constitute a 
significant part of innate immunity in vertebrates (Yang, Biragyn et al. 2004). Cathelicidins 
belong to a family of proteins generally characterised by an N-terminal putative signal 
peptide, a conserved cathelin-like domain  and a C-terminal heterogeneous antimicrobial 
domain (Zanetti, Gennaro et al. 1995). Their gene structure characteristically consists of four 
exons (Gudmundsson, Magnusson et al. 1995), the first three of which encode the pre-
proregion (the putative signal peptide and Cathelin-like domain) and the last exon encodes 
the appropriate protease cleavage site and the C-terminal microbicidal domain. Cathelicidins 
usually exist in their inactive proform state stored in neutrophil granules. The mature peptide 
is formed by post-translational cleavage of the proform by different proteases depending on 
the species. Extrinsic factors, including LPS and LTA have been shown to stimulate 
mammary epithelial cells (Daly, Mailer et al. 2009) and keratinocytes (Frohm, Agerberth et 
al. 1997) to express cathelicidin genes.  
Numerous functions have been attributed to the two domains of the proform cathelicidin 
(Yang, Biragyn et al. 2004). The cathelin-like domain is thought to act as a buffer against 
possible intracellular cytotoxicity of the cationic C-terminal domain (Zanetti, Gennaro et al. 
1995) in addition to antimicrobial activity (Li, Post et al. 2000). The human cathelicidin 
peptide LL-37 has been shown to stimulate colonic mucus synthesis , induce mast cell 
chemotaxis , suppress neutrophil apoptosis, act as chemoattractant to neutrophils and CD4 T-
lymphocytes and neutralise LPS (Yang, Biragyn et al. 2004).  Several studies involving LL-
37 in various human tissues have demonstrated that cathelicidins play a significant role in 
wound healing and tissue remodelling. LL-37 enhances re-epithelization of wounds in oral, 
intestinal, lung,  and corneal epithelia implying a possible role in epithelial cell proliferation 
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(Yang, Biragyn et al. 2004). Cathelicidins expressed in the mammary gland during lactation 
may therefore play a role in mammary tissue remodelling and epithelial cell proliferation.  
The structure of a number of tammar mammary-derived cathelicidins has been elucidated and 
found to consist of typical cathelicidin features (Daly, Digby et al. 2008) but their function in 
lactation is not understood. MaeuCath1 and MaeuCath7 and their C-terminal peptides Con73 
and Con218, respectively are for the first time characterised for bactericidal activity. The 
effect on the proliferation of tammar mammary epithelial cells (WallMEC) is examined and 
lactation-phase specific differential splicing investigated.  
2.1.3 Materials and Methods 
Experimentation with animals 
Wallabies were kept in an open yard with adequate vegetation and water. Tissues were 
obtained following animal ethics approval by the University Animal Welfare Committee 
(AWC) 
RNA purification and RT-PCR  
Twenty-six mammary glands were excised for RNA isolation, including two each from non-
pregnant (NP) and Phase 1, four from Phase 2A and six each from phases 2B, 3 and weaned 
(INV) animals. RNA was isolated in two lots of 13 using Tripure Isolation reagent (Roche 
Diagnostics, Castle Hill, NSW 2154, Australia) according to manufacturer’s guidelines and 
treated with RQ1 RNase-free DNAse (Promega Corporation). Concentrations of RNA were 
measured using a Nanodrop 2000 Micro-Volume UV-Vis Spectrophotometer (Wilmington, 
DE 19810 USA). Reverse transcription was performed using Superscript IIITM First Strand 
Synthesis system (Invitrogen Mount Waverly, Victoria, Australia) with 1μg of total RNA as 
template. PCR was then performed in two lots of 13 using GoTaq™ DNA Polymerase 
(Promega). MaeuCath1 primers (5’- ATGCAGGTACTCCTATTGGTG-3’; 5’-
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CCCTGGCAGTGGGATAGGAAT-3’ were designed using a tammar mammary gland cDNA 
library and the draft tammar genome sequence (Lefevre, Digby et al. 2007). Amplification 
comprised 30 cycles of 94oC 30’, 55oC 40’, 72oC 45’ and a final extension of 72oC for 5 
minutes. These primers were designed to amplify a 474bp fragment. To confirm the integrity 
of RNA and the first strand synthesis product, tammar wallaby GAPDH was amplified using 
the oligonucleotides 5’-GACTCATGACTACAGTCCATGCCAT-3’ and 5’-
GGACATGTAGACCATGAGGTCCAC-3’ under the same cycle conditions. PCR products 
were loaded onto a 1.2% agarose gel in Tris Acetate/EDTA (TAE) buffer for electrophoresis 
and band intensity determined using the Image Lab software (Biorad). 
Cloning and sequencing of splice variants  
RT-PCR amplification products were electrophoresed on 1.2% agarose gel and specific bands 
excised and purified using the QIAquick Gel Extraction kit (Qiagen, Doncaster, VIC 3108 
Australia) according to manufacturer’s guidelines. The purified DNA was cloned into 
pGEMT Easy (Promega) and sequenced (BD Biosciences, North Ryde, NSW, 2113 
Australia). 
Peptide design and synthesis  
In order to investigate the active domains of both MaeuCath1 and MaeuCath7 proteins, 
peptides were designed that contained putative active domains. The peptide positive control, 
CAP18 constitutes the 37 amino acid residues at the C-terminal of the rabbit CAP18 protein 
[GenBank:AAA31187.1] and has bactericidal activity against Pseudomonas aeruginosa, 
Escherichia coli, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus 
(Travis, Anderson et al. 2000). Peptide Con218 was derived from the heterogeneous carboxyl 
end of MaeuCath7 sequence (Lefevre, Digby et al. 2007, Daly, Digby et al. 2008) modelled 
on CAP18 except for an extra lysine at the N-terminal to improve the GRAVY score and 
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cationicity. Peptide Con73 was derived from MaeuCath1 (Daly KA et al 2008) and modelled 
on Con218 but was designed to limit the peptide to the region with the highest percentage of 
cationic residues and best GRAVY score (Figure 3A). Peptides were synthesized 
(Mimotopes, Clayton Victoria 3168 Australia) utilizing solid-phase chemistry. Peptides were 
dissolved in PBS at 1mg/ml and stored at -20oC.  
Cationicity, hydropathicity and alpha helicity 
The grand average of hydropathicity (GRAVY) of peptides was determined by ProtParam 
software using the Kyte-Doolittle algorithm (Kyte and Doolittle 1982) available through the 
Expasy Proteomics server.  Hydropathicity plots were also generated using ProtParam and 
window size n=7. Alpha-helicity plots were generated by ProtScale using the Deleage & 
Roux scale  (Deleage and Roux 1987) available at the Expasy Proteomics server.  
Bacterial strains and bactericidal assays 
All bacterial strains, Pseudomonas aeruginosa ATCC 27853, Salmonella enterica ATCC 
43971, Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 10100 were 
sourced from American Type Culture Collection (ATCC), Manassas, VA 20108 USA and 
were a kind donation from Dr. K. Walder (MRU, Deakin University, Australia). Bacteria 
were streaked onto IsoSensitest (ISA) agar (Oxoid) plates and incubated overnight at 37oC to 
form isolated colonies. Four individual colonies of each strain were inoculated into 3ml 
IsoSensitest media for overnight growth at 37oC with agitation on an orbital shaker. The 
overnight culture was re-inoculated into fresh ISA at a ratio of 1:10 and grown at 37oC until 
O.D600 = 0.6. An empirically determined count of 2000 cells in 80μl ISA were added to each 
well of a 96 well black wall clear bottom plate (Costar; Corning Incorporated, Corning, 
N.Y.). AlamaRblue reagent (10μl) and peptides (final concentration100μg/ml) were then 
added to each well. Either PBS or BSA (100μg/ml) in PBS was added to control wells. A 
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florescence reading was measured at time zero (t=0) on Flexi Station II 384 
(Excitation=544nm and Emission=590nm) before plates were incubated at 37oC with 
agitation. Florescence readings were then taken hourly and relative bacterial survival 
determined by normalising to the PBS treated wells. 
Preparation of cathelicidin conditioned media 
In-frame expressed sequence tag (EST) clones of MaeuCath1 and MaeuCath7 in 
pCMV.SPORT6 plasmid or empty vector (Invitrogen Corp, Mount Waverly, Victoria, 
Australia) were used to transfect HEK293T cells at passage number 9 or earlier using the 
Lipofectamine 2000 (Invitrogen).  A pCDNA3.1 plasmid expressing the green fluorescent 
protein (GFP) was used as a transfection control and success of transfection verified using the 
IX81 flourescent microscope (Olympus Imaging Europa GmbH, Hamburg). Media were 
collected 48 hours post-transfection and filter-sterilised using the 0.2μm Acrodisc syringe 
filter unit (Pall Corporation) and stored at -80oC until required. Synthetic peptide conditioned 
media were prepared by adding peptide at the appropriate concentration to media from 
untransfected wells.  
Purification of cathelicidin protein from conditioned media 
MaeuCath1 sense primer, 5’ATGCAGGTACTCCTATTGGTG3’ was used together with 
FLAG-tagged antisense primers, 
5’CTACTTGTCATCGTCATCCTTGTAATCCCCTGGCAGTGGGATAGG 3’ and 5’ 
CTACTTGTCATCGTCATCCTTGTAATCGAATCCCTTCCCAGCCCA3’ to amplify full 
length MaeuCath1 and MaeuCath1b respectively from Phase 2A cDNA. Similarly 
MaeuCath7 sense primer, 5’ATGCAGGTACTCCTATTGGTG3’ was used in combination 
with FLAG -tagged antisense primers 
5’CTACTTGTCATCGTCATCCTTGTAATCCTGGCGGGGGACAGGAAA3’ and  
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5’CTACTTGTCATCGTCATCCTTGTAATCGTCAATGGTTCCAATGCA3’ to amplify 
MaeuCath7 and its C-terminal-deleted truncated derivative, tMaeucath7 respectively and 
PCR products cloned in pTARGET mammalian expression vector (Promega). Sequence-
verified pTARGET clones were used alongside an empty vector control to transfect 
HEK293T cells (ref. section 2.6) in a six well plate and FLAG-tagged protein purified using 
ANTI-FLAG M2 Affinity Gel (Sigma) according to manufacturer’s instructions. To verify 
size and purity of recombinant proteins, SDS-PAGE was performed and the gel stained using 
the Pierce Silver Stain kit (Thermoscientific). Purified protein was used at 100μg/ml in 
bactericidal assays. 
Preparation of tammar mammary cells (WallMEC’s) 
Mammary tissue was obtained from tammar wallabies which were confirmed to be pregnant 
and non-lactating from inspection of the uterus and mammary glands, respectively. Tissue 
was immediately transferred to 1u Hanks’ Balanced Salt Solution (Sigma Aldridge, Sydney, 
Australia) with 10 μL/mL penicillin/streptomycin (Gibco, USA) and 2.5 Pg/mL Fungizone 
(Gibco, USA) on ice and transported back to the laboratory for enzymatic digestion to harvest 
mammary epithelial cells. Mammary tissue was dissected free from fat, weighed, sliced 
finely and digested with collagenase and hyaluronidase (25 g tissue per 100 mL media) at 
37qC for 4 hr. Cells were harvested by filtration  (Nalgene filter, 53 Pm and 200 Pm mesh). 
The suspension was centrifuged at 80 g /5 min and pellets were washed twice with Hanks 
Balanced Salt Solution (HBSS). Cell suspensions were centrifuged, resuspended in M199 and 
90% FCS/10%DMSO (DMSO-Sigma, Sydney, Australia), and frozen at a density of ~2 u 107 
cells/ml. 
Culture of WallMEC’s and proliferation assays 
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Mammary epithelial cells were cultured in growth media (M199/Hams/Hepes media with 1 
μg/ml cortisol, 10 ng/ml EGF, 1 μg/ml insulin supplemented with 20% horse serum and 5% 
foetal bovine serum 1mM glutamine and penicillin/streptomycin). Cells in 100μl of growth 
media were seeded at 2000/well in a 96 well tissue culture plate (Costar; Corning 
Incorporated, Corning, N.Y.). After 24hr, 100μl conditioned media was added to each well 
and cells were maintained at 37oC and 5% CO2 until confluency.  Rates of cell proliferation 
were measured by assaying incorporation of Sulforhodamine B (Skehan, Storeng et al. 1990, 
Gercel-Taylor, Ackermann et al. 2001, Voigt 2005).  Briefly, cells were fixed at days 0, 7 and 
11 by addition of 50μl of pre-chilled 50% TCA (wt/vol in water) to each well, incubated for 
1hr at 4oC and washed six times with 100μl MilliQ filtered water. The plates were air dried , 
treated with 0.4% wt/vol Sulforhodamine B (SRB) in 1% acetic acid for ten minutes, washed 
five times in 1% acetic acid then allowed to air dry. Incorporated SRB was then solubilised in 
10mM unbuffered Tris and optical absorbance measured at 515nm on XMark Microplate 
spectrophotometer (Biorad, Gladsville, NSW, Australia).  
Statistical analysis 
Statistical analysis of all comparative data was done using the two-tailed t-test with a 
statistical significance cut-off of 5%. 
2.1.4 Results  
Alternate splicing of MaeuCath1  
Differential splicing of the MaeuCath1 gene was observed during specific phases of the 
lactation cycle. Two different splice forms, MaeuCath1a and MaeuCath1b were confirmed by 
sequence analysis and their structure determined by comparison to the genomic MaeuCath1 
gene sequence (Figure 1 A and 2). MaeuCath1a is 489bp and comprises all four exons with 
no intron. MaeuCathlb is 697bp and comprises exons 1 and 2, 256bp of retained intron 
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sequence and the 3’untranslated region. The translation stop codon in exon 2 in MaeuCath1b 
is preceded by 30bp which translate into the peptide sequence VRVSWAGKGF. 
MaeuCath1a and MaeuCath1b share 100% sequence homology with Maeucath1 and 
MaeuCath2 which were previously thought to be separate genes (Daly, Digby et al. 2008). 
Analysis of MaeuCath1 RT-PCR amplicons revealed the two splice variants were 
differentially expressed in the tammar mammary gland throughout the lactation cycle (Figure 
1B). The level of MaeuCath1a   transcripts was low in the mammary gland from non-
pregnant tammars and at day 16 of pregnancy. However during early lactation MaeuCath1a 
expression increased to five-fold compared to the non pregnant tammar gland but then 
declined during mid to late lactation and early involution. In late involution (Day 10), 
MaeuCath1a expression increased to the same level as the phase 2A gland. MaeuCath1b was 
expressed at a low level in the non-pregnant (NP) mammary gland, throughout pregnancy and 
early lactation (day 2 and day 80 lactation). However there was a three-fold increase in 
MaeuCath1b expression in mid lactation commencing at day 135 lactation. A high level of 
expression of MaeuCath1b was sustained in the mammary gland throughout late lactation and 
early involution. At day 10 involution MaeuCath1b expression declined to a level comparable 
to the non-pregnant gland.  
The grand average of hydropathicity (GRAVY) of cathelicidin peptides. 
The grand average of hydropathicity (GRAVY) of entire cathelicidin peptides is shown in 
Figure 3. All three cathelicidin peptides, CAP18, Con73 and Con218 had a negative GRAVY 
indicating they were all hydrophilic. Con73 was the most hydrophilic with GRAVY score of 
-1.573 followed by CAP18 (-1.097) and Con218 (GRAVY = -0.945). These hydropathicity 
scores were in agreement with the respective percentages of cationic amino acid residues of 
57.7, 37.8 and 31.6. 
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Kyte and Doolittle hydropathicity plots of the peptides. 
Unlike GRAVY scores which represent the average hydropathicity of the entire peptide, Kyte 
and Doolittle plots present hydropathicity scores of individual amino acids computed based 
on neighbouring residues in a specified shifting window size. Using window size n=7 the N-
terminal sequence of the longer cathelicidin peptides, CAP18 and Con218 was hydrophilic 
while the C-terminal was hydrophobic (figure 4). A linear decrease in hydrophilicity from the 
N-terminal to the C-terminal was observed for CAP18 except for the threonyl35, aspartyl36 
and tyrosyl37residues. The entire Con73 peptide was hydrophilic with the region Gly10-Arg16 
attaining an average Kyte and Doolittle score of -2.01. This hydrophilicity is attributable to 
the arginine and lysine repeats in this region. Con218 was relatively the least hydrophilic 
(mean score =-0.83 compared to -1.57 and -1.03 for Con73 and CAP18 respectively). 
Deleage-Roux Alpha-helicity plots for the peptides 
The alpha-helicity of tamar cathelicidin peptides determined using the Deleage-Roux 
algorithm and with a cut-off score of 0.99 showed there is significant alpha-helical structure 
in the N-terminal portion of the longer peptides CAP18 and Con218 (figure 5). There is 
decreased alpha-helicity in the section spanning residues 15-25 of Con218 and the C-terminal 
portion of both Con218 and CAP18. The entire sequence of Con73 is above the cut-off score 
although the middle hydrophilic region had the highest score. 
Bactericidal activity of cathelicidin peptides 
Synthetic tammar mammary cathelicidin peptides Con218, and Con73 were examined for 
inhibition of growth of bacterial species (Gram positive bacteria, Staphylococcus aureus and 
Enterococcus faecalis; Gram negative bacteria, Pseudomonas aureginosa and Salmonella 
enterica) and were compared to the known antimicrobial rabbit cathelicidin peptide CAP18 
(Travis, Anderson et al. 2000), over a 4 -16 hour period (figure 6).  A BSA control was used 
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for these analyses and showed no significant inhibition of growth of bacteria. CAP18 acted as 
a positive control and significantly inhibited the growth of all the four bacterial species tested 
as expected.  
E.faecalis growth inhibition 
The relative bacterial survival indicated that CAP18 inhibited the growth of E. faecalis by 
more than eight-fold compared to the untreated sample. This level of inhibition was achieved 
within the first two hours of treatment and extended to sixteen hours of treatment. Peptide 
Con218 and Con73 had a similar inhibitory effect on E. faecalis to CAP18, with a relative 
bacterial survival value of 0.18 and most of the inhibition within the first two hours of 
treatment. CAP18 and Con218 however showed marginally but statistically significantly 
more activity than Con73 (p<0.001). 
S. aureus growth inhibition 
CAP18 inhibited the growth of S. aureus by more than eight-fold compared to the untreated 
sample. Peptide Con73 demonstrated a more rapid effect than CAP18 (relative bacterial 
survival=0.42 and 0.60 at 2 hours respectively) but a greater activity was observed with 
CAP18 treatment at the four hour time-point (relative bacterial survival =0.16 and 0.33 
respectively). Compared to Con 73 and CAP18, Con218 was significantly less active against 
S. aureus (relative bacterial survival = 0.68, p=0.003). 
S. enterica growth inhibition  
 Over a 4 hour period CAP18 and Con218 had an identical inhibitory effect on growth of S. 
enterica. Con73 was relatively slower acting than CAP18 and Con218 but was equally 
effective after four hours.  
P. aureginosa growth inhibition 
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P. aureginosa was the most susceptible bacterial species to cathelicidin peptides. Con73 
completely inhibited the growth of P. aureginosa for the 16hr treatment period. CAP18 and 
Con218 were equally potent with relative bacterial survival of 0.07 and 0.08 respectively.  
Bacterial growth inhibition by full length and truncated MaeuCaths 
In all the bacterial species tested, growth inhibition by full length cathelicidin proteins 
(MaeuCath1 and MaeuCath7) generally mimicked their derivative C-terminal synthetic 
peptides. MaeuCath1b and the truncated MaeuCath7 (tMaeuCath7) however did not show 
significant inhibition of bacterial growth (figure 7b). 
Enhancement of WallMEC Cell proliferation MaeuCaths 
A significant stimulation of proliferation of WallMEC’s was observed when the cells were 
cultured in growth media supplemented with MaeuCath1, MaeuCath1b and MaeuCath7 
(figure 8). The difference in proliferation between MaeuCath1b and MaeuCath1 treated cells 
did not reach statistical significance (p=0.104). On the contrary tMaeuCath7 did not stimulate 
growth (figure 8b).  By day 7 of treatment cell proliferation of MaeuCath1 and MaeuCath7 
treated wells was 7.0% greater than the control. By day 11 treatment, this difference had 
increased to 9.4% (p=0.006) for MaeuCath1 and 13.3% (p=0.002) for MaeuCath7 treated 
cells. Peptide Con218 significantly inhibited cell proliferation (15.2% and p=0.026) but by 
day 11 the proliferation rate was comparable to the control. 
2.1.5 Discussion 
 Lactation in the tammar starts with birth of an altricial young and the immune-compromised 
neonate relies on antibodies and other immune factors secreted in the mother’s milk for 
defence against microbes (Daly, Digby et al. 2007). The pouch of the tammar wallaby and 
other marsupials is rich in microflora, including potentially pathogenic bacteria (Yadav, 
Stanley et al. 1972, Ambatipudi, Joss et al. 2008). Thirty species of bacteria, including 
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Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus 
spp have been isolated from tammar pouches (Old and Deane 1998, Ambatipudi, Joss et al. 
2008). The presence of two of these bacterial species, K. pneumoniae and P. aeruginosa has 
been associated with mortality of the pouch young in koala (Osawa, Blanshard et al. 1992). 
Importantly, both K. pneumoniae and P. aeruginosa and a broad spectrum of other bacterial 
species are susceptible to the bactericidal activity of cathelicidins from various species (Bals, 
Wang et al. 1998, Skerlavaj, Benincasa et al. 1999).  
The design of antimicrobial peptides from cathelicidins presents a challenge relating to the 
inter-species heterogeneity of the antimicrobial region. Various attributes of peptide 
secondary structure including helicity and amphipathicity are however good indicators of 
peptide efficacy. The extent of amphipathicity and alpha-helicity has been shown to 
positively correlate with antibacterial activity (Blondelle and Houghten 1992, Johansson, 
Gudmundsson et al. 1998). High amphipathicity, hydrophobicity and enhanced helical 
structure are also linked to increased peptide-induced hemolysis (Blondelle and Houghten 
1992, Oren and Shai 1996, Oren and Shai 1997, Wieprecht, Dathe et al. 1997, Kondejewski, 
Jelokhani-Niaraki et al. 1999). This study utilised user-friendly algorithms made available by 
the ExPaSy server to incorporate the amphipathic and alpha-helical sequence in the peptides.  
Computational hydropathicity, amphipathicity and alpha-helicity data obtained for peptides 
Con73, Con218 and rabbit CAP18 were in agreement with the respective percentages of 
cationic amino acid residues.  The grand average of hydropathicity (GRAVY) scores 
obtained for all three peptides was negative implying hydrophilicity which complements the 
hydrophobicity of the C-terminal residues to form an amphipathic structure suitable for 
interaction with bacterial membranes (Hancock and Sahl 2006). The linear decrease in 
hydrophilicity from the N to the C-terminal observed in Con218 and CAP18 as deduced from 
Kyte and Doolittle hydropathicity scores indicated a higher amphipathicity than the less 
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hydrophobic Con73 (Kyte and Doolittle 1982, Gasteiger, Gattiker et al. 2003).  The Deleage-
Roux Alpha-helicity plots revealed a lower helicity for Con218 than Con73 and CAP18. The 
difference in amphipathicity and alpha-helicity between peptides was however not reflected 
in bactericidal activity probably because all the peptides attained the threshold and 
demonstrated broad spectrum antimicrobial activity.  
This work is the first study to report the antimicrobial activity of mammary-derived 
marsupial cathelicidins against S.aureus, E.faecalis, P.aureginosa and S.enterica.  Growth 
inhibition of S.enterica, an entero-invasive pathogen and P.aureginosa by cathelicidin would 
be crucial for protection of the young against gut and other systemic diseases. Similarly 
inhibition of S.aureus an agent of mastitis (Siqueira, Aessio et al. , Oliver and Mitchell 1983) 
would provide protection of the mother’s mammary gland. It is paradoxical however that 
cathelicidin peptides also inhibited growth of E.faecalis, a commensal of the gut that is 
thought to inhibit pathogens including S.aureus (Alomar, Lebert et al. 2008). We propose that 
temporal regulation of cathelicidin synchronized with mother-to-neonate immune transfers as 
shown in this work, may circumvent this problem.  
In the first 48 hours postpartum (Deane et al, 1990) and later on in phase 2B , two immune 
transfers, marked by an elevated and differential expression of immunoglobulins in milk 
occur (Daly, Digby et al. 2007). The two periods represent the pouch young’s greatest 
vulnerability to pathogens hence the need for enhanced protection. In this study we 
demonstrate that enhanced differential expression of at least one tammar cathelicidin 
(MaeuCath1a) coincides with the first immune transfer (Daly, Digby et al. 2007) and remains 
highly expressed until the period preceding the second immune transfer (Daly, Digby et al. 
2007). Leading to the second immune transfer there was an estimated five-fold increase in 
MaeuCath1a transcript. At this stage of neonatal development, cathelicidins would be 
required to act in synergy with humoral and cellular immune systems to provide protection 
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from pathogens (Daly, Digby et al. 2007). Following this co-operative microbicidal activity, 
MaeuCath1a and other tammar cathelicidins would be required to neutralise endotoxins 
including LPS and LTA (Giacometti, Cirioni et al. 2004) to prevent endotoxic shock. We 
propose that enhanced MaeuCath1a expression together with immune transfer indicates a 
possible role of MaeuCath1a in chemotaxis for T cells, neutrophils, mast cells and monocytes 
which is a typical function of cathelicidins (Yang, Biragyn et al. 2004). 
Intriguingly, we observed initiation of MaeuCath1a expression at day 10 involution 
suggesting that MaeuCath1a may have a role in mammary gland re-modelling during 
involution.  Following milk stasis mammary epithelial cells undergo apoptosis and are 
cleared through phagocytosis by neighbouring epithelial cells and by macrophages that 
migrate into the mammary glands (Richards and Benson 1971). The process of milk stasis 
and involution predisposes the mammary gland to pathogen-mediated mastitis (Oliver and 
Mitchell 1983).  MaeuCath1a may play a chemotactic role to macrophages leading them to 
the apoptotic epithelial cells and an antimicrobial role protecting the gland from pathogens, 
hence its up-regulation at involution.  
The second MaeuCath1 splice variant (MaeuCath1b) is expressed in all the phases of 
lactation although a significant up-regulation in expression is observed from mid-lactation to 
early involution. The intron retention splicing strategy observed in MaeuCath1b eliminates 
the expression of the 3’ cationic domain leaving only the cathelin-like region. Intron retention 
is a regulatory mechanism in which the retained intronic sequence is either part of open 
reading frames (Ner-Gaon, Halachmi et al. 2004) or present in the UTR region (Galante, 
Sakabe et al. 2004, Ner-Gaon, Halachmi et al. 2004) or sometimes present as the last intron in 
the transcript. Up to 14.8% of alternately spliced human genes have been reported to have 
intron retention (Galante, Sakabe et al. 2004) while the frequency in Arabidopsis is as high as 
30%  (Ner-Gaon, Halachmi et al. 2004).  
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The abundant expression of MaeuCath1b transcripts is sustained after the timing of immune 
transfers and the neonate has developed adaptive immunity suggesting it may play a 
physiological role for the maintenance and proliferation of mammary epithelia during high 
milk production (Dove and Cork 1989, Bird, Hendry et al. 1994). This is consistent with 
several studies showing the involvement of cathelicidins in epithelial cell proliferation during 
wound healing, maintenance and re-establishment of the intestinal barrier integrity and 
proliferation of lung epithelial cells (Heilborn, Nilsson et al. 2003, Shaykhiev, Beisswenger et 
al. 2005, Otte, Zdebik et al. 2009). Enhanced WallMEC proliferation following MaeuCath1b 
treatment in this study supports this hypothesis. 
This work further, has ascertained that MaeuCath1a and MaeuCath1b which were earlier 
reported to be separate genes namely, MaeuCath1 (GenBank: EF624481.1) and MaeuCath2 
(GenBank: EF624482.1) (Daly, Digby et al. 2008) are in fact splice variants of the same 
gene. The study shows that the reproductive strategy of the tammar wallaby can be exploited 
to show that the cathelicidin gene is temporally regulated by alternate splicing to provide 
protection for both the pouch young and mammary gland at the time of increased risk of 
infection and the proliferation of the mammary gland during the time of increased growth of 
this tissue. 
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2.1.7 Figures 
 
 
Figure 1:  Differential splicing of MaeuCath1. 
RT-PCR on tammar mammary gland cDNA from various phases of lactation revealed 
lactation-phase dependent splice variation. A: Schematic representation of MaeuCath1 exon 
structure. All mature mRNA sequence is boxed. Black boxes represent translated sequence. 
White boxes represent 5’ and 3’ untranslated sequence.  B: Agarose gel of the amplicons 
showing relative expression levels of MaeuCath1a and MaeuCath1b amplicons. NP, D16P, 
2A, 2B, 3, and INV represent Not Pregnant (well 1), Day 16 Pregnant (well2), phase 2A 
lactation, phase 2B, phase 3 and Involution respectively.  Phase 2A includes day 2 and day 80 
lactation, Phase 2B includes day 135, 150 and 168 lactation. Phase 3 includes day 220, day 
235 and day 260 lactation. Involution represents samples collected 1, 5 and 10 days after 
weaning. Samples in each phase were loaded onto the gel in order of increasing days of 
lactation.  
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Figure 2:  
 Translated sequence of MaeuCath1 splice variants. Panel A represents the translated 
sequence from the 489bp (MaeuCath1b) variant. Amino acids translated from Exon 1 are 
marked in black bold letters, Exon 2 in grey box, Exon 3 in black letters and Exon 4 
underlined. Panel B represents the translated sequence from the 697bp splice form 
(MaeuCath1a) which spans exons 1 and 2.  The additional 5’ translated sequence of the intron 
in MaeuCath1a is in plain box.  
 
MRGLTMQVLLLVLGLLSLMNPLGYAQDQPYQDVLNRFIQEYNTKSESESLFRLSVLNLPSQESNDPTAPQ
LLKFTIRETVCSKSEHRNPEECDFKKNGLVEECIGTVDLDSSSPSVDISCDGPEKVKRGFGKKLRKRLKKFRNS
IKKRLKNFNVVIPIPLPG* 
MRGLTMQVLLLVLGLLSLMNPLGYAQDQPYQDVLNRFIQEYNTKSESESLFRLSVLNLPSQESNDPTAPQ
LLKFTIRETVCSKSEHRNPEECDFKKNG VRVSWAGKGF 
A 
B 
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 A 
Gene Name Amino acid sequence ID 
MaeuCath1 
GLTMQVLLLVLGLLSLMTPLGYAQDQPYQDVLNRFIQEYNTKSESESLFRL
SVLNLPSQESNDPTAPQLLKFTIRETVCSKSEHRNPEECDFKKNGLVEECIG
TVDLDSSSPSVDISCDGPEKVKRGFGKKLRKRLKKFRNSIKKRLKNFNV
VIPIPLPG 
 
[Genbank:ABV019
38.1] 
MaeuCath7 
ARALSTKRMRDSTMQVLLLVLGLLRLMTSLACAQDQPYQDVLNRFIQEYN
TKSESESLFRLSVLNLPPEESNDPAVPLLKFTIRETVCPKTEHRNADECDFKK
NGLVKQCIGTIDLDSPNPSVDISCDRPAKVKRGLWESLKRKVTKLGDDIR
NTLRNFKIKFPVPRQG 
 
[Genbank:ABV019
43.1] 
 
B 
 
Peptide 
 
Peptide sequence 
 
GRAVY 
Percentage  
Cationic 
Residues 
 
CAP18 
 
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY 
 
 
-1.097 
 
37.8 
 
Con73 
 
KVKRGFGKKLRKRLKKFRNSIKKRLK 
 
 
-1.573 
 
57.7 
 
Con218 
 
KVKRGLWESLKRKVTKLGDDIRNTLRNFKIKFPVPRQG 
 
 
-0.945 
 
31.6 
 
Figure 3: 
Amino acid sequence of MaeuCaths and GRAVY scores of cathelicidin peptides. A: Partial 
amino acid sequence of MaeuCath1 and MaeuCath7. Both Con73 and Con218 peptide 
sequences are shown in grey boxes in their respective parent protein sequence. B: The grand 
average of hydropathicity (GRAVY) of cathelicidin peptides. GRAVY is the computed mean 
of hydrophobicity and hydrophilicity values for individual amino acid residues. A negative 
GRAVY indicates hydrophilicity while a positive value indicates hydrophobicity. 
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Figure 4: 
 Kyte and Doolittle hydropathicity plots of the peptides. Amino acid position is presented on 
the X-axis. The X-axis is scaled to include only those amino acids which fall in a window 
whose hydropathicity score is computed.  Kyte and Doolittle hydropathicity scores (window 
size n=7) for individual amino acids are on the Y-axis. 
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Figure 5 
Deleage-Roux Alpha-helicity plots for the peptides. On the X-axis is the amino acid residue 
position. The Deleage –Roux alpha-helicity score is on the Y-axis. A cut-off score of 0.99 
represents significant alpha-helical structure.  
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Figure 6: 
Relative bacterial survival following tammar cathelicidin peptide treatments. Relative 
bacterial survival (on the Y- axis) was calculated as a fraction of the untreated control. 
Experiments were performed in triplicate and repeated 3 times. Standard error bars are 
shown.  
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A 
 
B 
 
Figure 7: Relative bacterial survival following treatment with purified FLAG-tagged 
MeuCath proteins. A: Silver stained SDS-PAGE gel of FLAG-tagged MaeCaths. i) Vector, 
ii) MaeuCath1, iii) MaeuCath1b, iv) MaeuCath7, v) tMaeucath7 B: Relative bacterial 
survival (on the Y- axis) was calculated as a fraction of the untreated control. Experiments 
were performed in triplicate and repeated 3 times. Standard error bars are shown.  
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Figure 8. 
 Wall-MEC cell proliferation. On the X-axis is the duration of treatment in days. On the Y-
axis is the absorbance at 515nm of total lysate of SRB-treated Wall-MEC cells. Treatments 
were done in quadruplicates and experiment repeated twice. Standard error bars are shown 
A:Treatment with synthetic peptides and their MaeuCath parent proteins. B:Treatment with 
purified FLAG-tagged protein  
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3.1.1 Abstract 
Asynchronous concurrent lactation (ACL) is an extreme lactation strategy in macropod 
marsupials including the tammar wallaby, that may hold the key to understanding local 
control of mammary epithelial cell function. Marsupials have a short gestation and a long 
lactation consisting of three phases; P2A, P2B and P3, representing early, mid and late 
lactation respectively and characterised by profound changes in milk composition. A lactating 
tammar is able to concurrently produce phase 2A and 3 milk from adjacent glands in order to 
feed a young newborn and an older sibling at heel.  Physiological effectors of ACL remain 
unknown and in this study the extracellular matrix (ECM) is investigated for its role in 
switching mammary phenotypes between phases of tammar wallaby lactation. Using the level 
of expression of the genes for the phase specific markers tELP, tWAP, and tLLP-B 
representing phases 2A, 2B and 3 respectively we show for the first time that tammar wallaby 
mammary epithelial cells (WallMECs) extracted from P2B acquire P3 phenotype when 
cultured on P3 ECM. Similarly P2A cells acquire P2B phenotype when cultured on P2B 
ECM. We further demonstrate that changes in phase phenotype correlate with phase- specific 
changes in ECM composition. This study shows that progressive changes in ECM 
composition in individual mammary glands provide a local regulatory mechanism for milk 
protein gene expression thereby enabling the mammary glands to lactate independently.  
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3.1.2 Introduction 
In contrast to eutherians, the reproductive cycle of the tammar wallaby (Macropus eugenii) 
consists of a short gestation (phase 1; P1) leading to the birth of an altricial young and a long 
lactation (Nicholas, Simpson et al. 1997). Tammar lactation has previously been divided into 
three post-parturition phases; 2A, 2B and 3 (representing early, mid and late lactation 
respectively) characterised by progressive remodelling of the mammary gland and profound 
changes in milk composition (Nicholas 1988, Nicholas, Simpson et al. 1997, Daly, Digby et 
al. 2007, Lefevre, Digby et al. 2007). After milk stasis the mammary gland progresses to 
involution (INV) and reverts to resemble a pre-pregnancy state.  During early and mid 
lactation the mammary gland is relatively small in size and produces small amounts of milk 
that is rich in carbohydrates but low in protein and lipids. In contrast late lactation is marked 
by an enlarged mammary gland secreting large volumes of milk that is rich in protein and 
lipid. (Nicholas, Simpson et al. 1997).   
In the early 1960’s an extreme lactation phenomenon known as asynchronous concurrent 
lactation (ACL) was described in macropod marsupials (Nicholas 1988). It was observed that 
at any stage of the reproductive cycle the marsupial could have a dormant blastocyst in the 
uterus and at the same time effect two parallel lactation cycles producing early and late 
lactation milk in adjacent glands to support a pouch young and an older sibling at heel 
concurrently (figure 1A)(Hendry, Simpson et al. 1998).  Later experiments showed that apart 
from the different volumes of milk secreted from adjacent teats, there was differential 
expression of specific milk protein genes in each mammary gland, suggesting a local intra-
mammary mechanism for ACL (Bird, Hendry et al. 1994, Nicholas, Simpson et al. 1997, 
Brennan, Sharp et al. 2007).  
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Clearly, paracrine rather than endocrine factors appear to modulate ACL since the observed 
differences between the individual mammary glands are realised while they are under 
identical hormonal control. The present study draws from earlier observations  that stromal-
epithelial interactions are key to mammary differentiation including the study  by Cunha et al 
in which they showed that undifferentiated epidermal cells acquire  mammary epithelial 
phenotype when cultured on mammary mesenchyme (Cunha, Young et al. 1995) and that the 
proliferative response of mammary epithelial cells to hormones is mediated by the stroma 
rather than receptors on the epithelial cells themselves (Cunha, Young et al. 1997).  Further, 
complex interactions between the mammary ECM and epithelial cells has previously been 
associated with changes in the stromal and alveolar structure during lactation (Schedin, 
Mitrenga et al. 2004, Maller, Martinson et al. 2010). Accordingly, we hypothesized that 
differences in ECM composition between the adjacent glands was the molecular mechanism 
regulating ACL. 
Mammary epithelial cells (MEC) are attached to ECM  whose tissue specific composition 
and stiffness transduces mechano-signals necessary for  modulation of  histogenic  processes 
including  apical/basal cell polarity (Schedin, Mitrenga et al. 2004, Maller, Martinson et al. 
2010) cell proliferation (Provenzano, Inman et al. 2009) and lineage determination of 
mesenchymal stem cells (Engler, Sen et al. 2006).  Bissel et al have described a dynamic 
reciprocity between the cell and its ECM in which biomechanical signals are transduced 
through ECM receptors on the surface of the cell to the nucleus resulting in altered gene 
expression, which in turn leads to altered ECM biomechanical properties (Xu, Boudreau et al. 
2009). Importantly, studies have shown that ECM composition dynamically changes under 
the control of the same effectors that regulate lactation including cytokines, growth factors 
and hormones (Labat-Robert 2003, Mott and Werb 2004). To understand the role of ECM in 
the local control of lactation, there is therefore a need to ascertain the lactation-phase specific 
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changes in mammary gland ECM composition and the subsequent effect on MEC function. In 
the present study we utilise the unique multi-phase lactation of the marsupial to analyse 
progressive changes in mammary gland ECM and the accompanying alteration in milk 
protein expression during the course of lactation. The study utilises ECM from an involuting 
mammary gland as a positive control for ECM remodelling. It has been shown in other 
models that the ECM undergoes metalloprotease (MMP)-mediated degradation during 
involution (Schedin, Mitrenga et al. 2004) and MECs cultured on this matrix undergo 
apoptosis. 
Each of the phases of wallaby lactation is characterised by the expression of a specific milk 
protein gene thereby enabling the quantitation of progressive changes in epithelial phenotype.  
The genes for the early lactation protein (tELP), whey acidic protein (tWAP) and late 
lactation protein (tLLP-B) are specifically expressed during early, mid and late lactation  
respectively (Nicholas, Simpson et al. 1997) whereas the major milk proteins α-casein, β-
lactoglobulin, α-lactalbumin are expressed throughout lactation (Messer and Elliott 1987, 
Bird, Hendry et al. 1994, Hendry, Simpson et al. 1998). By culturing tammar mammary 
epithelial cells (WallMECs) collected from different phases of lactation on ECM extracted 
from mammary glands representing each phase of lactation and measuring the level of 
expression of these markers, it was possible to investigate ECM-induced changes of lactation 
phase phenotype. The study shows that the ECM regulates the morphology of the alveolar-
like acini which are formed by in-vitro WallMEC cultures and are capable of milk protein 
secretion.  We additionally show how mammary ECM composition changes during each 
phase of lactation and that the ECM ultimately governs phase-specific milk composition 
during lactation in the wallaby mammary gland allowing expression of different milk protein 
genes and ACL of individual glands. 
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3.1.3 Results 
H&E stain of mammary tissue for ECM extraction 
Prior to extraction of ECM from the mammary glands at each phase of lactation, histological 
sections and the expression of the phase-specific marker genes tELP, tWAP and tLLP-B were 
examined to confirm the phase of lactation and the integrity of the tissues. In the H&E 
sections pregnant (PG) mammary tissue had few alveoli surrounded by extensive stroma 
while early lactation and mid lactation mammary glands had a large number of polygonal 
alveoli with significant retention of stroma (figure 1B). Late lactation glands had enlarged 
alveoli with more distended lumina surrounded by less but dense stroma, consistent with 
earlier observations (Nicholas 1988). The involuting gland (INV) had fewer alveoli in a 
disordered arrangement within the stroma.  The phase specific markers, tELP, tWAP and 
tLLP-B were expressed exclusively in early, mid and late lactation tissues respectively while 
β-casein was expressed in all the lactating glands (early, mid, late and INV). GAPDH was 
uniformly expressed in all the tissues (figure 1C).   
Characterisation of acini  
In order to investigate the effect of mammary ECM on acini morphology, wallaby mammary 
epithelial cells (WallMECs) were cultured until they formed acini on ECM extracted from 
mammary glands representing the different phases of wallaby lactation. Acini were 
characterised using bright field microscopy and allocated to 6 groups; M1, M2, M3, M4, M5 
and M6 in the order of decreasing diameter (figure 2A). Acini were considered mature if they 
had a smooth outline free of attached cells on the periphery and were greater than 200μm in 
diameter.  M1 were the mature acini measuring 200-250μm. M2, M3 and M4 had free cells 
attached on their periphery and were 150-200, 100-150 and 50-100 μm in diameter, 
respectively. M5 and M6 were acini in the rudimentary stage and measured 25-50 μm and 
  
70 
 
less than 25μm in diameter, respectively.  Acini were subsequently stained to identify nuclei 
using Hoechst 33342 and examined under a confocal microscope to investigate the degree of 
apoptotic clearance of the lumen. WallMECs derived from all phases of lactation formed 3D 
acini consisting of a thin layer of cells encapsulating a lumen (figure 2B). The degree of 
apoptotic clearance of the lumen progressively changed through the various stages of acini 
maturity (figure 2B).  M1 acini were devoid of cells at 0.25 depth into the lumen and M2 at 
0.5 depth while there was no strong evidence of existence of a lumen in M3, M4, M5 and M6 
acini.  
ECM from non-autologous lactation phase alters acini morphology  
We hypothesized that culturing cells from a lactation phase on ECM extracted from the 
mammary gland of another phase would alter the phenotype to mimic the phase from which 
the ECM was extracted.  WallMECs from mid lactation were cultured on late lactation ECM 
and acini morphology and numbers compared to that of acini formed when mid lactation cells 
were grown on their own phase ECM. On late lactation ECM, acini were more numerous and 
smaller in size than acini on mid lactation ECM (figure 3), but attained a similar degree of 
apoptotic clearance of the lumen to M1 type acini.  In order to further confirm that changes in 
acini morphology were caused by the ECM, early lactation cells were cultured on mid 
lactation ECM and acini compared to those formed when cells were cultured on early 
lactation ECM. There was no significant difference in the morphology and numbers of acini 
between early and mid lactation ECM (figure 4). However early lactation cells did not form 
mature acini on late lactation ECM and involuting ECM (supplementary data). 
Latter phase ECM changes the phenotype of earlier phase WallMEC to resemble the latter 
phase.  
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In order to further investigate the effect of ECM on lactation phase phenotype we 
hypothesized that culturing earlier phase cells on latter phase ECM would fast-track gene 
expression to mimic the latter phase phenotype.  To test this hypothesis early lactation cells 
were separately cultured on early and mid lactation ECMs and the expression of the phase 
specific markers (tELP and tWAP respectively) measured by isolating RNA from the cells 
and performing quantitative PCR. Similarly we cultured mid lactation cells on mid and late 
lactation ECMs and compared the expression of tWAP and tLLP-B (late lactation) between 
the ECM treatments. The expression of the gene for β-casein was measured as a marker for 
initiation of lactation (supplementary data).  When early lactation cells were cultured on mid 
lactation ECM they expressed significantly higher levels of tWAP compared to when they 
were cultured on early lactation ECM (figure 5A). Similarly when mid lactation cells were 
cultured on late lactation ECM they expressed significantly more tLLP-B (p=0.003; figure 
5B) but less tWAP (p=0.005) than when they were cultured on their own phase (mid) ECM.  
Earlier phase ECM does not reverse the phenotype of latter phase WallMEC to the earlier 
phase  
We hypothesized that culturing WallMEC from a latter phase on ECM from an earlier phase 
would reverse milk protein gene expression to the earlier phase phenotype. To test this 
hypothesis we cultured mid lactation cells on early, mid and late lactation ECM and 
measured the expression of the gene for tWAP.  There was no difference in expression of 
tWAP between cells cultured on early and mid lactation ECM but tWAP expression was 
significantly lower on late lactation ECM (figure 6A).  
The ECM changes WallMEC phenotype forwards in a step-wise manner 
In order to confirm whether the ECM changes the phase phenotype of WallMEC in a 
sequential manner, early lactation cells were cultured on early, mid and late lactation ECM 
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and the expression of tLLP-B measured. There was no significant difference in tLLP-B gene 
expression between early lactation cells cultured on mid or late lactation ECM and their own 
phase (early lactation) ECM (figure 6B).   
ECM protein composition is different in each lactation phase 
Individual ECM proteins have been shown to differentially elicit changes in milk protein 
gene expression in mammary epithelial cells (Li, Aggeler et al. 1987, Lin, Dempsey et al. 
1995).  In the present study we hypothesized that the differential expression of milk protein 
genes observed after treating cells with ECM from different lactation phases was a result of 
changes in the protein composition of the ECM during transition from one lactation phase to 
another. Accordingly, ECMs from PG, early, mid and late lactation and involuting mammary 
glands were resolved by SDS-PAGE, silver-stained and differentially expressed bands 
excised for mass spectroscopy.  The larger molecular weight (≥ 250kDa) proteins did not 
resolve efficiently leading to multiple identities for individual bands (figure 7A). Differential 
expression of ECM proteins from the various lactation phases was observed. Although all the 
major classes of basal lamina proteins (collagen IV, laminins, heparan sulphate proteoglycans 
and nidogens) were represented in all the ECMs, the multimeric high molecular weight 
molecules were more abundant in the lactating gland ECMs than INV ECM. The bands 
corresponding to the mix of laminin 1 and tenascin and the mix of heparan sulphate 
proteoglycan core protein and glycogen IV were at least twice as dense in PG, early, mid and 
late lactation as observed in INV ECM while fibronectin could not be detected by silver 
staining in the INV ECM.  
Conversely, low molecular weight, monomeric or breakdown products of the major ECM 
proteins including nidogen-1 precursor, byglycan, laminin 1 and decorin-like isoform 1 
migrating at lower than 24 kDa were predominantly present in late lactation and INV ECM.  
Fragments of vimentin and alpha-actinin which are mainly cytoskeletal proteins co-purified 
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with ECM and were predominantly expressed in early and mid lactation ECMs. Bands which 
were unique to early and mid lactation and involution (marked with a red ellipse) and 
migrating at 60, 42 and 15kDa respectively were observed but their identity could not be 
established using either Swissprot or the wallaby database (figure 7A). 
Matrix metalloproteases are differentially expressed during lactation 
In order to establish whether the progressive variation in the ECM protein profiles correlates 
with differential expression and activity of matrix metalloproteases (MMP’s) we performed 
gelatin zymography using cleared tissue homogenates of pregnant, early, mid and late 
lactation and involuting mammary glands. Gelatinolytic activity (attributed to matrix 
metalloproteinase-2) was detectable as latent and/or active forms in mid, late and involution 
phases of lactation (figure 7B). Cleaved MMP activity was observed to be significantly 
higher in late lactation and involution and absent in the earlier phases (figure 7 C).   
3.1.4 Discussion 
The regulation of asynchronous concurrent lactation (ACL) in macropod marsupials has 
remained perplexing for the reason that two adjacent mammary glands under the same 
systemic control not only differ significantly in size but produce milk with profoundly 
different composition (Lincoln and Renfree 1981, Nicholas 1988, Nicholas, Simpson et al. 
1997). Several mechanisms have been suggested for ACL (Lincoln and Renfree 1981, 
Nicholas and Tyndale-Biscoe 1985, Nicholas, Simpson et al. 1997) but ultimately there are 
two crucial requirements for ACL; firstly, for ACL to be possible the mammary glands have 
to function independently of each other and be intrinsically controlled (Nicholas 1988, 
Nicholas, Simpson et al. 1997) and secondly, for ACL to involve such profound differences 
not only in milk composition and volume but also mammary morphology, the underlying 
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autocrine regulation is likely to be exerted on the whole mammary gland including, epithelial, 
myoepithelial and stromal cells.  
Clearly, the overt differentiation of mammary tissue, expression of individual milk protein 
genes and ultimately, secretion of milk in all mammals cannot proceed in the absence of 
maternal hormones (Ono and Oka 1980, Topper and Freeman 1980, Nagamatsu and Oka 
1983, Silberstein 2001). Both in-vivo and in-vitro lactation models require at least one of the 
several different combinations of insulin (I),  progesterone, growth hormone (GH), prolactin 
(P), cortisol (F), thyroid hormones (T3 and T4) and β17-estradiol (E2) in order to function 
(Turkington and Hill 1969, Bolander and Topper 1981, Nagamatsu and Oka 1983, Nicholas 
and Tyndale-Biscoe 1985, Terada, Wakimoto et al. 1988). However, although hormones are 
required for the expression of tELP (Simpson, Shaw et al. 1998), tWAP (Simpson, 
Ranganathan et al. 2000, Topcic, Auguste et al. 2009) and tLLP (Nicholas, Simpson et al. 
1997, Trott, Wilson et al. 2002, Trott, Adams et al. 2005), available evidence suggests that 
their differential expression in-vivo is unlikely to be directly regulated by hormones (Nicholas 
1988, K. R. Nicholas C.J.W 1995, Nicholas, Simpson et al. 1997, Hendry, Simpson et al. 
1998), leading to the proposition that ACL is initiated by altered responsiveness to hormones 
by the individual mammary glands and that the hormones may play a permissive role. It has 
indeed been demonstrated in the agile wallaby (Macropus agilis) that differences in milk 
volumes between the mammary glands may result from progressive changes in sensitivity to 
oxytocin (Lincoln and Renfree 1981). Accordingly, deciphering differences, whether 
structural or biochemical, between mammary glands in various phases of lactation has the 
potential to reveal the effectors of ACL.  
The role of mammary ECM in lactation is well documented and includes modulation of 
epithelial cell growth (Wang, Ballestrem et al. 2011) and differentiation (Streuli 2009), 
regulation of specific milk protein expression in various eutherian species (Bissell, Hall et al. 
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1982, Wicha, Lowrie et al. 1982, Li, Aggeler et al. 1987), determination of stromal content 
(Bissell and Aggeler 1987) and modulation of mammary myo-epithelial cell function 
(Deugnier, Faraldo et al. 1999). Due to temporal changes observed in the distribution of 
major mammary ECM proteins during the menstrual cycle (Ferguson, Schor et al. 1990, 
Ferguson, Schor et al. 1992)  the ECM has also been suggested to mediate the response of 
mammary epithelial cells to hormones.  
The present study reports for the first time the involvement of ECM in the phase-to-phase 
transition in tammar lactation and its possible role in ACL. We observed that the tendency to 
form mature luminal acini, by both early and mid lactation  WallMECs was greatest when the 
cells were cultured on pregnant, early and mid lactation ECMs and greatly diminished when 
the cells were cultured on INV (involuting gland) ECM, the latter only supporting the 
formation of rudimentary acini. In late pregnancy and early lactation the mammary gland 
undergoes extensive alveolar development (Nicholas, Simpson et al. 1997), as observed in 
the tissue cross sections,  necessary for lactation and therefore the ability of pregnant, early 
and mid lactation ECMs to support formation of mature acini is a pointer to the significant 
role the ECM must play in the transition from one phase of lactation to the next. Similarly the 
inability of INV ECM to support formation of mature acini is consistent with apoptotic 
activity that characterises involution leading to decreased numbers and size of alveoli 
(Wicha, Lowrie et al. 1982, Debnath, Mills et al. 2002, Schedin, Mitrenga et al. 2004, 
Brennan, Sharp et al. 2007, Schedin, O'Brien et al. 2007, Sharp, Lefevre et al. 2007, Khokha 
and Werb 2011) as observed in this study. However, it is not clear from this study whether 
acinar size is dependent on the ECM or a factor extrinsic to it since mid lactation cells formed 
functional acini on late lactation ECM but they were much smaller and more numerous than 
those formed on other ECMs. 
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Concordant with dynamic reciprocity between cells and their ECM, in this study we observed 
that ECM extracted from a late lactation mammary gland altered mid lactation cells to adopt 
a late lactation phenotype that included mature acini expressing β-casein and tLLP-B. Since 
previous studies have reported an increase in circulating prolactin at the on-set of late 
lactation, accompanied by the induction of tLLP-B expression (Nicholas and Tyndale-Biscoe 
1985, Nicholas 1988) there was a need to show that the observed increase in tLLP-B was 
caused by the ECM and not prolactin. Accordingly, in the current study, media on test 
samples were uniformly supplemented with the full complement of lactogenic hormones 
(IFPT3E2) at concentrations known to induce maximal milk protein synthesis (Topper and 
Freeman 1980) and control media were supplemented with IF only. These hormone 
concentrations failed to induce tLLP-B gene expression when cells were treated with ECM 
from other phases of lactation leading us to conclude that tLLP-B was specifically induced by 
culturing WallMECs on late lactation ECM. This was consistent with an earlier study in 
which elevation of prolactin from a physiological concentration of 20ng/ml to as high as 
200ng/ml failed to induce expression of tLLP-B in a tammar mammary explant culture using 
tissue from pregnancy (Nicholas 1988, Trott, Wilson et al. 2002, Trott, Simpson et al. 2003). 
Equally noteworthy, when mid lactation WallMECs were cultured on pregnant, early and mid 
lactation ECMs they expressed at least four times (p≤0.0001) more tWAP than when they 
were cultured on late lactation and INV ECM without a significant difference in the level of 
β-casein expression between the treatments. This specific regulation of tWAP expression by 
ECM is consistent with reports which showed that mouse MEC’s only express WAP when 
cultured on ECM-induced 3-D alveolar structures (Lin, Dempsey et al. 1995) and that the 
absence of ECM leads to induction of TGFα expression which inhibits WAP expression. 
Taken together with the ability of mid lactation cells to express tLLP-B when cultured on late 
lactation ECM, this observation confirmed that the loss of mid lactation phenotype and 
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switch to late lactation phenotype was mediated by the ECM. Similarly mid lactation ECM 
changed the phenotype of early lactation cells to resemble mid lactation.  We therefore have 
demonstrated for the first time that ECM effects the phenotypic changes that occur when the 
wallaby mammary gland transits from one lactation phase to another. Intriguingly, although 
early lactation ECM caused a small but significant increase in tELP expression in mid 
lactation cells relative to the IF treated control, implying some degree of dedifferentiation, 
similar levels of tELP expression were observed when mid lactation cells were cultured on 
ECMs from other phases. These observations may have resulted from the insensitivity of 
tELP gene expression to lactogenic hormones as earlier observed by Simpson et al (Simpson, 
Shaw et al. 1998).  
In this study the transition between phases appeared to correlate with the progressive changes 
in ECM composition of the mammary gland across the lactation cycle. Although the large 
multimeric proteins (collagen IV, laminins and heparan sulphate proteoglycans) were 
uniformly represented in all the phases except at involution, their monomeric or breakdown 
forms were more abundant in late lactation and involution ECM. The appearance of lower 
molecular weight fibronectin, laminin and nidogen especially at involution is consistent with 
degradative remodelling of the ECM by ECM metalloproteases (MMP’s) (Schedin, Mitrenga 
et al. 2004, Green and Lund 2005). We have demonstrated by gelatin zymography that MMP 
activity is increased during involution which is consistent with other studies showing 
increased activity of MMP-2, MMP-9 (Watson and Kreuzaler 2011), MMP-14 and MMP-19 
(Rabot, Sinowatz et al. 2007). The increased MMP activity during late lactation follows the 
period of peak milk production and suggests that the mammary gland may be underdoing 
gradual involution during late lactation. The phenomenon of gradual involution has 
previously been reported in the tammar wallaby (Khalil, Digby et al. 2011) and eutherians 
(Peaker and Wilde 1996, Wilde, Knight et al. 1999).  
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The uniqueness of mammary ECM from each phase is however exemplified by the phase-
specific proteins observed in early and mid lactation and involution (here named P2Ax, P2Bx 
and INVx respectively because they did not return any ID from Swissprot database). Further 
investigations are required to identify these products and determine their role in ACL. 
Notably annexin A2 and serpinH1 which are typically not integral parts of the ECM were co-
purified with ECM proteins. Annexin A2 exists at the extracellular surface of endothelial 
cells and through its interaction with the plasminogen activator system activates MMP’s thus 
mediating ECM degradation (Hajjar, Guevara et al. 1996). SerpinH1, while primarily an 
endoplasmic reticulum protein, is involved in post-translational maturation of collagens 
(Razzaque and Taguchi 1999) by acting as a molecular chaperon. These associations with 
ECM may explain their presence, especially in INV ECM. However, taken together, this 
study has shown that a local mechanism mediated by the mammary gland ECM may 
modulate the transition between the phases of lactation thereby enabling ACL.  
3.1.5  Materials and Methods 
Animal ethics and handling 
Wallabies were fed ad libitum in an open yard with adequate water. Tissues were obtained in 
strict adherence to animal ethics guidelines provided by the Deakin University Animal 
Welfare Committee (AWC). 
Preparation of tammar mammary epithelial cells (WallMECs) 
Mammary tissue was obtained from tammar wallabies at day 80 (early) and 163 (mid) 
lactation.   The tissue was immediately transferred to 1u Hanks’ Balanced Salt Solution 
(Sigma 55021C) with 10 μl/ml penicillin/streptomycin (Gibco, USA) and 2.5 Pg/mL 
Fungizone (Gibco, USA) dissected free from fat, weighed and sliced finely. Tissue slices 
were digested with collagenase and hyaluronidase (25 g tissue per 100 mL media) at 37qC for 
  
79 
 
up to 4 hr and cells harvested by filtration (Nalgene filter, 200Pm mesh followed by 53Pm 
mesh). The suspension was centrifuged at 80xg for 5 min and pellets were washed twice with 
Hanks Balanced Salt Solution (HBSS). Cell suspensions were centrifuged at 80xg for 5 min, 
resuspended in M199 and 90% FCS (Invitrogen)/10%DMSO (Sigma, D8418), and frozen at a 
density of ~2 u 107 cells/ml.  
Histology 
A mammary tissue sample weighing approximately 0.5g from wallabies at day 17 of 
pregnancy, day 80  (early), 163 (mid) and 260 (late) of lactation, and day 10 of involution 
(INV) was fixed in 10% formalin and processed for hematoxylin and eosin (H&E) staining 
observing standard histology procedures and the sections characterised by bright field 
microscopy. 
ECM preparation 
Mammary tissue (100mg) was homogenised and RNA purified using the RNeasy Lipid 
Tissue Mini Kit (Qiagen) and reverse transcription-PCR (RT-PCR) performed as summarised 
in section 5.9.  After confirming tissue integrity, mammary ECM was extracted as described 
by O’Brien et al (O'Brien, Fornetti et al. 2010) . Briefly, 3g of  mammary tissue from the 
indicated phases of  tammar lactation were individually pulverised to a fine powder in liquid 
nitrogen and homogenised in a high salt buffer containing 2 mM n-ethylmaleimide (NEM), 
200 μg/ml phenylmethylsulfonyl fluoride (PMSF) and  2x protease inhibitor (PI) cocktail 
(Sigma, P8340). The lysates were subsequently enriched for insoluble extra-cellular ECM 
proteins through a series of centrifugations and high salt and urea extractions. The ECM was 
aliquoted and frozen at -20oC until required. 
WallMECs culture 
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WallMECs from mid lactation at passage 4 or earlier were cultured on ECM from pregnant 
(PG), early, mid and late lactation and involuting mammary glands and assayed for changes 
in tELP, tWAP and tLLP-B gene expression. Briefly, 200μl of ECM was added to each well 
of a 6 well tissue culture plate (Costar; Corning Incorporated) and incubated at 37oC for 1 hr 
to allow coating of the wells. Cells were seeded at 5x104 cells per well in growth media 
(M199/Hams/HEPES media supplemented with 1 μg/ml cortisol (F), 10 ng/ml EGF, 1 μg/ml 
insulin (I), 1mM glutamine, 20% horse serum, 5% foetal bovine serum and 
penicillin/streptomycin). The cells were incubated at 37oC/5% CO2 until they formed mature 
acini as earlier described (Sharp, Cane et al. 2006), typically 13 days after seeding. Acini 
were considered mature after attaining a diameter of 200μm or wider and appeared totally 
dark under bright field. Upon maturity, acini were washed once with 2ml differentiation 
media (IF) consisting of 2% FBS in growth media without EGF and incubated in IF 
containing lactogenic hormones, including 0.2μg/ml prolactin, 650pg/ml triodothyronine and 
1 pg/ml estradiol (IFPT3E2) for 5 days. Control wells were treated with media containing IF.  
Milk protein gene expression 
RNA extraction from WallMECs and cDNA synthesis were performed as earlier described 
(Wanyonyi, Sharp et al. 2011)and quantitative PCR’s performed using β-casein, tELP, 
tWAP, tLLP-B and GAPDH primers and the SsoFast EvaGreen (BioRad) method and 
quantities determined using the CFX manager software (BioRad). Primers were designed 
from the tammar mammary gland cDNA library and the draft tammar genome sequence 
(Lefevre, Digby et al. 2007) as follows: β-casein, 5’- CACCAGCTTCTCCTGATTCT-3’, 5’-
CGAGAGAGAGGCTGGACTTT-3’; tELP, 5’-ATTTACCATCGTTGCCCTCT-3’, 5’-
CAGGACAGCATCACCAGAGT-3’; tWAP, 5’-AAACATGAGATGCTGCCAAC-3’, 5’-
TGCATTGATCATCTCTCTGACA-3’; tLLP-B, 5’-CTCTATCCTCCAGGCTCAGG-3’, 5’-
TGAGGTTGAAGGGAATCCTC-3’; GAPDH, 5’-
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GACTCATGACTACAGTCCATGCCAT-3’,  5’-GGACATGTAGACCATGAGGTCCAC-
3’. Amplification comprised 40 cycles of 95oC 45’, 55oC 45’, 72oC 45’ and melt curve 
performed from 55 oC to 95 oC in increments of 0.5 oC every 45 seconds. β-casein expression 
was used as a positive control for milk protein gene expression throughout lactation. GAPDH 
was amplified under identical cycle conditions as a control for RNA quality. 
ECM protein analysis 
The ECM isolated from mammary tissue was thawed in a water bath at room temperature and 
diluted 10 times to allow estimation of protein concentration using BCA Protein Assay 
Reagent (Pierce, Product No. 23227) and 100μg protein loaded on either a 7.5% or 12.5% 
polyacrylamide gel for the resolution of high and low molecular weight proteins respectively. 
Silver-stained protein bands were excised and subjected to in-gel tryptic digestion 
(Rosenfeld, Capdevielle et al. 1992) followed by reduction and alkylation (Shevchenko, 
Tomas et al. 2006). Mass Spectroscopy was performed using Agilent LC/MSD Trap XCT 
plus and peptide identity was determined from the SwissProt proteomics database using the 
Mascot MS/MS Ions Search software (www.matrixscience.com). Peptide ID was further 
confirmed using a tammar wallaby database (Lefevre, Digby et al. 2007) . 
Gelatin zymography 
Zymography was performed as earlier described (Raser, Posner et al. 1995). Briefly a 
hundred milligram of cryo-preserved mammary tissue was homogenised in 2.5ml of 
homogenisation buffer and centrifuged at 16,000xg/4oC for 20min and protein concentration 
of the supernatant estimated using the BCA protein assay reagent. The homogenate was 
diluted to 2μg/μl  and 20μl   mixed with 5μl  non-reducing loading dye (333mM Tris/HCl pH 
6.8, 10% SDS, 50% glycerol) and loaded without heating on 8% SDS-PAGE Mini-Protean II 
gel (Biorad) containing 0.1% v/v gelatin for resolution at 20mA. Following SDS-PAGE the 
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gel was washed twice in 2.5% triton X-100 in MilliQ water, each wash lasting 1hr and 
transferred to assay buffer (50mM Tris/HCl pH 7.5, 10mM CaCl2, 150mM NaCl) for a 16 hr 
incubation at 37oC with gentle agitation. Following gelatinolytic digestion, the gel was rinsed 
once in MilliQ water and stained in 0.25% Coomassie Brilliant Blue (R250),10% acetic acid, 
30% methanol for 20min and destained briefly to allow visualisation of digested represented 
byclear bands corresponding to MMP activity. To estimate the MMP activity, the gel was 
photographed and unstained bands compared using the Image Lab software (Biorad).  
Microscopy 
Wallaby MEC’s isolated from early, mid and late lactation mammary tissue were cultured as 
described in section 5.3. Thirteen days after plating cells, acini were fixed in 4% 
paraformaldehyde for 16 hr at 4oC, washed twice with PBS, permeabilised in 0.5% triton 
X100 for 10 minutes and stained with 10mg/ml Hoechst 33342 (Sigma, B 2261) for 90 
minutes. Fluorescent images of nuclear stained acini were captured on Leica TCS SP5 
confocal microscope (Leica Microsystems) at excitation 352 nm and emission 454nm. The 
diameter of acini was estimated by extending the microscopic scale across the image in a 
cross format and a z-stack cross-section performed at different depths of the acini lumen to 
determine presence of cells in the lumen. Acini were classified based on their diameter into 6 
groups, M1, M2, M3, M4, M5 and M6.  
Statistical analysis 
Statistical analysis of all comparative data was performed using the two-tailed t-test with a 
statistical significance cut-off of 5%. 
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3.1.7 Figures 
 
Figure 1: Phase specific mammary morphology and milk protein gene expression. A: 
Tammar mammary glands showing asynchronous lactation. Q represents quiescent and non-
lactating mammary gland, P2A and P3 represent mammary glands producing early lactation 
milk for the pouch young (PY) and late lactation milk for the young at heel respectively. B: 
H&E stained cross sections of mammary tissue from various phases of lactation. PG, Early, 
Mid, Late and INV represent  pregnant (day 17 pregnant), early lactation (day 40), Mid 
lactation  (day 168), late lactation (day 260) and Involution (day 10 post weaning) 
respectively. Alveoli are marked with A while stroma is marked with S. C:  Milk protein gene 
expression of ECM source tissues. NTC, PG, Early, Mid, Late and INV represent No 
template control, and cDNA synthesized from pregnant, early, mid and late lactation and 
involuting mammary glands respectively while tELP, tWAP, tLLP-B and tβ-cas represent 
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tammar early lactation protein, whey acidic protein, late lactation protein-B and β-casein, 
respectively. PCR products were resolved on a 1.2% agarose gel. PCR’s were performed on 
cDNA from mammary glands obtained on three different days for each lactation phase in 
order to confirm reproducibility. Representative samples from each phase are shown.  
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Figure 2: Acini classification according to morphology. A: Acini at 100x magnification 
under bright field.  M1 were classified as mature acini measuring 200-250μm. M2, M3, M4 
have free cells attached on their periphery and are 150-200, 100-150 and 50-100 μm in 
diameter respectively. M5 and M6 are acini in the rudimentary stage and measure 25-50 μm 
and less than 25μm in diameter respectively. B: Hoechst 33342 nuclear stained acini. z-stack 
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sections were performed at 2.5, 12.5, 25 and 50% depth  of acini from the surface. The degree 
of apoptotic clearance of the lumen can be determined by observing varying degrees of 
staining of the lumen. 
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Figure 3: Acini morphology and abundance after culturing mid lactation WallMEC on 
mid and late lactation ECM . A: 40x magnification of acini after culturing cells for 13 days. 
Mid and Late represent mid and late lactation ECM respectively. B:  Effect of ECM phase on 
acini morphology.  On the y-axis is the number of acini counted for each acini type. Each 
treatment was performed in triplicate and the experiment repeated three times. Standard error 
bars are shown. M1-M6 represent the various acini types in order of decreasing size. Due to 
the significant difference in the numbers of acini subtypes the y-axis scale is specific to each 
acinus subtype.  
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Figure 4: Acini morphology and numbers after culturing early lactation WallMECs on 
early and mid lactation ECM.  A: 40x magnification images of acini after culturing cells 
for 13 days. Early and Mid represent early and mid lactation ECM. B:  Effect of ECM phase 
on acini morphology. On the y-axis is the number of each type of acini. Each treatment was 
performed in triplicate and the experiment repeated three times. Standard error bars are 
shown. M1-M6 represent the various acini types in order of decreasing size. 
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Figure 5: Milk protein gene expression after culturing early and mid lactation 
WallMECs on ECM.  A: tELP and tWAP expression in WallMEC cultured on early and mid 
lactation ECM. On the y-axis is the gene expression level expressed as a percentage of 
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GAPDH expression. Early and Mid represent the lactation phase of the ECM. Samples were 
either treated with insulin and cortisol (IF) or the hormone cocktail consisting of insulin, 
cortisol, prolactin, tri-iodothyronine and estradiol (IFPT3E2).  The asterisk denotes significant 
difference (p=0.011) between early and mid lactation ECM. Samples were treated in duplicate 
and the experiment repeated twice. Standard error bars are shown. B: tWAP and LLP-B 
expression in WallMEC cultured on mid and late lactation ECM. Mid and Late represent the 
lactation phase of the ECM. The asterisk represents significant difference (p≤0.005) between 
mid and late lactation ECM. 
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Figure 6: A: tWAP expression in WallMEC cultured on early, mid and late lactation ECM. 
On the y-axis is the gene expression level expressed as a percentage of GAPDH. Early, Mid 
and Late represent the lactation phase of the ECM. The asterisk denotes significantly lower 
expression compared to mid lactation ECM. Samples were treated in duplicate and the 
experiment repeated twice. Standard error bars are shown.  B: LLP-B expression in early 
lactation WallMEC cultured on early, mid and late lactation ECM.  The y-axis scale is 
unique for each of the proteins due to the significant difference in their expression levels. 
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Figure 7: ECM protein composition and differential expression of matrix 
metalloproteases (MMP’s) during the lactation cycle:  A: Silver stained SDS-PAGE of 
ECMs from mammary glands of various lactation phases. The high molecular weight 
(HMW) ECM proteins were resolved on a 7.5% gel while the low molecular weight (LMW) 
were resolved on a 12.5% gel. Resolution of HMW was poor and clear bands were difficult to 
isolate for mass spectrometry. Only differentially expressed bands from the LMW gel were 
isolated for mass spectrometry. Proteins that are unique to only certain phases of lactation are 
shown in ellipses. B: Gelatin zymography of cleared homogenates of mammary tissue. C 
represents collagenase control, BL is a blank well, PG, Early, Mid, Late and INV represent 
cleared tissue homogenates from pregnant, early, mid and late lactation and involution 
respectively. The unstained bands were predicted to be tammar pro-MMP-2 and active MMP-
2 based on molecular size.  C:  Relative activity of MMP-2: MMP-2 activity in the mammary 
gland of the tammar during all phases of lactation is shown in arbitrary units determined 
using the Image Lab software.   
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4.1.1 Abstract 
We have previously shown that the gene for MaeuCath1, a cathelicidin secreted in wallaby 
milk is alternately spliced into two variants, MaeuCath1a and Maeucath1b which are 
temporally regulated in order to provide antimicrobial protection to the newborn and 
stimulate mammary growth respectively. The current study investigated the extracellular 
matrix (ECM) for its regulatory role in MaeuCath1 gene expression. Reverse transcription 
qPCR using RNA isolated from mammary epithelial cells (WallMEC) cultured on ECM 
showed that ECM regulates MaeuCath1a gene expression in a lactation phase-dependent 
manner. Luciferase reporter-based assays and in-silico analysis of deletion fragments of the 
2245 bp sequence upstream of the translation start site identified ECM-dependent positive 
regulatory activity in the -709 to -15 region and repressor activity in the -919 to -710 region. 
Electrophoretic Gel Mobility Shift Assays (EMSA) using nuclear extract from ECM-treated 
WallMEC showed differential band shift in the -839 to -710 region. 
Keywords:  
Extracellular matrix, mammary epithelial cells, cathelicidin, lactation, cathelicidin promoter, 
gene regulation 
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4.1.2 Introduction 
Cathelicidins and other host defence peptides delivered through milk constitute a significant 
part of neonatal innate immunity (Armogida, Yannaras et al. 2004) and may regulate the 
function of mammary epithelial cells. Apart from their primary role as antimicrobial proteins, 
cathelicidins have been shown to effect the chemotaxis of mast cells, neutralise endotoxins, 
chemo-attract CD4 T-lymphocytes (Zanetti, Gennaro et al. 1995, Yang, Biragyn et al. 2004) 
and stimulate mammary cell proliferation in a domain-specific manner (Wanyonyi, Sharp et 
al. 2011).    Therefore understanding how the expression of cathelicidins is regulated during 
the course of lactation has the potential to provide a platform for strategic delivery of milk 
bioactives needed for neonatal development and the optimal function of the lactating 
mammary gland. 
However, except for studies which have associated the expression of cathelicidins by immune 
cells with pathogenic infections (Daly, Mailer et al. 2009), no regulatory factors have been 
described for cathelicidins secreted in milk. Additionally, the majority of studies on 
mammalian cathelicidins have been performed in eutherian models (Yang, Chen et al. 2004) 
in which milk composition does not change significantly after the colostrum phase and the 
neonate is born precocious, making it difficult to correlate early developmental changes with 
bioactives in milk.  
This study utilises the unique reproductive strategy of the tammar wallaby (Macropus 
eugenii) to investigate how the expression of the gene for MaeuCath1, a cathelicidin 
expressed in milk, is regulated. Compared to eutherians, marsupials including tammar 
wallaby have a short gestation leading to the birth of an immune-incompetent fetus-like 
young that relies on the mother’s ability to profoundly change its milk composition 
throughout lactation (Nicholas, Simpson et al. 1997). Tammar lactation is divided into three 
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post-partum phases (P2A, P2B and P3). During P2A and P2B the milk is rich in carbohydrate 
but low in protein and lipid, but during P3 the mother produces concentrated milk that is rich 
in lipid and protein but low in carbohydrates. Interestingly, the wallaby is capable of an 
extreme lactation phenomenon known as asynchronous concurrent lactation (ACL) whereby 
the mother simultaneously produces P2A milk from one mammary gland and P3 milk from 
another in order to feed a newly born pouch young and an older sibling at heel concurrently 
(Nicholas 1988). Since these differences in milk composition are realised while the two 
lactating mammary glands are under identical hormonal influence (Nicholas 1988, Nicholas, 
Simpson et al. 1997), it has been suggested that milk composition is controlled significantly 
by paracrine factors in addition to endocrine factors. Specifically, the mammary extracellular 
matrix (ECM) appears to modulate the expression of major milk protein genes in a lactation 
phase-dependent manner (Wanyonyi In Press). 
We have previously shown that the gene for MaeuCath1 is regulated through alternate 
splicing resulting in two variants MaeuCath1a and Maeucath1b (Wanyonyi, Sharp et al. 
2011). The expression of MaeuCath1a, the splice variant containing the antimicrobial region 
(Wanyonyi, Sharp et al. 2011) is synchronised with periods of increased vulnerability of both 
the pouch young and the lactating mammary gland to microbial infections. Such periods of 
vulnerability include the early post-partum period (P2A) when the PY has not developed a 
competent immune system (Daly, Digby et al. 2007) and late involution when the mammary 
gland environment resembles a wound-healing process (Oliver and Mitchell 1983, O'Brien, 
Martinson et al. 2012) and is pre-disposed to potential mastitic infections (Oliver and 
Mitchell 1983). MaeuCath1b which does not appear to have antimicrobial activity is 
expressed predominantly during peak lactation and may play a role in the growth of the 
mammary gland by enhancing mammary epithelial cell proliferation (Wanyonyi, Sharp et al. 
2011).  
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Earlier studies have shown that mammary epithelial cell (MEC) differentiation and gene 
expression are dependent on temporal changes in the mammary ECM (Bissell, Hall et al. 
1982, Schedin, Mitrenga et al. 2004), and therefore we hypothesised that the ECM regulates 
the lactation phase-specific expression of MaeuCath1 by MEC.  The pathogen-induced 
expression of the human cathelicidin hCAP18 in gingival epithelial cells has indeed been 
shown to be signalled through the fibronectin-integrin pathway (Ouhara, Komatsuzawa et al. 
2006), suggesting that cathelicidins including MaeuCath1 may be regulated by the ECM 
through enhanced response of epithelial cells to external stimuli.  
Therefore the current study investigated the effect of mammary ECM extracted from different 
phases of lactation on MaeuCath1 gene expression in wallaby mammary epithelial cells 
(WallMEC).  
4.1.3 Results 
Differential expression of MaeuCath1 and effect of ECM 
In order to determine the effect of ECM on MaeuCath1 gene expression WallMEC were 
cultured on mammary ECM from P2A and P2B in growth media alone (NH) or in the 
presence of the full complement of lactogenic hormones (IFPT3E2) RNA was extracted for 
cDNA synthesis and quantitative PCR. A modified image of an agarose gel previously 
published by us (Wanyonyi, Sharp et al. 2011) showing RT-PCR products of RNA isolated 
from mammary tissue from P2A and P2B   (figure 1A) has been presented alongside RT-PCR 
expression data for MaeuCath1 in WallMEC in order to compare the in vivo and in vitro data. 
MaeuCath1a expression was significantly higher when WallMEC were cultured on P2A 
ECM than P2B ECM (p=0.002; figure 1B) which is similar to the expression profile observed 
in mammary tissue. However, both P2A and P2B WallMEC did not express MaeuCath1b 
irrespective of the substratum on which they were cultured (figures 1B and C). The 
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expression of MaeuCath1a in both P2A and P2B WallMEC cultured on P2A ECM was 
significantly higher when they were treated with IFPT3E2 than NH (p≤0.04; figure 1D). A 
similar effect was observed when P2A WallMEC were cultured on plastic although the 
expression level was significantly lower than that observed on ECM (p<0.001; figures 1E).  
In order to determine that the differential expression of MaeuCath1a on ECM is specific to 
ECM treatment, P2A WallMEC were grown on a tissue culture plate (plastic) in the absence 
of ECM and analysed for MaeuCath1 gene expression by qPCR. WallMEC expressed 
significantly less MaeuCath1a (p≤0.002) when cultured on plastic than on P2A ECM (figure 
1B) but 70% higher (p=0.01) than the expression level observed on P2B ECM. 
In order to determine whether MaeuCath1a expression in WallMEC is dependent on the  
lactation phase from which the cells were extracted, P2B WallMEC were cultured on P2A 
ECM in NH or IFPT3E2 media and RNA isolated for cDNA synthesis and qPCR. 
MaeuCath1a expression was significantly lower (p=0.001) in P2B than P2A WallMEC when 
both were cultured on the same ECM (figure 1C).     
Activity of MaeuCath1 promoter fragment -709 to -15. 
In order to determine the putative promoter region for MaeuCath1, the 5’-UTR of the 
MaeuCath1 gene (Ensembl, Scaffold97912 wallaby genome) was subjected to preliminary in-
silico studies to locate prominent regulatory elements including the TATA box (figure 2) and 
the    2245 bp  sequence 5’ to the ATG translation start site selected for further investigation. 
Deletion fragments of the putative promoter region (figure 3A and B) were amplified by PCR 
using the primers in table 1, cloned in the pGL3 basic (luciferase reporter) vector and 
sequenced. The deletion fragments were analysed for promoter activity in P2A WallMEC 
cultured on either plastic, P2A or P2B ECM.  Each well was co-transfected with pSV-β-
Galactosidase for normalisation of activity data and control wells were transfected with 
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pMAX-GFP (Amaxa) for visual comparison of transfection efficiency by bright field and 
fluorescent microscopy. The pGL3/Rat β-casein promoter construct (Rβ-cas) was included as 
a positive control for response of WallMEC to lactogenic hormones. There was no difference 
in transfection efficiency between cells cultured on the three substrata although by day 2 
post-transfection the cells cultured on ECM had started aggregating into pre-acini structures  
(labelled PA in figure 3C). 
When P2A WallMEC were cultured on P2A ECM, fragment -709 to -15 elicited at least 2.5 
times higher promoter activity (p≤0.05) than the remaining fragments (figure 4A). Fragment -
919 to -15 which includes the -709 to -15  sequence and the 210 bp immediately 5’ to it was 
4.3 times less active than the -709 to -15 fragment (p<0.001). Similarly the -484 to -15 
fragment which constitutes the 3’ end of the -709 to -15 fragment  was  6.3 times less active 
than the -709 to -15 fragment (p<0.01). When P2A WallMEC were cultured on plastic and 
P2B ECM, promoter activity for all the fragments was similar to background activity (pGL3 
basic) observed when the cells were cultured on P2A ECM (p≥0.4; figure 4B and C). When 
P2B WallMEC were used, except for the Rβ-cas control which had 13.2 times higher activity 
(p=0.009) than the pGL3 basic control, all the fragments exhibited background promoter 
activity irrespective of the substratum (figure 4D-F). 
In order to establish whether the promoter activity of deletion fragment -709 to -15 is 
dependent on lactogenic hormones, P2A cells were transfected with the promoter fragment 
and treated with either IFPT3E2 or NH and promoter activity measured. Promoter activity was 
twice as high (p=0.048) in IFPT3E2-treated cells as in NH-treated cells (figure 5A).   
Activity of MaeuCath1 promoter region -919 to -710 
Since the 210 bp sequence immediately 5’ to the -709 to -15 fragment appeared to decrease 
the activity of the -709 to -15 fragment, we hypothesized that the -919 to -710  (210 bp) had 
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repressor elements. We also hypothesised that the 225 bp sequence from -709 to -485 (figure 
5B) contained positive regulatory elements since it appeared to be the active part of the -709 
to -15 fragment. To test this hypothesis the 210 and 225 bp fragments were ligated to 
pGL3/Rβ-cas immediately 5’ to the casein promoter and the constructs transfected into P2A 
WallMEC to examine luciferase activity. Fragment -919 to -710 reduced Rβ-cas promoter 
activity by 1.6 times (p=0.01) while fragment -709 to -485 increased Rβ-cas promoter 
activity by 1.9 times (p=0.005; figure 5C). 
In order to confirm the repressor activity of the region -919 to -710, primers (table 1) were 
designed so as to clone the promoter regions -2245 to -920 and -1260 to -920 upstream of the 
active promoter region -709 to -15 in pGL3 Basic vector, in effect reconstructing fragments -
2245 to -15 and -1260 to -15 excluding the putative repressor, and constructs (figure 6A) 
transfected into P2A WallMEC to examine luciferase activity.  After exclusion of the putative 
repressor region, fragment 1260 to -15 had 4.05 times higher (p=0.022) promoter activity 
than -709 to -15 (figure 6B). Similarly fragment -2245 to -15 had 2.75 times higher (p=0.02) 
activity than -709 to -15 (figure 6B).  
Putative transcription factor binding sites in the MaeuCath1 promoter 
In order to predict the regulatory elements responsible for the activity of the MaeuCath1 
promoter, the entire -2245 sequence was searched against the TRANSFAC proteomics 
database using P-Match, Patch 1.0 and AliBaba 2.1 software and a plot of the binding sites 
made to scale (figure 7).  Seventy one putative transcription factor binding sites including 23 
Specificity protein 1(Sp1), 17 CCAAT-enhancer-binding proteins (C/EBPα), 12 Yin Yang 
(YY1), 7 Nuclear factor 1 (NF-1), 5 Signal transducer and activator of transcription (STAT5), 
4 TG-interacting factor (TGIF),  2 Glucocorticoid receptor (GR) and 1 Activating protein-2 
(AP-2) were identified (figure 7). Specific transcription factor binding sites appeared to 
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cluster in certain regions of the promoter. For example, 8 out of 12 binding sites in the region 
-2014 to -1515 were C/EBPα-specific while 7 out of fifteen binding sites in the region -514 to 
-15 were Sp1-specfic.  Similarly 8 out 12 YY1 sites were found in the region -1165 to -625 
while all the TGIF binding sites were found in the region -919 to -710 (figure 6A and 7).  
Putative transcription factor binding sites in the MaeuCath1 promoter region -839 to -
710  
In order to identify the regulatory elements  present in the putative repressor region -919 to -
710, the respective sequence was used to probe the TRANSFAC database as described in 
section 2.7 and 50 bp overlapping primer pairs designed for EMSA as described in section 
4.8 to identify transcription factors by gel shift assay. In-silico results showed that fragment -
919 to -710 contained one C/EBPα, three YY1, two NF-1 and four TGIF putative binding 
sites (figure 6A). Although faint band shifts were observed in all nuclear extract/DNA mixes 
(figure 8), the most prominent band shift occurred when primer pairs GS3F/GS3R, 
GS4F/GS4R and GS5F/GS5R representing regions -759 to -710, -799 to -750 and -839 to -
790 respectively were included in a binding reaction with the nuclear extract from cells 
cultured on P2A ECM.  
4.1.4 Discussion 
In a previous study (Wanyonyi, In Press), using wallaby mammary extracellular matrix 
(ECM) extracted from the different phases of lactation, we showed that the switch from the 
P2A lactation phenotype to P2B and finally P3 is mediated by temporally regulated changes 
in the ECM composition. Using SDS-PAGE and mass spectrometry we showed that although 
the large multimeric proteins (collagen IV, laminins and heparan sulphate proteoglycans) 
were uniformly represented in all the phases except at involution, their monomeric or 
breakdown forms were more abundant in late lactation and involution ECM.  Gelatin 
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zymography data from the study showed that the changes in the ECM could be mediated by 
temporal changes in matrix metalloprotease activity during lactation.  In a separate study, we 
reported that the gene for MaeuCath1, a cathelicidin secreted in wallaby milk was alternately 
spliced into two variants, MaeuCath1a which is expressed in P2A and involution and 
MaeuCath1b which is expressed during mid to late lactation (Wanyonyi, Sharp et al. 2011). 
The current study has examined the possible link between the ECM and the temporally 
regulated expression of MaeuCath1 by first examining the expression of MaeuCath1 in 
WallMEC cultured on ECM from different phases of lactation and then  performing 
luciferase reporter-based assays on WallMEC cultured on ECM and  transfected with  
MaeuCath1 putative promoter fragments. 
MaeuCath1a was highly expressed in cells cultured on P2A ECM but poorly expressed on 
P2B ECM which is similar to mammary tissue data (Wanyonyi, Sharp et al. 2011). Equally 
noteworthy, cells cultured on plastic expressed significantly less  MaeuCath1a  than those 
cultured on P2A ECM, consistent with a large number of studies in which mammary 
epithelial cells did not attain cyto-differentiation and secretion of milk proteins when cultured 
on plastic (Bissell and Ram 1989, Talhouk, Neiswander et al. 1998, Rose, Aso et al. 2002) 
and highlighting the possible role of the ECM in the temporal regulation of  MaeuCath1 
expression. However the failure of P2B cells to express MaeuCath1a when cultured on P2A 
ECM, implies that ECM-induced cyto-differentiation of WallMEC may be directional and 
once the cells have acquired a later phase phenotype they cannot be programmed backwards 
to an earlier phase by the ECM. We have indeed observed that while P2B ECM can program 
P2A cells to express tammar whey acidic protein (tWAP), a marker for P2B, the ECM from 
P2A does not program P2B cells to express the early lactation protein (tELP), the marker for 
P2A (Wanyonyi, In Press) .  This would similarly explain why P2A cells retained their 
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phenotype (expressing MaeuCath1a) when they were cultured on P1 ECM (supplementary 
data). 
Changes in the biochemical and biomechanical properties of the ECM that surrounds 
mammary epithelial cells initiate the transduction of signals into the nucleus of the cells 
causing  changes in the chromatin structure, altered gene expression and ultimately another 
cycle of change in the ECM (Bissell, Hall et al. 1982, Nicholas and Tyndale-Biscoe 1985, 
Nicholas, Collet et al. 1991). However, it is apparent that for the ECM-cell crosstalk to 
mediate epithelial cell polarity and milk protein gene expression, there has to be a synergistic 
involvement of lactogenic hormones (Topper and Freeman 1980, Bissell and Aggeler 1987).  
It is not surprising therefore that when WallMEC were cultured on P2A and INV (involuting 
mammary gland) ECM in the presence of IFPT3E2, they expressed more MaeuCath1a than 
the NH treated cells (supplementary data) and the activity of promoter fragment -709 to -15 
was enhanced by IFPT3E2. However the reason for the lack of expression of the second 
variant (MaeuCath1b) is unclear and requires further investigation. We postulate that the 
splice site preference in vivo is different from the selection in vitro as has been observed for 
the mouse kappa-immunoglobulin precursor in which the in vivo splicing mechanism 
preferentially selected the 5'-most donor splice site whereas such selectivity was lost in vitro 
(Perry, Kelley et al. 1980, Lowery and Van Ness 1988). Other complex splice site selection 
mechanisms have been suggested to be responsible for the expression of different variants in 
vitro and in vivo (Aebi, Hornig et al. 1986).   
The ECM modulates milk protein gene expression through transcription factors which 
recognise regulatory elements on milk protein gene promoters. For instance studies have 
shown that β-casein expression is signalled by the binding of laminin I to β1-integrin through 
the integrin-linked kinase (ILK) –mediated activation  of Rho GTPase and Rac1 (Akhtar, 
Marlow et al. 2009). In the presence of prolactin, Rac 1 then activates the PrlR/STAT5 
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signaling cascade in effect recruiting STAT5 which drives β-casein transcription (Wakao, 
Gouilleux et al. 1995). Therefore transcription factor binding sites present on the ECM-
responsive MaeuCath1 promoter fragment -709 to -15 and the proximal -919 to -710 
sequence which has repressor properties are of particular interest with regard to cathelicidin 
expression and how it is regulated by the ECM. Transcription factor binding sites on the 
DNA fragment -709 to -15 showed there were 10 Sp1, 4 STAT5, 3 YY1, 3 C/EBPα and 1 
NF-1 sites while the putative repressor region -919 to -710 had 10 transcription factor binding 
sites 4 of which were TGIF, 2 YY1, 2 NF-1, 1 C/EBPα and 1 Sp1. 
Through binding to the highly ubiquitous GC boxes Sp1 positively regulates a large number 
of genes  (Li, He et al. 2004) but it is especially prominent in myeloid cell differentiation in 
which, together with C/EBP it activates individual genes including lactoferrin (Khanna-
Gupta, Zibello et al. 2000) and would probably be playing a similar role in MaeuCath1 
expression.  The link between Sp1 and the ECM has been demonstrated in several in vitro 
studies including one in which silencing of Sp1 down-regulated collagens, TIMP-1 and 
decorin (Verrecchia, Rossert et al. 2001) and another in which together with NF-1, Sp1 was 
shown to enhance COL1A1 promoter activity in Tsk2 fibroblasts (Christner, Hitraya et al. 
1998). However a feedback effect of ECM on Sp1 activity needs to be established in order to 
link ECM regulation of MaeuCath1 to Sp1.   Similar to Sp1, YY1 is ubiquitously expressed 
but it is a context-dependent regulator of transcription (Gordon, Akopyan et al. 2006) that can 
not only initiate transcription, but also activate (Guo, Casolaro et al. 2001) and repress (Shi, 
Lee et al. 1997, Sui, Affar el et al. 2004) gene expression. In the context of MaeuCath1 
expression it is feasible therefore to suggest that YY1 may determine the phase-specificity of 
its expression.   
Interestingly, the regulatory elements found on the active promoter fragment -709 to -15  
have been shown to exist in clusters known as composite regulatory elements (CoRE) acting 
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together to regulate milk protein genes. For example the CoRE in whey protein gene 
promoters includes NF-1, glucocorticoid receptor (GR) and STAT5 while casein promoters 
have STAT5, YY1, GR and C/EBP binding sites (Groner, Altiok et al. 1994, Rosen, Zahnow 
et al. 1998). Therefore it appears that the overall function of the regulatory elements on the -
709 to -15 fragment is to activate the expression of MaeuCath1 through the synergistic effect 
of the ECM and lactogenic hormones hence the elevated promoter activity. Conversely the 
clustering of TGIF binding sites on the putative repressor sequence -919 to -710 suggests that 
this region may be responsible for the temporal down-regulation of MaeuCath1a expression 
during P2B and P3 since TGIF is a potent repressor of transcription (Wotton, Lo et al. 1999, 
Liu and Huang 2008, Melhuish, Chung et al. 2010).  
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4.1.6  Materials and Methods 
Animal ethics and handling 
Tammar wallabies (M. eugenii) were reared in an open grass yard where they had free access 
to adequate shelter and water and were fed ad libitum. Animal ethics guidelines provided by 
the Deakin University Animal Welfare Committee (AWC) were observed.  
Isolation of tammar mammary epithelial cells (WallMEC) 
Wallabies at day 21 and 136 lactation representing P2A and P2B respectively were 
euthenised and mammary tissue surgically removed and immediately placed in 1u Hanks’ 
Balanced Salt Solution (HBSS) (Sigma 55021C) containing 10 μg/ml penicillin/streptomycin 
(Gibco, USA) and 2.5 Pg/mL Fungizone (Gibco). After removal of fat, the tissue was 
weighed and sliced repeatedly into tiny fragments followed by incubation at 37qC for up to 4 
hr in 400 units/ml Collagenase Type 3 and 100 units/ml Hyaluronidase (Worthington) 
observing a ratio of 25 g tissue per 100 mL digest media and cells harvested by filtration, first 
through 200Pm mesh and then 53Pm mesh Nalgene filter. The filtrates were centrifuged at 
80xg for 5 min and cell pellets washed twice by suspending in HBSS and centrifuging at 
80xg for 5 min. After the final wash, cells were resuspended in freezing media (90% FCS 
(Invitro Technologies)/10%DMSO (Sigma, D8418), at a density 2 u 107 cells/ml and frozen 
in liquid nitrogen.  
Preparation of ECM  
ECM was isolated from mammary tissue by homogenisation followed by sequential high salt 
washes and urea extraction as described by O’Brien et al (O'Brien, Fornetti et al. 2010) . 
Briefly, previously snap-frozen mammary tissue was added to a ceramic mortar containing 
liquid nitrogen and pulverised to a fine powder followed by homogenisation in a high salt 
buffer (1g of tissue in 2ml) containing 2 mM n-ethylmaleimide (NEM), 200 μg/ml 
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phenylmethylsulfonyl fluoride (PMSF) and  2x protease inhibitor (PI) cocktail (Sigma, 
P8340). The homogenate was enriched for insoluble ECM proteins by performing a second 
high salt wash and urea extraction, including a high speed centrifugation step (1 hr at 
100,000xg) between the washes and the ECM serially dialysed to remove protease inhibitors 
and urea. The final dialysis was performed in Hams F12/ M199 media (Gibco® ) in the 
absence of serum and the ECM aliquoted for freezing at -20oC until required. 
Investigating the effect of ECM on MaeuCath1 expression  
Undiluted ECM ( 380 - 420 μg/ml) was added to each well of a 6 well tissue culture plate 
(Costar; Corning Incorporated) so as to completely cover the bottom and the plate incubated 
at 37oC for 1 hr to allow coating. To the control wells (plastic), growth media containing 
serum was added without ECM. After coating the wells, WallMEC from P2A and 2B at 
passage 5 and earlier were seeded at a density of 5x104 cells per well in growth media (Hams 
F12/ M199/HEPES containing 5% foetal bovine serum (FBS), 20% horse serum, 1mM 
glutamine and 100U/ml penicillin/100 μg/ml streptomycin and cells incubated overnight at 
37oC/5% CO2.  Growth media was aspirated from the cells and fresh media containing 2% 
FBS added to the no hormone (NH) treated samples while the media on the hormone treated 
(IFPT3E2) wells was supplemented with 1 μg/ml cortisol (F), 10 ng/ml EGF, 1 μg/ml insulin 
(I), 0.2 μg/ml prolactin, 650 pg/ml triodothyronine and 1 pg/ml estradiol and the cells 
incubated for a further 2 days.  The cells were harvested for RNA purification using the 
RNeasy protocol (Qiagen) and 1μg of RNA used for cDNA synthesis and RT-PCR using 
primers shown in table 1. 
Cloning of MaeuCath1 promoter fragments 
Cloning primers were designed to include Xho I (Forward) or Hind III (Reverse) restriction 
enzyme sites to allow cloning of MaeuCath1promoter fragments into the multiple cloning site 
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(MCS) of the pGL3 basic vector (Promega) 5’ to the luciferase gene. For cloning promoter 
fragments without the putative repressor (-919 to -709) the Hind III site in the reverse primers 
was replaced with a Kpn I site.  Promoter fragments were amplified by PCR using wallaby 
genomic DNA isolated from the mammary gland as template and 30 cycles of denaturation 
for 45 s at 94oC, annealing for 45 s at 60 oC and extension for 1 min at 72 oC followed by a 
final extension at 72 oC for 5 min and PCR products purified using the QIAquick kit 
(Qiagen). Purified PCR products and pGL3 plasmid (10 μg each) were double digested with 
Xho I and Hind III in buffer 2 ( New England Biolabs) and gel-purified using the QIAquick 
Gel Extraction Kit (Qiagen) before ligation of 100 ng of plasmid to 150 ng promoter 
fragment. Transformation of the ligation mix into JM109 cells and screening for 
recombinants was done according to standard procedure (Maniatis 1982).      
Luciferase assay 
WallMEC were seeded (without antibiotics) in a 96 well plate so as to achieve 80% 
confluency after overnight incubation and the cells washed twice with Opti-MEM® I Reduced 
Serum Media (Life Technologies) and 30 μl fresh Opti-MEM added to each well at room 
temperature. Twenty microlitre of freshly prepared transfection mix consisting of 0.4 μg each 
of pSV-β-Galactosidase Control Vector (Promega) and the pGL3/MaeuCath1 promoter 
constructs and 1.3 μl FuGENE® HD Transfection Reagent (Promega) in Opti-MEM was 
added to each well. In the control wells pGL3/MaeuCath1 promoter constructs were replaced 
with pGL3 basic or pMAX-GFP plasmid constructs. The cells were incubated at 37oC/5% 
CO2 for 5 hr and 200 μl growth media added to the transfection mix in each well and the cells 
left incubating for 48 hr following which the pMAX-GFP transfected wells were observed 
under a fluorescent microscope to determine transfection efficiency.  Media was aspirated 
and cells washed twice with PBS making sure to completely remove residual PBS and cells 
lysed in Reporter Lysis Buffer (Promega) according to supplier’s instructions. Luciferase 
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activity was measured using the GloMax® 96 Microplate Luminometer and data normalised 
using β-Galactosidase activity.  
Preparation of nuclear extract 
Prior to Electrophoretic Mobility Shift Assays (EMSA), WallMEC from P2A were cultured 
in 2x T75 TC-treated culture flasks (Corning) in growth media alone (plastic) or growth 
media underlaid with ECM from P2A or P2B wallaby mammary tissue until they were fully 
confluent and nuclear extract isolated using the NE-PER kit (Pierce) according to 
manufacturer’s instructions.   The protein concentration of the nuclear extract was estimated 
using the BCA Protein Assay kit (Pierce) and the extract diluted to 1 μg/μl using NER buffer 
(Pierce) and immediately aliquoted for storage at -80oC  until required.  
Electrophoretic Mobility Shift Assays (EMSA) 
EMSA was performed using the Molecular ProbesTM EMSA kit (E33075) according to 
manufacturer’s instructions.  Briefly, complementary primer pairs (table 1) were annealed by 
mixing equimolar  (100 μM) amounts in a 1.5 ml centrifuge tube and boiled in a 1l water bath 
for 5 min, the heater switched off and the water bath left to cool down to room temperature. 
Annealed primers were diluted to10 ng/μl and 1 μl added to a binding reaction containing 4 
μg nuclear extract and 2 μl binding buffer in a total volume of 10 μl and the binding mix left 
at room temperature for 20 minutes.   On completion of the binding reaction, 2 μl of 6x DNA 
loading buffer was added to the mix and the complexes resolved on a 6% polyacrylamide gel 
in TBE at 200V.  The gel was first stained with SYBR green and photographed under UV 
light in a ChemiDoc gel imaging system (Biorad) to view DNA bands and then stained with 
Sypro Ruby to view proteins.     
Prediction of transcription factor binding sites 
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MaeuCath1 cDNA sequence [Genbank:ABV01938.1] was used to perform a BLAST search 
against the wallaby draft genome sequence at Ensembl and found to match the cathelicidin 
translated sequence on Scaffold97912. Consequently the 10 kb sequence proximal to the 
ATG start codon on the 5’ side was searched against the TRANFAC database for known 
regulatory elements including the TATA box and transcription start site, and lactation 
hormone responsive elements including the STAT5 binding site upon which the -2245 region 
was selected for further investigation using P-Match, Patch 1.0, AliBaba 2.1 software 
available at http://www.gene-regulation.com/pub/programs.html. Only elements that were 
recognised by at least two of the software at the same position in the sequence were 
considered. A cut-off homology of 87.5% and maximum 2 bp mismatch was allowed. 
Statistical analysis 
Statistical analysis of all comparative data was performed using the two-tailed t-test with a 
statistical significance cut-off of 5%. 
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4.1.7 Figures 
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Figure 1. 
MaeuCath1 expression in wallaby mammary gland and mammary epithelial cells 
(WallMEC). A: Agarose gel of RT-PCR products of Maeucath1 amplified from mammary 
gland obtained from P2A and P2B (Wanyonyi, Sharp et al. 2011).  P2A and P2B represent, 
phase 2A (days 2 and 80 lactation) and phase 2B (days 135, 150 and 168 lactation). Samples 
were loaded in order of increasing days of lactation. The splice variants MaeuCath1a and 
MaeuCath1b are indicated with an arrow. B: Agarose gel showing MaeuCath1a gene 
expression in P2A WallMEC cultured on ECM. PL represents plastic. P2A and P2B represent 
the lactation phase of the ECM. NH represents cells cultured in the absence of hormones and 
H represents cells treated with the full complement of lactogenic hormones (IFPT3E2) C: 
Agarose gel showing MaeuCath1a gene expression in P2B WallMEC cultured on ECM.  P2A 
and P2B represent the lactation phase of the ECM. D: Quantitative PCR of MaeuCath1 using 
cDNA from P2A WallMEC.  NH represents no hormones while IFPT3E2 represents the full 
complement of lactogenic hormones. The asterisk represents expression significantly higher 
than observed on P2B ECM (p≤0.01). The & sign implies MaeuCath1a expression was 
significantly higher in H treated WallMEC than the NH treated WallMEC (p≤ 0.04). 
Treatments were performed in triplicate and repeated twice. Error bars are shown. E: 
Quantitative PCR of MaeuCath1 using cDNA from P2A and P2B WallMEC cultured on P2A 
ECM. The lactation phase of WallMEC is shown on the x-axis. The asterisk represents 
expression significantly higher in P2A WallMEC than observed in P2B WallMEC  (p≤0.002) 
while & implies MaeuCath1a expression was significantly higher in H treated WallMEC than 
the NH treated WallMEC. Treatments were performed in triplicate and repeated twice. 
Representative results with their error bars are shown. 
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Figure 2. 
MaeuCath1 putative promoter sequence. Promoter sequence was obtained from the annotated wallaby genomic DNA sequence at Ensembl. 
Sense primers used for amplifying deletion fragments are shaded grey and shown with a forward arrow and the corresponding distance in base 
pairs from the ATG start site. The universal reverse primer is shown with reverse arrow. The TATA box and translation start site are shown.
 
 
TTTGGAGAGGGCAATCAATTGATGTCTCTAGTTGTTCTGGTGCTAAAAGTCTGGAATTATATTAGGCTCACAAACTTTTACCTAGCACATACAATTCTGAGACTTCACT
TTAATGCCAAAAATGTCCTTATATCAAGGACCTGTGATTTCAACATTTTGAGAAATTCCTCCAGTGTGCAAAATGTCCTTATATCAAGGACCTGTGATTTCAACATTTT
GAGAAATTCCTCCAGTGTGCAACCCAGTGTAACTTACAGACTTCAAGAGTTTCCTAGGCTCGCAGAGATCAGGTGATTAGCCTGCCATCACACAAATGTTCAGAAGCAC
GATTTGAACCCAGATCTTCCTGATTCGCAGTCCTTTACTCACCAAATTATGTTACCTCTCATTCACAGGCAAGAGGAGTAAAATGAATGTAGATAATGGGCTCCATTAA
CAGTTCAGTGGCAAAACCACCACACCTTTTCTCTTAGCAGCTAGCAATGATTGTTTTCTGTATTTCACTCACAGAACAATTTTTGATACTTATCTAGCACACTTAATCT
AGCCAAAGAGGAAAAGTTAGCTTTACTTCTTACAACTTCCCATTAAATCTAAGATCAGCTCCTTCCTTTTTTTTCTATGAAGCAAAAGCAAAGAAGAGATGTAAAATAT
ATGCACTCATTTAAAAAGTAAAAAATTAATTCTATTATGAGTAAAATCACCTCAGTACAATGCCTGCCTAACAAAGCTATTAAAAGGTGTAAAGAGTTACGTGGAAAAA
GGGGAGGAGAGTGTGACTTTCCTCTCAAGAAAGAGGGATTCTTGTTGAGGCATAGCTTGAATTAGATGACCTCTGAAAAGTCTGTCCCCGAAGCCTGCTGGGAACTGCT
CCTCTTGGTGCCGCGCAGCCAAGCCAGGGCTGGGCTCTGCTCTGGGTCTGGTGTATGATGGACCTTTCGAGTCAGGTTTTCAGGGATCTCTGGAACAGAAATCTCCTCA
GCTCTGTTGTTCTGTGGCTTCTGGTGCTCCAGAATTTGTTGGGAGTTCTTCTTTACAGATATTTTATGGGCTGTGGGTTCAGAGGTAGCATATGTGTGTCTTTCTACTC
TGCCATCTTGGCTCCTCCCCCCGACTGTTCCTTCAATAATCCATTCATTCTGTTGGGAGTTCTTTCCAATTAAACCAGATGTGTGTGGATAATATGGAATATGATATAT
TCATTCTCTTTTGCTTAATATACAATATCTCTTCATTTCATTACCTTTCAGATGTGACCCATTGTCACTATGAATCTGTATTCCATAATAAAGACTTACAATATCTAGA
GTTTTAGAGATGTTTTTCTGGGTCACATTCTCATAATGACAAGCCATTGTTACATCTCAATTGGTGTCAAGACAAGTGCATATAAATTTGCATCCTTTATGTTGGGGTA
GGAGTCCAATATAATCCATTTGTCAAATTTGGACTAGGACTTTTCTCCTTGCTTTCTATCCATTTACTACCCAAGGAATAGTTCCTTCCTTCTCCAGTTGACATATATG
ACATTCCTCTGCCACCTGTTTCAGCAGTGAATGAGAGATAGCAATACCTCAGTTTCACGCCCACTGGTAGGTGGCCACCCCTAAATGGCCAACTGTTGCTGGACTCATT
TTGCTAGTACCAGATGATCAGGTGGTTTCAGAGTAGGGACAAGATGTTGAGTAGCAATCTTTGCTAGTCAATCAACATATGCATTGTACTCATGTTCCGGTGTATTGAG
GGCCACGTGAGGATCTACATGAAAAACTGACTAATTAGTAACCTGTGGCCTGAGCATTTGGGAAGGATTAGAGTAGAATACAGAGGTCAGTTTAAACAACTCTAACTCT
GTTGCAAAGTTCCTTGAGTAACTAGAAAGACAACCCAATATGGCAGCTGACTGAACCATCCACTCATCTGCACATCCTCTAGGTCTTTGTAAGACAGAGAGAGGTGGGG
AACATATTTATTTCTTCATATCCCTGTGCCTCTCAAATTTACTGTCTTCCTCCTCTACTTTTTCTCCATACTTCCCCTCTTTGCCCAATCCTTCCTTTTGATTAAGTCA
AGGGCTGTATGATGAAATTGAAGAAGGAGACTGCTAGCCCTGGGGATAAGAGGTGACCAATGACAGAAGAATGGAGGAAATCACAGACCTCAGGGAACTGTTAGAGGCC
AATGGCTGGAGGTATCTATTGTCCTTGTGTAAGGGTGGGGAGGAGCCAGTAAATAAAAGACAGTTTCTTTCTGCCCAGAGCATTGAGCACCAAGAGGATG  
-1885 Fwd 
-1577 Fwd 
-1260  Fwd 
-919   Fwd 
-709  Fwd 
-484 Fwd 
-2245 Fwd 
common reverse  
Translation start site TATA box 
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Figure 3. 
Deletion fragments of MaeuCath1 putative promoter and optimisation of transfection of 
WallMEC with reporter/promoter constructs. A: Schematic diagram of deletion 
fragments of the -2245 bp putative promoter. The numbers represent base pairs 5’ to the ATG 
translation start site. Each fragment is 14 bp shorter than the indicated size since the universal 
reverse primer was designed to anneal 14 bp 5’ to the start site. B: Agarose gel of promoter 
fragments. The sense cloning primer for each fragment was designed so as to include an Xho 
I restriction site while the universal reverse primer contained a Hind III restriction site. C: 
Optimisation of transfection of WallMEC. Cells were cultured on plastic or ECM and 
transfected separately with pMAX-GFP plasmid and luciferase/promoter constructs and 
observed under bright field and fluorescence microscope. Bright field and fluorescent images 
are shown.   
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Figure 4: 
Promoter activity of the Maeucath1 putative promoter deletion fragments. A-C: 
Promoter activity in P2A cells cultured on P2A ECM, P2B ECM and plastic. WallMEC were 
cultured overnight in a 96 well plate and co-transfected with 0.8 μg each of the promoter 
construct, pMAX-GFP and β-galactosidase per well. Separate transfections with pGL3 basic, 
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pGL3 Basic/Rat beta casein (Rbeta cas on the graphs) as negative and positive controls for 
promoter activity respectively. Transfection with pMAX-GFP was included as a control for 
transfection efficiency. Luciferase activity was normalised using β-galactosidase activity. 
Transfections were done in triplicate and repeated three times. Representative data including 
error bars is shown. The asterisk represents promoter activity significantly lower than the 
activity of the -709 to -15 fragment (p≤0.05) D-F: Promoter activity in P2B cells cultured on 
P2A ECM, P2B ECM and plastic. Promoter activity higher than the activity of the -709 to -15 
fragment is indicated with ** (p≤0.004). 
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Figure 5. 
Enhancer or repressor activity and hormone dependence of MaeuCath1 promoter.      
A: Hormone response of MaeuCath1promoter. The -709 to -15 fragment representing the 
highest positive regulatory effect was used to transfect P2A WallMEC cultured on P2A ECM 
and treated with IFPT3E2 or no hormone (NH). Luciferase activity was normalised with β-
galactosidase. The asterisk represents promoter activity higher than the NH control 
(p=0.048). B: Schematic diagram of deletion fragments cloned into the Rat β-casein 
promoter construct to test for enhancer or repressor activity. The 225 bp fragment spanning 
the region -709 to -485 represents a putative enhancer while the 210 bp fragment spanning -
919 to -709 represents a putative repressor. C: Activity of Rat β-casein promoter after 
ligating to Maeucath1 promoter fragments. The -709 to -485/R-β-cas and -919 to -709/Rβ-
cas constructs were used to transfect P2A WallMEC cultured on P2A and treated with no 
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hormone (NH) or IFPT3E2. Luciferase activity was normalised with β-galactosidase. 
Treatments were performed in triplicate and repeated twice. Representative results are shown 
with error bars. Promoter activity significantly lower than that of the Rat β-casein promoter is 
indicated by * (p=0.01) while higher activity is indicated by ** (p=0.005). 
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Figure 6. 
MaeuCath1 promoter activity after deleting the putative repressor element. A: 
Schematic diagram of MaeuCath1 promoter deletion fragments without the putative 
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repressor element.  The repressor element is the 210 bp sequence from -919 to -710 and 
represented by a white box in the diagram.  The predicted transcription factor binding sites 
are shown. The repressor-deleted fragments -2245 to -15 and -1260 to -15 are presented as a 
black box. The positive regulatory fragment -709 to -15 was included as a standard for 
activity. B: Activity of the repressor-deleted promoter fragments. Promoter constructs were 
used to co-transfect P2A WallMEC cultured on P2A ECM with β-galactosidase and 
luciferase assays performed.  Luciferase activity was normalised with β-galactosidase. The 
asterisk represents luciferase activity significantly higher than observed for the -709 to -15 
fragment (p≤0.022).   Treatments were done in triplicate and repeated twice. Error bars are 
shown.  
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Figure 7.  
Transcription factor binding sites on MaeuCath1 putative promoter. Transcription factor 
binding sites were predicted using the P-Match, Patch 1.0, AliBaba 2.1 based on the 
TRANSFAC® database of experimentally and in-silico determined regulatory elements. The 
numbers represent distance in base pairs from the ATG start site. Only elements in the 
forward strand and bearing higher than 87.5% homology to the experimentally determined 
binding site (TRANSFAC) are shown.  The key of transcription factors is shown. 
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Figure 8:  Electrophoretic mobility shift assay (EMSA) of repressor primer duplexes. Fifty base pair complementary oligonucleotides were 
designed spanning the 210 bp repressor fragment so as to allow 10 bp overlap between primer pairs. Nuclear extracts (equivalent to 4 μg of 
protein) from P2A cells cultured on plastic, P2A ECM and P2B ECM were used for binding assays. Gels were first stained with SYBR green to 
detect DNA and photographed and then stained with Sypro ruby to detect proteins. Both SYBR green and Sypro ruby stained images are shown. 
The shifted band was excised for mass spectrometry and is shown by an arrow. GS1F/GS1R, GS2F/GS2R, GS3F/GS3R, GS4F/GS4R and 
GS5F/GS5R represent gel shift assay primer sets in the order of increasing distance from the ATG start site.  L represents DNA ladder while P, 
2A and 2B represent nuclear extract isolated from cell cultured on plastic, P2A ECM and P2B ECM respectively.  D represents oligonucleotide 
duplexes alone while D+P, D+2A and D+2B represent oligonucleotide duplexes plus nuclear extract from cells cultured on plastic, P2A ECM 
and P2B ECM respectively.  
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Table 1.  
Primers for amplifying MaeuCath1 cDNA  
Name Primer sequence (5’-3’)   
MaeuCath1 Fwd ATGCAGGTACTCCTATTGGTG   
MaeuCath1 Rev CCCTGGCAGTGGGATAGGAAT   
Primers for generating promoter deletions 
Name Primer sequence (5’-3’) Restriction enzyme site 
-2245 Forward gcaatcCTCGAGTGTTCTGGTGCTAAAAGTCTGG Xho I 
-1885 Forward gcaatcCTCGAGCAGGCAAGAGGAGTAAAATG Xho I 
-1577 Forward gcaatcCTCGAGTCACCTCAGTACAATGCCTG Xho I 
-1260 Forward gcaatcCTCGAGTGTTGGGAGTTCTTCTTTAC Xho I 
-919 Forward gcaatcCTCGAGTACATCTCAATTGGTGTCAAG Xho I 
-709 Forward gcaatcCTCGAGAATACCTCAGTTTCACGCCCA Xho I 
-484 Forward gcaatcCTCGAGCTGAGCATTTGGGAAGGATT Xho I 
Common Reverse ggatctAAGCTTATGCTCTGGGCAGAAAGAA Hind III 
Primers for cloning MaeuCath1 promoter fragments into Rβ-casein  promoter construct 
Name Primer sequence (5’-3’) Restriction enzyme site 
-1260 Forward gcaatcCTCGAGTGTTGGGAGTTCTTCTTTAC Xho I 
-919 Reverse ggatctAAGCTTGCTATCTCTCATTCACTGCTG Hind III 
-709 Forward gcaatcCTCGAGAATACCTCAGTTTCACGCCCA Xho I 
-709 Reverse ggatctAAGCTTGCCACAGGTTACTAATTAGTC Hind III 
Primers for gel shift assay 
Name Primer sequence (5’-3’)   
GS1F CATATATGACATTCCTCTGCCACCTGTTTCAGCAGTGAATGAGAGATAGC    
GS1R GCTATCTCTCATTCACTGCTGAAACAGGTGGCAGAGGAATGTCATATATG    
GS2F ATTTACTACCCAAGGAATAGTTCCTTCCTTCTCCAGTTGACATATATGAC    
GS2R GTCATATATGTCAACTGGAGAAGGAAGGAACTATTCCTTGGGTAGTAAAT  
GS3F GTCAAATTTGGACTAGGACTTTTCTCCTTGCTTTCTATCCATTTACTACC   
GS3R GGTAGTAAATGGATAGAAAGCAAGGAGAAAAGTCCTAGTCCAAATTTGAC 
GS4F CATCCTTTATGTTGGGGTAGGAGTCCAATATAATCCATTTGTCAAATTTG   
GS4R CAAATTTGACAAATGGATTATATTGGACTCCTACCCCAACATAAAGGATG   
GS5F TACATCTCAATTGGTGTCAAGACAAGTGCATATAAATTTGCATCCTTTAT   
GS5R ATAAAGGATGCAAATTTATATGCACTTGTCTTGACACCAATTGAGATGTA   
Primers for excluding repressor fragment from MaeuCath1 promoter (the region between -709 and -919) 
Name Primer sequence (5’-3’) Restriction enzyme site 
-919 rep Rev  ggatctCTCGAGACAATGGCTTGTCATTATGAG Xho I 
-1260 rep Fwd gcaatcGGTACCTGTTGGGAGTTCTTCTTTAC Kpn 1 
-2245 rep Fwd  gcaatcGGTACCTGTTCTGGTGCTAAAAGTCTGG Kpn 1 
Except for gel shift assay primers, all primers were designed so as to utilise restriction enzyme sites in the 
multiple cloning site of pGL3 basic vector and enable cloning the fragments 5’ to the luciferase or Rβ-casein 
gene. The respective restriction enzyme sites are shown. 
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Chapter Five 
5.1 Transcriptome analysis (RNA-seq) of WallMEC cultured on ECM 
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5.1.1 Background  
After confirming that the expression of milk protein genes in wallaby is regulated through 
temporal changes in the composition of the mammary extracellular matrix (ECM) (chapter 
3), this study used the Illumina platform to perform RNA-seq in order to explore the 
molecular pathways  which are collectively impacted by changes in ECM resulting in altered 
milk protein gene expression. 
RNA-Seq also known as transcriptome sequencing is becoming immensely popular as a tool 
for gene discovery and quantitation due to a number of advantages it has over preceding 
technologies including DNA and RNA microarrays. Unlike microarray technologies, RNA-
Seq does not require probes and hybridisation and provides the numerical frequency of 
individual genes thereby significantly eliminating bias and background signals (Febbo and 
Kantoff 2006) which characterise hybridisation technologies.  Apart from generating gene 
expression profiles, RNA-seq enables abundant and rare transcript discovery (Su, Li et al. 
2011), isoform identification (Urashima, Messer et al. 1992), elucidating alternate splice site 
usage (Su, Li et al. 2011) and analysis of single nucleotide polymorphisms (SNPs) (Zarnegar 
and Michalopoulos 1995, Zeng, Chen et al. 2002). Several platforms are available for RNA-
seq including Illumina Genome Analyzer platform, ABI Solid Sequencing  and 454 
Sequencing provided by life sciences but all of them allow for customised sequence depth. 
This study utilised the Illumina genome Analyser platform.  
5.1.2  Methods 
WallMEC culture and isolation of RNA 
Total RNA was isolated from P2A WallMECs cultured on P2B or P3 ECM in the presence of 
the full complement of lactogenic hormones (H) (see Chapter 3, section 4.5)  or absence of 
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hormones (NH) and the sequencing service contracted to Beijing Genomics Institute (BGI). 
Culturing of WallMECs on ECM and RNA isolation was performed as described in chapter 
3, section 4.5. The RNA samples were designated P2B_NH, P2B_H, P3_NH and P3_H 
representing WallMECs cultured on P2B ECM with no hormones, P2B ECM with hormones, 
P3 ECM with no hormones and P3 ECM with hormones respectively.  On average 4.5 
million reads, 49bp long were obtained from each sample. 
RNA-seq data analysis 
The sequence output in FastQ format (Cock, Fields et al. 2010) was screened for quality 
using FastQC software provided by Babraham Bioinformatics 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and the Macropus eugenii 
genome (Ensembl reference, Macropus_eugenii.Meug_1) used as a reference for annotation 
of the sequence reads. The pipeline for sequence data analysis consisted of the software 
described in the Tuxedo protocol (Trapnell, Roberts et al. 2012) (figure 1). Briefly sequence 
reads were mapped to the M.eugenii genome using the Bowtie2 function of TopHat 2.0.5 
(Kim and Salzberg 2011, Langmead and Salzberg 2012) and transcripts assembled using 
Cufflinks (Trapnell, Williams et al. 2010). The final transcriptome assembly was performed 
by merging assembled transcripts using Cuffmerge and SAMtools (Li, Handsaker et al. 2009) 
and the differential expression of the mapped reads determined using Cuffdiff. In order to 
visualise the differential expression of transcripts, volcano plots were generated using 
CummeRbund (R Package) and the location where the reads aligned confirmed using 
SeqMonk (version 0.22.0).  
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Figure 1. 
The tuxedo protocol. Huang da, W., B. T. Sherman, et al. (2009). Nature Protocols. 
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Functional clustering and pathway analysis     
In order to perform functional annotation clustering, the gene ID’s for the differentially 
expressed genes (both up-regulated and down-regulated) were uploaded into DAVID v6.7 
(the Database for Annotation, Visualization and Integrated Discovery) (Huang da, Sherman 
et al. 2009, Huang da, Sherman et al. 2009) and the gene ID’s converted to symbols which 
are compatible with the DAVID database. Only gene clusters with an enrichment value equal 
to or higher than 1.3 (following authors’ recommendations) (Huang da, Sherman et al. 2009) 
were considered representative of the treatments unless the cluster or pathway has previously 
been associated with interactions between the extracellular matrix and epithelial cells and 
milk protein gene expression. Pathway analysis was performed using the BioCarta and 
KEGG databases which are available at DAVID (http://david.abcc.ncifcrf.gov/).  
5.1.3 Results and discussion 
Transcript abundance 
Of the 31313 transcripts available in the wallaby genome, 24582, 24646, 24899, 24804 
mapped to transcripts from the P2B-NH, P2B-H, P3-NH, P3-H treatments respectively.  
Differential regulation of gene expression by ECM and hormone treatments  
In order to visualise the differential expression of genes between treatments, volcano plots 
were constructed for four datasets representing, P2B ECM with and without hormones 
(P2B_NH versus P2B_H), P3 ECM with and without hormones (P3_NH versus P3_H), P2B 
ECM and P3ECM without hormones (P2B_NH versus P3_NH) and P2B ECM and P3 ECM 
with hormones (P2B_H versus P3_H). The plots are shown in figures 2A – D. The dots on 
the left side of zero represent down regulated genes while the dots on the right side represent 
up-regulated genes.  The statistical significance of the difference between treatments 
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expressed as –log10(p value) is shown on the y-axis. Blue dots represent genes whose 
expression level is significantly different. In order to enhance the level of confidence only 
genes with –log10(p value) higher than 2.5were differentially expressed between the 
treatments. 
 
Figure 2A 
Volcano plot comparing the fold change in gene expression of WallMEC cultured on P2B 
ECM without hormones (NH) and in the presence of hormones (H). Except for one 
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unannotated gene there were no significantly differentially expressed genes between H and 
NH treated WallMEC.    
 
Figure 2B 
Volcano plot comparing the fold change in gene expression of WallMEC cultured on P3 
ECM without hormones (NH) and in the presence of hormones (H).  Fourteen genes were 
differentially regulated (13 up-regulated and 1 down-regulated in the presence of hormones).  
Five of the up-regulated genes were identified as CSF3, ENSMEUG00000006814, MMP1, 
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OLFM4 and GPR83. The remaining 7 genes were unknown. The down-regulated gene was 
unknown.    
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Figure 2C 
Volcano plot comparing the fold change in gene expression of WallMEC cultured on P2B 
ECM versus P3 ECM without hormones (H). Relative to P2B ECM, 598 genes were up-
regulated by P3 ECM (303 annotated or wallaby transcript ID known,  295 unknown) and 
203 down-regulated (75 annotated or wallaby transcript ID known, 128  unknown).  
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Figure 2D 
Volcano plot comparing the fold change in gene expression of WallMEC cultured on P2B 
ECM versus P3 ECM with hormones (H).  Relative to P2B ECM 601 genes were up-
regulated (286 annotated or wallaby transcript ID known, 315 unknown) and 207 genes were 
down-regulated (79 annotated or wallaby transcript ID known, 128 unknown).   
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Treatments compared 
Up-regulated Down-regulated 
Annotated  Unknown Total  Annotated  Unknown Total 
P2B_NH versus P2B_ H 0 1 1 0 0 0 
P3_NH versus P3_H 6 7 13 1 0 1 
P2_NH versus P3_NH 303 295 598 75 128 203 
P2_H versus P3_H 286 315 601 79 128 207 
 
Table 1 
Summary of differentially regulated genes after culturing WallMEC on P2B or P3 ECM in 
the presence or absence of lactogenic hormones. Annotated represents genes whose ID is 
available at GenBank and/or Ensembl and genes which have no gene name but have been 
assigned a transcript number at Ensembl eg ENSMEUG00000006814. Unknown represents 
genes that returned no gene or transcript ID when mapped to the wallaby geneome.  
 
 
 
 
 
 
 
 
Functional clusters of differentially expressed genes 
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In order to determine the differential effect of ECM and hormones on WallMEC gene 
expression, functional clusters of genes were generated by uploading the ID’s of 
differentially regulated genes from the P2B_NH versus P2B_ H, P3_NH versus P3_H, 
P2_NH versus P3_NH and P2_H versus P3_H treatments onto the DAVID functional 
annotation software.  The relative abundance of functional clusters for each dataset are shown 
in figures 3A-D. No clustering was done for the P2B_NH versus P2B_ H because only one 
gene was differentially expressed. Although functional annotation was attempted for the 5 
differentially expressed genes in the P3_NH versus P3_H dataset, no functional cluster was 
obtained. 
In all the datasets glycoproteins constituted the highest percentage of differentially expressed 
genes, averaging 16% (figure 3A-D). Post-translational glycosylation of proteins regulates 
the function of a large number of proteins and in the context of milk, glycosylation protects 
proteins from proteolysis (Brines and Brock 1983), modulates interaction of milk 
antimicrobials with target pathogens (Newburg 1999) and plays a role in neonatal 
development.  Therefore the differential expression of a large number of glycoprotein genes 
upon culturing WallMEC on ECM points to a global rather than specific modulatory role of 
ECM in MEC function.  
Also prominent in all the datasets were the ECM and cell adhesion clusters (3%), dominated 
by matrix metalloproteases (MMP’s) and ADAM metallopeptidase with thrombospondin 
(ADAMTS’s) and they appeared to be regulated both by the ECM and hormones. For 
example while   MMP1, MMP7, MMP9, MMP16, ADAMTS1, ADAMTS8 and ADAMTS15 
were up-regulated in the P2B_H versus P3_H dataset, only MMP1, MMP16 and 
ADAMTS15 were up-regulated in the P2_NH versus P3_NH dataset (higher in P3_NH; 
tables 3 and 4).  The ECM related cluster also consisted of structural ECM proteins including 
collagen VII, a basal lamina protein secreted by epithelial cells and collagen XV which is 
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expressed mainly in fibroblasts but also in renal, pancreatic, lung and placental epithelial 
cells (Kivirikko, Saarela et al. 1995).  Tenascin C which is expressed in fibroblasts but also in 
mammary epithelial cells (Gonzalez-Sancho, Alvarez-Dolado et al. 1999) in a lactation 
phase-dependent manner (Jones, Boudreau et al. 1995, Wirl, Hermann et al. 1995) was also 
differentially regulated by the ECM (tables 3 and 4). 
Mammary luminal epithelial cells have been shown to express various MMP’s (Djonov, 
Hogger et al. 2001, Park, Zeng et al. 2001) and ADAMTS’s (Porter, Scott et al. 2004) 
constitutively and in an inducible manner although these proteases are mainly expressed in 
the stroma and myoepithelium (Porter, Scott et al. 2004). Therefore it is conceivable that 
fibroblasts were present in the WallMEC culture and this study should have included 
epithelial-enriching and fibroblast-sequestering steps. However the overarching cause for 
change in WallMEC phenotype was evidently the synergistic effect of hormones and the 
ECM since there were marked differences in gene expression between P2B ECM and P3 
ECM treated cells.   
Similar to the ECM related cluster, genes in the hormone response cluster were abundant 
(3%) in both NH and H datasets (figures 3A-D) but surprisingly absent in the down-regulated 
gene category of both clusters (tables 5 and 6). This lop-sided expression of hormone 
response genes requires further investigation because it can help dissect the hormone effect 
from the ECM effect.   
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Figure 3A:  Relative abundance of up-regulated functional clusters for the P2_NH versus 
P3_NH dataset. 
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Figure 3B 
Relative abundance of down-regulated functional clusters for the P2_NH versus P3_NH dataset. 
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Figure 3D 
Relative abundance of up-regulated functional clusters for the P2_H versus P3_H dataset. 
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Up-regulated genes (P2B_NH < P3_NH) 
DAVID 
Enrichment 
score 
P value 
ADAM metallopeptidase with thrombospondin type 1 motif, 15  
CD248 molecule, endosialin  
Kazal-type serine peptidase inhibitor domain 1  
acetylcholinesterase (Yt blood group)  
amyloid beta (A4) precursor-like protein 1  
angiogenin, ribonuclease, RNase A family, 5  
bone morphogenetic protein 4  
cartilage oligomeric matrix protein  
coagulation factor III (thromboplastin, tissue factor)  
collagen, type VII, alpha 1  
collagen, type XV, alpha 1  
fibulin 5  
lysyl oxidase  
matrix metallopeptidase 1 (interstitial collagenase)  
matrix metallopeptidase 16 (membrane-inserted)  
netrin 4  
tenascin C  
tumor necrosis factor receptor superfamily, member 11b  
wingless-type MMTV integration site family, member 7A 
 
 
 
 
 
 
 
 
 
 
3.76 
 
 
 
 
 
 
 
 
 
 
6.0E-6 
Down-regulated genes (P2B_NH >P3_NH) 
DAVID 
Enrichment 
score 
P value 
MAM domain containing 2  
SPARC related modular calcium binding 2  
cell adhesion molecule with homology to L1CAM (close homolog of 
L1)  
collagen, type XIV, alpha 1  
matrix metallopeptidase 19  
matrix metallopeptidase 7 (matrilysin, uterine)  
spondin 2, extracellular matrix protein 
 
 
 
 
2.59 
 
 
 
 
1.6E-4 
 
Table 3 
 
Differentially regulated extracellular-matrix related genes in WallMEC cultured on P2B or 
P3 ECM without hormones (P2B_NH versus P3_NH). The genes marked in bold letters are 
unique to the NH treated samples 
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Up-regulated genes (P2B_H < P3_H) 
DAVID 
Enrichment 
score 
P value 
ADAM metallopeptidase with thrombospondin type 1 motif, 1 
ADAM metallopeptidase with thrombospondin type 1 motif, 15 
Kazal-type serine peptidase inhibitor domain 1 
amyloid beta (A4) precursor-like protein 1 
bone morphogenetic protein 4 
cartilage oligomeric matrix protein 
chitinase 3-like 1 (cartilage glycoprotein-39) 
coagulation factor III (thromboplastin, tissue factor) 
collagen, type XV, alpha 1 
fibulin 5 
matrix metallopeptidase 1 (interstitial collagenase) 
matrix metallopeptidase 16 (membrane-inserted) 
matrix metallopeptidase 7 (matrilysin, uterine) 
matrix metallopeptidase 9  
tenascin C 
tumor necrosis factor receptor superfamily, member 11b 
wingless-type MMTV integration site family, member 7A 
 
 
 
 
 
 
 
 
 
 
2.12 
 
 
 
 
 
 
 
 
 
 
5.0E-5 
Down-regulated genes (P2B_H > P3_H) 
DAVID 
Enrichment 
score 
P value 
ADAM metallopeptidase with thrombospondin type 1 motif, 16  
MAM domain containing 2  
SPARC related modular calcium binding 2  
cell adhesion molecule with homology to L1CAM (close homolog of 
L1)  
extracellular matrix protein 2, female organ and adipocyte 
specific  
matrix metallopeptidase 19 
 
 
 
 
2.24 
 
 
 
 
1.5E-3 
 
Table 4 
Differentially regulated extracellular-matrix related genes in WallMEC cultured on P2B or 
P3 ECM in the presence of hormones (P2B_H versus P3_H). The genes marked in bold 
letters are unique to the H treated samples
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Up-regulated genes DAVID Enrichment 
score 
p-Value 
adrenomedullin  
angiogenin, ribonuclease, RNase A family, 5  
bone morphogenetic protein 4  
crystallin, alpha B  
cytochrome P450, family 27, subfamily B, polypeptide 1  
enolase 2 (gamma, neuronal)  
gamma-glutamyl hydrolase (conjugase, 
folylpolygammaglutamyl hydrolase)  
growth hormone receptor  
high-mobility group box 2  
insulin-like growth factor 2 (somatomedin A); insulin; INS-
IGF2 readthrough transcript  
interleukin 6 (interferon, beta 2)  
lysyl oxidase  
nuclear receptor subfamily 4, group A, member 3  
phospholipase A2, group IVA (cytosolic, calcium-dependent)  
tumor necrosis factor receptor superfamily, member 11b  
very low density lipoprotein receptor 
 
 
 
 
 
 
 
 
 
 
2.16 
 
 
 
 
 
 
 
 
 
 
6.5E-4 
Down-regulated genes Enrichment score 
p-Value 
 
No functional cluster identified - - 
 
Table 5 
Differentially regulated hormone response related genes in WallMEC cultured on P2B or P3 
ECM without hormones (P2B_NH versus P3_NH) 
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Up-regulated genes 
DAVID 
Enrichment 
score 
p-Value 
FOS-like antigen 1  
adrenomedullin  
bone morphogenetic protein 4  
cytochrome P450, family 27, subfamily B, polypeptide 1  
enolase 2 (gamma, neuronal)  
growth hormone receptor  
high-mobility group box 2  
interleukin 6 (interferon, beta 2)  
phospholipase A2, group IVA (cytosolic, calcium-dependent)  
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H 
synthase and cyclooxygenase)  
regulator of calcineurin 1  
tumor necrosis factor receptor superfamily, member 11b 
 
 
 
 
 
 
 
2.92 
 
 
 
 
 
 
 
4.3E-4 
Down-regulated genes Enrichment 
score 
p-Value 
 
No functional cluster identified - - 
 
Table 6 
Differentially regulated hormone response related genes in WallMEC cultured on P2B or P3 
ECM in the presence of hormones 
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Differentially regulated functional pathways 
Because only one gene (unknown) was differentially expressed between no hormone (NH) 
and hormone-treated (H) WallMEC cultured on P2B ECM, pathway analysis was not done 
for the P2B-NH versus P2B_H dataset. Similarly, although pathway analysis was done for 
the 5 differentially expressed genes in the P3_NH versus P3_H dataset, the query did not 
return any pathway.  The comparison between WallMEC cultured on P2B ECM and P3 ECM 
in the presence of hormones (P2B_H versus P3_H) identified 12 pathways in which genes 
were differentially up-regulated (higher in P3_H; table 7). Nine out of these pathways were 
affected in the comparison between P2B ECM and P3 ECM in the absence of hormones 
(P2B_NH versus P3_NH).  Therefore although there appeared to be little or no influence of 
hormones in the change of WallMEC phenotype (table 1), the hormones appeared to exert 
their effect in the presence of ECM.  For example, while the entire p53 signalling pathway 
was not affected in the P2B-NH versus P3_NH dataset, five genes in the pathway were up-
regulated in the P2B-H versus P3_H dataset (higher in P3_H; table 7). Similarly, although the 
Galactose metabolism and Nod-like receptor signalling pathways were up-regulated in the 
P2B_NH versus P3_NH dataset (higher in P3_NH), their enrichment score was significantly 
lower than the P2B_H versus P3_H dataset and below the cut-off of 1.3.   
Equally interesting, three down-stream member genes of the canonical Wnt signaling 
pathway including Fra1, CyclinD and Uterine which link Wnt signaling to cell cycle and 
Smad3 which links it to TGF-β signaling were only up-regulated in the presence of hormones 
(table 7). The effect of hormones on WallMEC phenotype is further confirmed by the down-
regulation of genes in three functional clusters including the lysosome pathway, complement 
and coagulation pathway and cell adhesion molecules (table 7B) only in the presence of 
hormones. These observations confirm a key hypothesis in this study that the ECM sensitizes 
mammary epithelial cells to lactogenic hormones.
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Table 7 
Up-regulated  
P2B_ NH versus P3_NH Regulated genes 
Jak-STAT signaling pathway IL6, CytokineR, PI3K, CycD 
Cytokine-cytokine receptor 
interaction 
IL6, IL11, LIF, BSF3, CSF3, GHR, CSF2RB,  SF11B, SF21, 
IL1R2, HGF, FLT, IL18 
Complement and coagulation 
cascades 
F3, THBD, serpinE1 
Hematopoietic cell lineage G-SCF, IL-6, IL-11,CD121 
TGF-beta signaling pathway THBS1, BMP, FST, Smad1/5/8 
Cell cycle Bub1, BubR1,  cd20, cyclinB, Plk1, cyclinD, MCM5 
oocyte meiosis IGF-1,  Bub1, PI3K, cdc20, Plk1, CycB1, AC 
Neurotrophin signaling pathway TrkC, PI3K, IkB, PKCδ, RIP2, IRAK 
Wnt signaling pathway FRP, Wnt, Frizzled, Nkd, NFAT 
  
P2B_H versus P3_H Regulated genes 
Jak-STAT signaling pathway IL6, CytokineR, PI3K, CyclinD  
Cytokine-cytokine receptor 
interaction 
IL6, IL11, LIF, BSF3, CSF3, GHR, CSF2RB,  SF11B, SF21, 
IL1R2 
Complement and coagulation 
cascades 
F3, THBD, serpinE1, PLAU, DF 
Hematopoietic cell lineage G-SCF, IL-6, IL-11,CD121 
TGF-beta signaling pathway Smad2,3, THBS1, BMP, FST, Smad1/5/8 
p53 signaling pathway CyclinD, CyclinB, IGF, PAI, p53R2 
Cell cycle Bub1, BubR1, Smad2,3, cd20, cyclinB, Plk1, cyclinD,  
Oocyte meiosis IGF-1,  Bub1, PI3K, cdc20, Plk1, CycB1, AC 
Neurotrophin signaling pathway TrkC, PI3K, IkB 
NOD-like receptor signaling 
pathway 
RIP2, IkB, IL-6 
Wnt signaling pathway FRP, Wnt, Frizzled, Nkd, Smad3, NFAT, fra1, CycD, uterine 
Galactose metabolism EC 2.7.1.1, EC 2.7.7.9, EC 5.1.3.2, EC 5.4.2.2 
Table 7B 
Down-regulated  
P2B_ NH versus P3_NH Regulated genes 
No pathway - 
  
P2B_H versus P3_H Regulated genes 
Lysosome cathepsins,ACP5, ASAH1, LAPTM 
Complement and coagulation 
pathway 
C1S, C2, C3,  
Cell adhesion molecules PVRL1, CNTN1, CDH3,  
 
Red = Differentially up-regulated between H and NH.  Green = Enrichment score of P2B_ NH versus 
P3_NH significantly below cut-off.  Blue = Pathway missing in the NH treated datasets.
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p53 signaling 
Four members of the p53 signaling pathway including Cyclin B, Cyclin D, IGF (insulin-like 
growth factor) and p53 R2 (the p53-regulated R2 subunit of ribonucleotide reductase) were 
up-regulated in P3_H  treated WallMEC relative to the P2B_H (table 7A; figure 4A). The 
p53 protein is a well known tumor suppressor that is induced by stress signals including 
hypoxia, nutrition deprivation and DNA damage agents (Oren 1999, Ryan, Phillips et al. 
2001). p53 transcriptionally regulates several genes including p21, Reprimo and Gadd45 
which repress cyclins leading to cell cycle arrest (Levine, Hu et al. 2006). The p53 signalling 
pathway also includes the activation of caspases (leading to apoptosis) (Haupt, Berger et al. 
2003) and regulation of DNA repair through activation of p48 (Levine, Hu et al. 2006).  
Cyclins B and D belong to the cyclin family of proteins which positively regulate the 
progression of cells through the cell cycle (Nigg 1995) and therefore their relative up-
regulation by treating cells with P3-H (P3 ECM in the presence of hormones) implies that P3 
ECM promotes cell division. This is consistent with the significant increase in the size of the 
mammary gland during phase 3 of wallaby lactation (Bird, Hendry et al. 1994). Similarly the 
increased expression of IGF implies that P3 ECM promotes the proliferative effect of growth 
hormone (GH) since GH exerts its growth stimulus through the induction of IGF expression.  
However the up-regulation of p53R2 was somewhat discordant with the proliferative function 
of P3 ECM since p53R2 has been shown to arrest cell cycle by suppressing cyclin D1 
expression (Zhang, Wu et al. 2011).  In the context of wallaby lactation, the balance between 
the proliferative activity of cyclins and the cell-cycle-arresting activity of  p53R2 may be 
needed to enable enhanced mammary growth during P3 while allowing for gradual involution 
which is evident in late lactation (Khalil, Digby et al. 2008).   
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Figure  4A:  
p53 signaling pathway. Up-regulated genes are marked with a red star 
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Galactose metabolism 
At the onset of phase 3 of wallaby lactation, there is a dramatic decrease in the carbohydrate 
content of milk that has been attributed to increased expression of β-galactosidase (Green, 
Newgrain et al. 1980, Green, Griffiths et al. 1983) and UDP-galactose hydrolase which 
catalyses the breakdown of UDP-galactose, a constituent monosaccharide of lactose (Messer 
and Nicholas 1991).  Because changes in enzymes that catalyse galactose metabolism (β-1,3 
galactosyltransferase and β-1,4 galactosyltransferase) are dependent on the phase of lactation 
in the wallaby, it has been suggested that these enzymes are regulated by the endocrine 
system and unknown factors within the mammary gland (Menzies and Nicholas 2007). This 
study reports for the first time the increase in the expression of the genes for four enzymes 
(EC 2.7.1.1, EC 2.7.7.9, EC 5.1.3.2 and EC 5.4.2.2) involved in galactose metabolism after 
culturing WallMEC on P3 ECM relative to P2B ECM (table 7; figure 4B).  
UDP-glucose 6-dehydrogenase (EC 2.7.7.9) catalyses the reversible conversion of UDP-
glucose into α-D-Glucose-1-P  while glucose phosphomutase (EC 5.4.2.2) catalyses the 
conversion of α-D-Glucose-1-P to α-D-Glucose-6P both of which are downstream steps in 
the incorporation of D-galactose into the glycolysis pathway (Berg JM, Tymoczko JL et al. 
2002).  UDP-galactose 4-epimerase (EC 5.1.3.2) reversibly converts UDP-galactose to UDP-
glucose (Holden, Rayment et al. 2003) while hexokinase (EC 2.7.1.1) phosphorylates α-D-
Glucose to form α-D-Glucose-6P (Berg JM, Tymoczko JL et al. 2002). This data suggests 
that although the reactions catalysed by these enzymes are reversible, changes in the ECM 
may progressively tilt the equilibrium towards catabolism of carbohydrates leading to the 
marked decrease in carbohydrates during P3.        
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Figure 4B: Galactose metabolism pathway. Up-regulated genes are marked with a red star. 
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TGF-β signalling 
Three genes in the TGF-β (Transforming growth factor beta) signalling pathway, including 
BMP, Smad8, THBS1 were up-regulated in the P2B-NH versus P3_NH and P2B-H versus 
P3_H datasets (higher in P3) while Smad3 was only up-regulated in the P2B-H versus P3_H 
dataset.  TGF-β negatively regulates epithelial cell proliferation (Moustakas, Pardali et al. 
2002) and has been known to induce apoptosis in several cells through the Smad pathway 
(Jang, Chen et al. 2002). TGF-β exists in a latent form as a TGF-β complex and is activated 
through proteolytic cleavage by matrix metalloproteases 2 and 9 in an integrin-dependent 
manner (Yu and Stamenkovic 2000).  Studies have shown that TGF-β is down–regulated 
when MEC are cultured on ECM (Streuli, Schmidhauser et al. 1993) and it represses β-casein 
expression in a Smad-dependent manner in MEC (Wu, Lee et al. 2008) implying that TGF-β 
may inhibit MEC differentiation. The relative up-regulation of genes in the TGF-β signaling 
pathway by P3 ECM is therefore worth further investigation. 
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Figure 4C: TGF-β signalling. Up-regulated genes are marked with a red star.
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Wnt Signalling pathway  
Nine genes in the canonical Wnt signaling pathway including the Wnt receptor, Frizzled and 
FRP (Frizzled related protein), an inhibitor of the Wnt/β-catenin signaling pathway were up-
regulated in the P2B-H versus P3_H dataset (higher in P3_H). Five of these genes including 
FRP, Wnt, Frizzled, Nkd and NFAT were also up-regulated in the P2B_NH versus P3_NH 
dataset (higher in P3_NH). Notably, three genes, Fra1, CycD and Uterine which link the Wnt 
signaling pathway to cell cycle progression (Gordon and Nusse 2006) were only up-regulated 
in the hormone treated samples. Similarly, Smad3 which links Wnt signaling to TGF-β 
signaling pathway (Gordon and Nusse 2006, McNeill and Woodgett 2010) was expressed 
exclusively in the hormone treated samples.  
The Wnt signaling pathway is involved in several cellular process including cell proliferation 
(Logan and Nusse 2004), stem cell differentiation (Nusse 2008), gastrulation (Biechele, Cox 
et al. 2011),  anti-apoptotic  protection  of several cell types (Chen, Guttridge et al. 2001, 
Shin, Park et al. 2009, Fragoso, Yi et al. 2011)  and stimulation of angiogenesis through 
positive regulation of  the Vascular Endothelial Growth Factor (VEGF)(Zerlin, Julius et al. 
2008, Phng, Potente et al. 2009).  Therefore it is possible that the balance between the 
activation of Wnt signaling and FRP-mediated inhibition of Wnt signaling is regulated by the 
synergistic effect of the ECM and the hormones in order to stimulate vascularisation during 
P3 while allowing gradual involution (Chapter 3, section 3). 
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Figure 4D: Wnt Signalling pathway. Up-regulated genes are marked with a red star.
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JAK-STAT Signaling 
The JAK/STAT system is a pleotrophic signalling pathway that is activated by a number of 
ligands including erythropoietin (EPO), growth hormone (GH), interleukins (Niemand, 
Nimmesgern et al. 2003) and interferons (Lau and Horvath 2002) leading to several cellular 
outcomes including cell proliferation, differentiation (Nishikomori, Usui et al. 2002) and 
migration. In mammals, major physiological processes including, mammary gland 
development, hematopoiesis, sexual differentiation and adipogenesis are regulated by the 
JAK/STAT signalling cascade (O'Shea, Gadina et al. 2002) (Aaronson and Horvath 2002, 
Lau and Horvath 2002). It is also evident that the response of the mammary gland to 
prolactin, leading to milk protein gene expression and lactation is mediated by the 
JAK/STAT signalling pathway through Jak2 and Stat5 (Watson and Burdon 1996).  
In this study four members of the JAK/STAT signalling cascade including IL-6, CytokineR 
PIK3 and CycD were up-regulated in both the P2B_NH versus P3_NH and P2B_H versus 
P3_H datasets (higher in P3). Therefore it appears that the differential expression of these 
signaling molecules was not hormone-dependent and is likely to be mediated by the ECM. 
This is consistent with earlier studies in the wallaby which showed that although there is 
increased prolactin expression during P3 (Nicholas 1988), the change in milk protein gene 
expression pattern between P2B and P3 was not dependent on hormones (Nicholas, Simpson 
et al. 1997).  Further, PI3K and CycD, the two signalling proteins downstream of JAK (figure 
4F) which were up-regulated in this study are likely to induce apoptosis (through PI3/Akt 
signaling)(Morgensztern and McLeod 2005) and regulate cell division (Nigg 1995) 
respectively rather than induce milk protein expression.   
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Figure 4E: JAK-STAT Signaling. Up-regulated genes are marked with a red star.
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Lysosome 
The lysosome functional cluster was among the three differentially down-regulated pathways 
in the P2B_H versus P3_H dataset (lower in P3_H), with four genes including cathepsin S, 
ACP 5 (Acid phosphatase 5), ASAH1 (N-acylsphingosine amidohydrolase) and LAPTM 
(Lysosomal-associated transmembrane protein 4B) being down-regulated (table 7B).  
Cathepsin S is a cysteine protease  that is constitutively expressed in immune cells (Shi, 
Villadangos et al. 1999) and is thought to signal apoptosis through the cleavage of Bid and 
the consequent release of  cytochrome C from mitochondria (Stoka, Turk et al. 2001, Watson 
and Kreuzaler 2009). Cathepsins that belong to the cysteine protease family have been 
associated with the necrotic cell death through lysosomal membrane permeabilisation (LMP) 
during mammary involution (Ferri and Kroemer 2001, Boya and Kroemer 2008). ACP5 
catalyses the release of mannose 6-phosphate the lysosome-targeting label from proteins 
which are marked for proteolytic degradation in the lysosome (Sun, Sleat et al. 2008). 
ASAH1 (N-acylsphingosine amidohydrolase) also known as acid ceramidase digests a type 
of spingolipids called ceramides and has been shown to regulate steroidogenesis and 
adrenocortical function (Lucki, Bandyopadhyay et al. 2012). The down-regulation of 
lysosomal proteases, manose 6-phosphatase and ceramidases upon culturing WallMEC on P3 
ECM could imply decreased proteolysis and lipid catabolism which is consistent with high 
protein and lipid content in milk during P3 of wallaby lactation (Nicholas 1988, Nicholas, 
Simpson et al. 1997, Kwek, Wijesundera et al. 2007). In bovine milk ceramides represent 
close to 30% of total phospholipid (Parodi 1997) and it would interesting to investigate 
ceramide metabolism in wallaby.  
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The complement and coagulation cascade 
The complement system is a multi-tasking family of more than 30 proteins that function in a 
cascade to effect immunological reaction to pathogens by opsonising pathogens, activation of 
immune cells, chemotaxis, and clearance of immune cells among other functions (Brown 
1991, Brown 1992).  In this study two of the five up-regulated genes (PLAU and DF) in the 
complement and coagulation system were up-regulated only in the P2B_H versus P3_H 
dataset (table 7A). PLAU (Urokinase-type plasminogen activator) is a serine protease that 
plays a role in the breakdown of the ECM by cleaving plasminogen to form plasmin. PLAU 
therefore may provide a link between a possible hormone-ECM mediated remodelling of the 
extracellular matrix during P3 of wallaby lactation and is worth further investigation. DF 
(Complement factor D) plays a role in in the alternative complement pathway by cleaving Bf 
(Zhou, Liu et al. 2012) 
Of particular interest is the down-regulation of the three serially connected members (C1s, C2 
and C3) of the classical complement pathway in the P2B_H versus P3_H dataset (table 7B). 
The mu chain of immunoglobulin M (IgM) has recognition sites for complement 1q (C1q) 
which upon binding to IgM activates C1s and C1s proteolitically cleaves C2 and C4 into two 
fragments each (Walport 2001, Walport 2001). The larger fragments of C2 and C4 (C2b and 
C4b respectively) then heterodimerise to form C4b.C2b which cleaves C3 to release C3b a 
well known opsonin for macrophages and neutrophils (Walport 2001, Walport 2001, Wallis, 
Mitchell et al. 2010). Whether this down-regulation of the complement molecules is aimed at 
preventing autophagy of immune cells during P3 is not clear from this study. However it is 
apparent that the ECM and hormones act synergistically to regulate immune activity during 
P3 through the complement cascade. 
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Other signalling pathways 
Among the differentially regulated signalling systems in both the P2B_NH versus P3_NH 
and P2B_H versus P3_H datasets were the cytokine-cytokine receptor interaction (table 7A; 
appendix 6), hematopoietic cell lineage, cell cycle, oocyte meiosis and the neurotrophin 
signaling pathway (table 7A). Thirteen genes (IL6, IL11, LIF, BSF3, CSF3, GHR, CSF2RB,  
SF11B, SF21, IL1R2, HGF, FLT, IL18) in the cytokine-cytokine receptor interaction cluster 
were up-regulated in the P2B_NH versus P3_NH dataset (higher in P3_NH). Out of the 
thirteen, three (HGF, FLT, IL18) were differentially expressed (higher in the NH than the H 
datasets) implying that their expression may be repressed by hormones in an ECM dependent 
manner.  
Four genes (TrkC, PI3K, IkB, IRAK) in the neurotrophin signaling pathway were up-
regulated in both the P2B_NH versus P3_NH and P2B_H versus P3_H datasets (higher in 
P3). However PKCδ, another member of the neurotrophin pathway was up-regulated only in 
the NH dataset while RIP2 was only up-regulated in the H dataset. Similarly in the cell cycle 
cluster, MCM5 was up-regulated in the NH dataset while Smad3 was up-regulated in the H 
dataset, implying that the expression of these genes is regulated by lactogenic hormones in an 
ECM dependent manner.    
 Both the H and NH datasets shared the up-regulation of the hematopoietic cell lineage genes 
G-SCF, IL-6, IL-11 and CD121 suggesting that the expression of these genes is dependent on 
the ECM rather than hormones. Similarly, the oocyte meiosis cluster (AC, IGF-1, Bub1, 
PI3K, cdc20, Plk1, CycB1) was up-regulated in both the NH and H datasets (P3 ECM) 
implying that their expression is dependent on the ECM.   
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Milk protein gene expression 
Beta-casein, the control for induction of lactation in this study was represented by 7 
transcripts the most abundant of which had FPKM values of 1939, 2652, 1416 and 1522 for 
the P2B_NH, P2B_H, P3_NH and P3_H treatments respectively (figure 5A). These FPKM 
values placed β-casein among the top 2.4 %, 2%, 3.4% and 3.3% most abundantly expressed 
transcripts in the respective treatments. Similarly β-lactoglobulin had FPKM values of 626, 
786, 282 and 664  placing it among the top 4.9% 4.3%, 8.1% and 5.0% most abundantly 
expressed transcripts respectively (figure 5B). However the difference between the H and NH 
treatments for β-casein was smaller than the expected 2-3 fold difference observed using 
quantitative PCR on RNA isolated from similarly treated WallMEC (chapter 3, section 2.4). 
This discrepancy may have arisen from a number of sources including the difference in 
sensitivity between RNA-seq and PCR due to positional bias by RNA-seq  (Roberts, Trapnell 
et al. 2011) and the ability of the data analysis pipeline to detect the relative quantities of 
individual transcripts of a gene. The cufflinks suite used for transcript assembly in this study 
relies on the accurate mapping of every read to its source isoform (Trapnell, Williams et al. 
2010, Trapnell, Roberts et al. 2012) and may function sub-optimally with genomes that are 
not fully annotated (Trapnell, Williams et al. 2010) as is the case with the wallaby genome. 
This may also be the reason why no tWAP transcript was identified when the reads were 
mapped to the wallaby genome. Taken together β-casein was expressed at significantly 
higher levels than the bulk of the genes in the WallMEC transcriptome suggesting lactation 
was induced.  
The FPKM values for the early lactation protein (tELP) were less than 25 for all treatments 
although P3 ECM appeared to elevate its expression level (figure 5C). The expression of 
tELP by P2A WallMEC on P2B and P3 ECM is likely to have resulted from P2A WallMEC 
retaining their phenotype and constitutively expressing tELP (Nicholas, Simpson et al. 1997, 
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Simpson, Bird et al. 1998) rather than an ECM effect. RT-PCR data (chapter 3, section 2.4 
and section 6, figure 4) showed that tELP was neither responsive to hormones or ECM and 
the difference observed presently may be an artefact arising from low FPKM values.  
Late lactation protein A (LLP-A) was represented by two transcripts. The more abundant 
transcript had FPKM of 108, 82, 66  and 61 values for the P2B_NH, P2B_H, P3_NH and 
P3_H treatments respectively, placing it in the top 13% most abundantly expressed 
transcripts in the P2B_NH treatment category.  Using single radial immunodiffusion, early 
studies (Nicholas, Messer et al. 1987) showed that LLP-A is detectable in  wallaby milk after 
week 24 post-partum. Consistent with data reported in chapter 3, Section 2.4 and figure 6 in 
which P2B ECM changed the phenotype of P2A cells to adopt a P2B phenotype, it is 
conceivable that P2B ECM (day 168 lactation) used in this study changed the phenotype of 
P2A WallMEC to express tLLP-A.  
Similar to tELP, the expression of tLLP-B was relatively low (the more abundant of two 
transcripts having the highest FPKM of 39.9) and the expression was neither hormone nor 
ECM dependent. This data is consistent with qPCR data in which both P2B and P3 ECM did 
not induce tLLP-B expression in P2B WallMEC leading to the conclusion that although latter 
phase ECM changes WallMEC phenotype to the latter phase, it does not fast-track the 
phenotype by more than one lactation phase.  
MaeuCath1 was represented by one transcript and its expression was the most ECM-
dependent among the milk protein genes. While the FPKMs for P2B-NH and P2B-H  
treatments were 24.7 and 45.4 respectively, the FPKMs for   P3-NH and P3-H were 1487.7 
and 1075.3 respectively. MaeuCath1 has two splice variants, MaeCath1a and MaeuCath1b 
(Wanyonyi, Sharp et al. 2011)  and WallMEC only express MaeuCath1a (chapter 4, section 
2.1). The significant down-regulation of MaeuCath1a by P2B ECM is consistent with the 
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lack of expression of MaeuCath1a in P2B mammary gland (Wanyonyi, Sharp et al. 2011), 
confirming the role of ECM in wallaby milk protein gene expression.  
Collectively this study has shown that the ECM and lactogenic hormones complement each 
other to change lactation phenotype from one phase of wallaby lactation to the other through 
the regulation of multiple molecular pathways.  
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Figure 5:  Milk protein gene expression level in FPKM  
 
On the y-axis is the gene expression level in fragments per kilobase of exon per million 
fragments mapped (FPKM).  P2B-NH, P2B-H, P3-NH and P3_H represent WallMECs 
cultured on P2B ECM without hormones, P2B ECM in the presence of IFPT3E2, P3 ECM 
without hormones and P3 ECM in the presence of IFPT3E2 respectively.  The y-axis scale is 
unique for every milk protein gene due to the large differences in the level of expression. 
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Chapter Six 
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6.0 General discussion 
6.1 The wallaby as a lactation model 
The birth of an altricial wallaby places a demand on the mother for postnatal investment in 
the development of the neonate (Nicholas 1988, Nicholas, Simpson et al. 1997). The pouch 
young’s (PY) transition from a fetus-like morphology at birth to adult-like features at the on-
set of phase 3 (P3) happens when it is dependent only on milk (Nicholas 1988, Nicholas, 
Simpson et al. 1997). It is feasible therefore to suggest that the molecular signals needed for 
the growth and development of the neonate from parturition until it ventures out of the pouch 
are contained in the milk. This proposition is indeed supported by evidence showing that the 
growth and development of the PY from an early phase of lactation is accelerated 
significantly when it is fostered onto a mother producing a later stage milk (Trott, Simpson et 
al. 2003, Kwek, Iongh et al. 2009). It is also well known that a major part of the adaptive 
strategy for neonatal survival in the wallaby is the ability of the mother to progressively vary 
the milk composition profoundly (Nicholas 1988, Nicholas, Simpson et al. 1997) in 
accordance with the stage of development of the PY, in effect ensuring that milk content is 
‘customised’ to the development needs of the PY.  
Therefore a great advantage of the wallaby as a lactation model is that the major 
morphological changes that occur in the neonate can be correlated with specific changes in 
milk composition which occur during the transition from one phase of lactation to another 
(Nicholas, Simpson et al. 1997).  
6.2 Key questions 
The individual studies that make up this thesis collectively addressed four key questions 
about the wallaby lactation strategy. Firstly, how does the timing of delivery of milk 
bioactives in milk correlate with their function in relation to neonatal development and 
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mammary function? To address this question, the study examined the expression profile of 
MaeuCath1, a wallaby cathelicidin expressed in milk, and performed in-vitro anti-bacterial 
and cell proliferative activity assays to assess MaeuCath1 bioactivity.  Secondly, what factors 
in the mammary gland regulate the timing of delivery of milk bioactives including 
cathelicidins? Drawing from previous studies on possible effectors of ACL (Lincoln and 
Renfree 1981, Nicholas 1988, Nicholas, Simpson et al. 1997, Trott, Simpson et al. 2003) and  
a large body of evidence suggesting that the extracellular matrix (ECM) regulates mammary 
epithelial cell function the ECM was investigated as a possible regulator of milk protein gene 
expression and delivery of bioactives in milk.  The third key question addressed which 
elements in the cathelicidin gene are responsive to regulatory stimuli provided by the ECM. 
This question was addressed by transfecting WallMEC with deletion fragments of the 2245 
bp sequence 5’ to the translation start site of the MaeuCath1 gene cloned in a luciferase 
reporter vector. The  cells were cultured on ECM and gene expression assessed by 
performing luciferase activity assays.  Lastly, what molecular pathways are regulated by the 
ECM leading to changes in lactation phenotype? To address this question WallMEC were 
cultured on ECM from P2B and P3 in either the presence or absence of lactogenic hormones 
and RNA isolated for transcriptome analysis.  
6.2.1 MaeuCath expression and function during lactation 
Eight cathelicidin genes, MaeuCath1-8, (GenBank accession numbers ABV01938.1, 
ABV01939.1, ABV01940.1, EF624484.1, ABV01941.1, ABV01942.1, ABV01943.1 and 
ACJ76797.1 respectively) have previously been reported in the wallaby (Daly, Digby et al. 
2008), the first seven of which are expressed in the mammary gland. MaeuCath1 is also 
expressed in the lymphoid tissues of the neonate during P2A and early P2B (Daly, Digby et 
al. 2008) while MaeuCath8 is expressed in the spleen and gut of the neonate in the immediate 
postpartum period and in a number of other tissues after seven days post-partum (Carman, 
  
176 
 
Old et al. 2009, Wang, Wong et al. 2011). However upon examining the wallaby and 
opossum (Monodelphis domestica) genomic sequence in the Ensembl database, this study 
found that ABV01938.1 and EF624482.1 representing MaeuCath1 and MaeuCath2 
respectively map to chromosome 6 of opossum with identical synteny and localise to the 
same gene scaffolds in the wallaby genome. Additionally they were homologous except for a 
retained intronic sequence and lack of exon 3 and 4 in MaeuCath2. Based on these findings 
this study concluded that MaeuCath1 and 2 are splice variants of the same gene. Therefore 
further studies may be required in order to clarify the identities of MaeuCaths genes.  
The present study demonstrated that both MaeuCath1 and MaeuCath7, cathelicidins secreted 
in wallaby milk have antimicrobial activity in their variable C’terminal portion and the 
capacity to enhance mammary epithelial cell proliferation in the cathelin domain (Wanyonyi, 
Sharp et al. 2011). Synthetic peptides (Con73 and Con218 designed from the heterogeneous 
C’terminal portion of MaeuCath1 and MaeuCath7 respectively) had bactericidal activity 
against Staphylococcus aureus, Pseudomonas aureginosa, Salmonella enterica and 
Enterococcus faecalis, consistent with the need to provide antimicrobial protection to the 
young before it develops its own immunity (Daly, Digby et al. 2007). The ability of 
MaeuCath peptides to kill S.aureus also pointed to a possible role in the protection of the 
lactating mammary gland against mastitis agents (Oikonomou, Machado et al. 2012).  
Although MaeuCath1 and MaeuCath7 expression had earlier been reported in wallaby 
mammary gland, this is the first study to demonstrate the antimicrobial activity of MaeuCaths 
both in the context of neonatal and mammary gland protection. However it was initially 
paradoxical that MaeuCath peptides could kill E. faecalis, a commensal of the gut until, upon 
examining the expression profile of MaeuCath1 it became evident that the delivery of 
cathelicidins through milk is temporally regulated so that they are available only when they 
are required. In the case of MaeuCath1, the study showed that it is regulated through alternate 
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splicing so that the antimicrobial domain (MaeuCath1a) is only expressed in early lactation 
when it is required for protection of the immune-compromised neonate (Daly, Digby et al. 
2007) and at involution when the mammary gland of the mother would be vulnerable to 
potential mastitic infections (Williams and Patnode 1948, Sordillo, Nickerson et al. 1987). In 
this way the mother provides broad-spectrum antimicrobial molecules through milk without 
perturbing the microfloral balance of the neonate’s gut. An interesting variation of this 
strategy is the delivery of antimicrobials with selective bactericidal activity as was observed 
in the case of WAP four-disulfide core domain 2 (WFDC2) (Watt, Sharp et al. 2012). While 
WFDC2 had a similar expression profile to MaeuCath1a in tammar milk, its antimicrobial 
domain (domain II) had no bactericidal activity against E.faecalis but strong activity against 
Staphylococcus aureus, Pseudomonas aureginosa and Salmonella enterica.  
6.2.1.1 MaeuCath1a 
This thesis focussed on the host defence role of MaeuCath1a but this is likely to be only one 
of several roles it plays in mammary gland function.  During involution (when MaeuCath1a 
is highly expressed) a large number of immune cells converge in the mammary gland akin to 
a wound healing environment (Findlay 1982, Schedin, O'Brien et al. 2007). Accompanying 
the complex milieu of pro-inflammatory activities is an elevated risk of mastitic infections 
(Williams and Patnode 1948, Sordillo, Nickerson et al. 1987) and a possible release of 
endotoxins due to bactericidal activity of immune cells.  Interestingly, cathelicidins have been 
shown to play a role in the different levels of immune response including regulation of 
immune genes (Yang, Biragyn et al. 2004),  chemotaxis of immune cells (Ciornei, 
Sigurdardottir et al. 2005)  and neutralisation of endototoxins (Bhunia, Mohanram et al. 
2009). Therefore it is conceivable that MaeuCath1a plays these roles in the involuting 
mammary gland.  
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 Apart from the possible roles in immune response, MaeuCath1a may participate in the 
process of involution by directly inducing apoptosis of epithelial cells as has been 
demonstrated for BMAP-28, a bovine cathelicidin. BMAP-28 induces apoptosis through the 
initiation of the mitochondrial permeability transition pore (MPT pore) and the consequent 
release of cytochrome c (Risso, Braidot et al. 2002). Although the mechanism by which 
BMAP-28 initiates MPT is not well understood, this role is likely to link it to a number of 
signaling pathways related to mitochondria-mediated apoptosis. BMAP-28 may initiate 
cytochrome c release through interaction with the Bcl-2 family of proteins which modulate 
apoptosis through MPT by interacting with survival factors via their downstream signaling 
molecules (Lorenzo and Susin 2004, Chalah and Khosravi-Far 2008, Rong and Distelhorst 
2008). For example the pro-apoptotic activity of Bad, one of the Bcl-2 family members is 
inhibited by survival factors including cytokines and growth factors through PI3K/Akt 
signaling. Conversely, death stimuli induce the expression of Bax, Noxa and PUMA (other 
pro-apoptotic members of the Bcl-2 family) through JNK (for Bax) and p53 signaling 
(Lorenzo and Susin 2004, Chalah and Khosravi-Far 2008, Rong and Distelhorst 2008, 
Brenner and Mak 2009, Eliseev, Malecki et al. 2009).  BMAP-28 has been shown to 
selectively kill transformed and proliferating lymphocytes relative to normal non-
proliferating cells through MPT (Zanetti 2004). If MaeuCath1a has pro-apoptotic properties 
similar to BMAP-28, it would be interesting to investigate it for selective killing of 
transformed cells and possible role in inhibition of tumour progression. 
6.2.1.2 MaeuCath1b 
The second splice variant, MaeuCath1b was expressed predominantly in late P2B and during 
P3 which represent the periods of active mammary enlargement and peak milk production 
(Nicholas, Simpson et al. 1997) respectively. The ability of MaeuCath1b to enhance 
mammary epithelial cell proliferation was consistent with the need for production of larger 
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volumes of milk to feed a rapidly growing neonate during P3. Interestingly, prior to the 
current study, tWAP, a member of the four-disulphide core domain (4-DSC) family of 
proteins to which WFDC2 belongs was shown to enhance mammary epithelial cell 
proliferation (Topcic, Auguste et al. 2009). Specifically, domain III of tWAP stimulated the 
proliferation of both the mouse mammary epithelial cell line (HC11) and WallMEC. 
Considering that tWAP is expressed mainly during P2B (Topcic, Auguste et al. 2009) and is 
almost undetectable at the onset of P3, it appears that while the cell-proliferative function of 
milk is retained, there is a change with respect to the specific peptides that carry out this 
function during the course of lactation.  
Two questions stem from the proliferative effect of MaeuCath1b; how does MaeuCath1b 
stimulate MEC proliferation and is MaeuCath1b involved in cell survival signaling? In a 
wound healing environment the porcine cathelicidin peptide, PR-39 has been thought to 
signal cell proliferation by inducing the expression of syndecans (Bernfield, Kokenyesi et al. 
1992), a family of heparan sulphate proteoglycans known for their regulatory roles  in 
multiple physiological processes including cell adhesion and blood coagulation (Bernfield, 
Kokenyesi et al. 1992).  The syndecans effect cell proliferation by sensitising cells to growth 
factors including the transforming growth factor-β (TGF-β), vascular endothelial growth 
factor (VEGF) and fibroblast growth factor (FGF) (Bernfield, Kokenyesi et al. 1992, Zanetti 
2004). The possibility of MaeuCath1b signaling cell proliferation through the syndecans 
therefore links Maeucath1b to multiple TGF-β-regulated physiological processes including 
angiogenesis, extracellular matrix neogenesis and immune-suppression (Ijichi, Otsuka et al. 
2004). However, this proposition although feasible is somewhat controversial because in 
normal epithelial cells TGF-β signals apoptosis instead of proliferation (Massague 2000). 
Nevertheless the possible role of Maeucath1b in mammary growth during peak lactation is 
worth further investigation. 
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6.2.2 The role of the extracellular matrix (ECM) in wallaby lactation  
The ability of the wallaby to initiate two parallel lactations in two adjacent mammary glands 
(asynchronous concurrent lactation; ACL) each with its own milk composition (Nicholas 
1988) offers an incredible advantage in investigating factors that regulate milk protein gene 
expression. Further, the progressive changes in milk composition in the individual mammary 
glands is marked by phase-specific induction and silencing of specific genes, providing what 
has been called natural gene knockout (Brennan, Sharp et al. 2007). Therefore by performing 
a comparative analysis of the molecular composition of the two mammary glands involved in 
ACL, it is possible to identify factors that instruct the asynchronous expression of milk 
protein genes. In this thesis I report that the asynchronous expression of milk protein genes in 
the mammary glands of the wallaby is regulated by progressive changes in the extracellular 
matrix.  
ECM extracted from a later phase of lactation changed the phenotype of WallMEC from 
earlier phase of lactation to resemble the later phase. For example when P2B cells were 
cultured on P3 ECM they expressed the late lactation protein-B (LLP-B) gene, consistent 
with published data showing that the ECM regulates mammary epithelial cell function (Li, 
Aggeler et al. 1987, Deugnier, Faraldo et al. 1999). However the ECM-directed transition of 
MECs from an earlier phase to a later phase appeared to proceed in a stepwise manner so that 
P3 ECM could not change the phenotype of P2A cells to P3. Additionally the ECM could not 
reverse the phenotype of WallMEC to an earlier phase phenotype. This inability of the ECM 
to program cells backwards or forward by more than one phase suggests that phase-specific-
milk protein gene expression in wallaby is tightly regulated especially considering that in an 
in-vitro  rat model, ECM from a late involuting mammary gland changed a culture from an 
alveolar structure back to a ductal structure (Schedin, Mitrenga et al. 2004). Therefore this 
study would have been enriched further by culturing P2A WallMEC on P2B ECM, 
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examining the change in phenotype and then transferring the cells onto P3 ECM, effectively 
confirming that change in phenotype must proceed in a stepwise manner.   
The tight regulation of milk protein gene expression is consistent with the need for the 
mother to produce milk that matches the level of gut development at every stage of lactation. 
Therefore it was particularly interesting when RNA-seq data revealed that relative to P2B 
ECM, P3 ECM differentially up-regulated the expression of enzymes that metabolise 
galactose including UDP-glucose 6-dehydrogenase, glucose phosphomutase (Berg JM, 
Tymoczko JL et al. 2002), UDP-galactose 4-epimerase and hexokinase (Holden, Rayment et 
al. 2003) possibly leading to reduction in milk carbohydrate. During P3, the milk is rich in 
protein and lipid but low in carbohydrate and whereas the main carbohydrates in P2 milk are 
complex oligosaccharides, P3 milk contains mainly monosaccharides (Menzies and Nicholas 
2007). Previous studies have attributed the decrease in oligosaccharides during P3 to the 
down-regulation of 3βGalT and 4βGalT which collectively catalyse the synthesis of 
oligosaccharides and the increase in the expression of UDP-galactose hydrolase which breaks 
down UDP-galactose, a building block of oligosaccharides (Messer and Elliott 1987, Messer 
and Nicholas 1991). However, prior to this thesis no association had been shown between 
ECM and the regulation of milk carbohydrate content during wallaby lactation.  
Equally interesting was the down-regulation of ASAH1 (N-acylsphingosine amidohydrolase) 
by P3 ECM relative to P2B ECM as revealed by RNA-seq data. ASAH1 also known as acid 
ceramidase digests ceramides (Lucki, Bandyopadhyay et al. 2012) which are the major 
phospholipid in the bovine milk fat globule (Parodi 1997). Although the ceramide content of 
wallaby milk is not well documented, it is possible that during P3 the ECM regulates milk 
lipid content by down-regulating lipid catabolic enzymes. Consequently, this thesis is the first 
to report a possible association between the ECM and the elevated milk lipid content during 
P3. 
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6.2.3 ECM-regulated functional pathways in WallMEC 
In this study the ECM appeared to exert a global effect on WallMEC, impacting several 
pathways linked to multiple cellular processes including apoptosis, proliferation, 
differentiation, sugar metabolism and lipid metabolism. Clearly there was a synergistic 
relationship between hormones and the ECM, since some pathways including the lysosome, 
complement and coagulation, cell adhesion molecules (CAM) and p53 signaling pathways 
were only responsive to ECM in the presence of hormones. Similarly, the galactose 
metabolism and Nod-like receptor signalling pathways had significant enrichment scores only 
in hormone treated samples. The implications of the impact of ECM on these signalling 
pathways in regard to mammary function and lactation are discussed in chapter 5, section 3.  
6.2.4 What regulates ECM composition? 
In this study, consistent with published evidence (Schedin, Mitrenga et al. 2004) the 
regulatory effect of the ECM appeared to be mediated by progressive changes in ECM 
composition in a lactation-phase dependent manner. ECM extracted from pregnant (P1), P2A 
and P2B mammary glands had predominantly intact multimeric proteins while ECM from P3 
and involuting mammary glands had a significant amount of breakdown and monomeric 
fragments of the large ECM proteins. Gelatin zymography of the ECMs showed that the 
changes in ECM may be mediated both by differential expression of the ECM protein genes 
and increase in matrix metalloprotease (MMP) activity in late lactation and involution. 
Therefore, while it is clear that ECM composition controls phenotype change in WallMEC, 
the instructive cues that signal changes in ECM composition according to the lactation phase 
need to be investigated.  
The concept of dynamic reciprocity between the ECM and epithelial cells suggests that the 
instructive cues that ultimately change ECM composition originate from the ECM (Bissell 
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and Aggeler 1987, Roskelley and Bissell 1995, Spencer, Xu et al. 2007, Maller, Martinson et 
al. 2010). Examination of the RNA-seq data in this study indeed appeared to confirm this 
concept. Among the differentially expressed functional gene clusters, the ECM related cluster 
represented at least 3% of the differentially regulated genes between P2B and P3 ECM 
treated WallMEC. This was true for the hormone (H) and no hormone (NH) treated cells and 
the differentially regulated genes included the ADAMTS’s, MMP’s, tenascin and collagens 
secreted by MECs, among other ECM constituent proteins. These observations are consistent 
with the ECM inducing the secretion of ECM-modulating proteins by cells, hence the 
dynamic and reciprocal relationship between ECM and epithelial cells. However, a question 
remains as to whether changes in ECM precede changes in the cell or the other way round.  
It is possible that the overarching instructive cues that direct changes in ECM composition 
originate from systemic developmental signals that determine tissue specificity and organ 
development rather than the cell-ECM interaction. Relative to other organ systems the 
mammary gland is unique because the major part of its development occurs  during puberty 
and only becomes functionally active in adulthood (Watson and Khaled 2008). Therefore it is 
conceivable that factors which program the development of other organs at the embryonic 
stage act on the mammary gland during puberty and possibly pregnancy and lactation. 
Understandably, the process would involve a complex set of molecular networks that are 
beyond the scope of this thesis. However I can speculate that development regulators 
including the Hedgehog (Hh) signalling network which determines organ patterning and stem 
cell lineage (Ingham and McMahon 2001, Watson and Khaled 2008) in embryos may play a 
role in specifying ECM composition. Other likely candidates include the parathyroid 
hormone-related protein (PTHrP), fibroblast growth factor 10 (FGF10) and the bone 
morphogenic protein 4 (BMP4) which collectively specify mammary bud formation in the 
embryo (Hens, Dann et al. 2007, Watson and Khaled 2008). PTHrP has indeed been shown to 
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instruct the secretion of mammary-specific mesenchyme during embryonic mammary 
development (Hens, Dann et al. 2007). 
However it is necessary to distinguish between cues that instruct pre-pubertal development 
and cues that lead to post-pubertal functional differentiation (at pregnancy and during 
lactation). At puberty the mammary gland comes under the control of estrogen and upon 
maturity is subjected to cyclical changes in ovarian hormones (Hens and Wysolmerski 2005, 
Hinck and Silberstein 2005, Sternlicht 2006) and similarly, during gestation and lactation the 
mammary gland is under strict control of lactogenic hormones in a species-dependent manner 
(Topper and Freeman 1980, Nicholas and Tyndale-Biscoe 1985, Nicholas 1988, Nicholas, 
Simpson et al. 1997).  Therefore it is possible that hormones play a more prominent role than 
other developmental signals during puberty, gestation and lactation. This suggestion is 
consistent with RNA-seq data in this study showing that specific ADAMTS’s, MMP’s and 
collagen VII were differentially expressed between the H and NH treated WallMEC.  
6.3 The role of ECM in MaeuCath1 gene expression 
After confirming that the ECM regulates the switch from one lactation phase to the next, it 
was of interest in this study to establish whether the temporal expression of MaeuCath1 was 
controlled by the ECM. By performing promoter activity assays on the 5’-proximal region of 
the MaeuCath1 ORF, the study showed that the sequence between -709 and -15 relative to the 
ATG start codon contained positive regulatory activity while the region between -919 and -
710 contained repressor activity both of which were dependent on the ECM. Therefore, this 
study showed for the first time that the ECM regulates MaeuCath1 expression through 
regulatory elements found in 5’-untranslated region of the gene.  
Previously MaeuCath1 expression in WallMEC and leucocytes has been shown to be induced 
by lipopolysaccharide (LPS) and lipotechoic acid (LTA) respectively (Daly, Mailer et al. 
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2009). Cathelicidin expression in other species is induced by a wide variety of stimuli 
including, DNA damage agents, injury, a break in the permeability barrier and ER stress 
(Park, Elias et al. 2011) and the effect of the stimuli appears to be tissue dependent but there 
is no clear association between ECM and cathelicidin expression. Therefore the identification 
of ECM responsive sequences in the MaeuCath1 gene adds a new dimension the regulation of 
cathelicidin  
6.4 Possible methodological refinement 
Numerous in-vitro culture models have shown that cells express higher amounts of β-casein 
when cultured on floating collagen gels than when cultured on individual ECM proteins 
(Parry, Cullen et al. 1987), attached collagen (Enami, Yang et al. 1979, Sasaki and Enami 
1996) or plastic (Emerman, Enami et al. 1977, Enami and Nandi 1978, Katiyar, Enami et al. 
1978, Bisbee, Machen et al. 1979, Enami, Yang et al. 1979, Sasaki and Enami 1996). Parry et 
al further demonstrated the need for floatation in MEC differentiation by obtaining a high 
level of β-casein expression on nitrocellulose filters touching media in tissue culture 
chambers (Parry, Cullen et al. 1987). These experiments demonstrated that baso-lateral 
contact with media is necessary for basal/apical polarity and milk gene expression.  In this 
study the ECM had no effect on the expression of the early lactation protein (tELP) probably 
because the expression of tELP in-vitro is dependent on baso-lateral contact with the media. 
Therefore, the findings of this study could have been enriched further by including a 
floatation component in the methodology for chapters 3 and 4.  
In chapter 3, although the study reports progressive changes in ECM during lactation the 
differences in ECM between the P3 and involuting mammary glands was minor, judging 
from the silver-stained gel. This may have been due to gradual involution in the P3 mammary 
gland (Khalil, Digby et al. 2008) but may also have been caused by insufficient time 
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difference in the dates the mammary glands were extracted. This problem could be resolved 
by using a larger number of samples that are spread out in time. Additionally the novel ECM 
protein bands (P2Ax, P2Bx and INVx) were not positively identified by mass spectrometry 
after in-gel proteolytic digest possibly due to the resistance of ECM proteins to proteolytic 
digest. A chemical approach such as the Bergmann degradation (Edman 1949, Niall 1973) 
method might have resolved this difficulty.  
It would also be possible to dissect the role of ECM in mammary function further by cloning 
and expressing the differentially expressed ECM protein genes and treating WallMEC from 
different phases of lactation with the individual ECM proteins then examining change in 
lactation phenotype.  The recombinant ECM proteins could be added to the ECM in different 
combinations and changes in the response of the cells to ECM examined.   
An in-vivo model of the antimicrobial activity of MaeuCath1a and the cell proliferative 
activity of MaeuCath1b could have significantly enriched this study. For example by 
generating a MaeuCath1a transgenic mouse and performing galactophore innoculation   with 
known mastitic agents such as S.aureus, the study could have confirmed the role of 
MaeuCath1a in the protection of the mammary gland against mastitis. Similarly by 
generating a MaeuCath1b transgenic mouse and measuring changes in mammary size, 
survival rate of litters and performing histological studies on the mammary glands the role of 
MaeuCath1b in mammary growth could have been confirmed.   
6.5 Conclusion 
This study has shown for the first time that ACL and the delivery of domain-specific 
bioactive peptides including MaeuCaths in milk are regulated through temporal changes in 
mammary extracellular matrix during lactation. 
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Appendix 1 
Acini morphology and abundance after culturing mid lactation WallMEC’s on ECM 
extracted from mammary glands representing various phases of lactation.  A: 40x 
magnification of acini after culturing cells for 13 days. PG, Early, Mid, Late and INV 
represent pregnant, early, mid and late lactation and involution respectively. B:  Effect of 
ECM phase on acini morphology. On the x-axis is the phase of lactation from which 
mammary ECM was isolated. On the y-axis is the number of acini. Each treatment was 
performed  in triplicate and the experiment repeated three times. Standard error bars are 
shown. M1-M6 represent the various acini types in order of decreasing size. Due to the 
significant difference in the numbers of acini subtypes the y-axis scale is specific to each 
acinus subtype.  
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Appendix 2 
Milk protein gene expression after culturing mid lactation WallMEC’s on ECM extracted 
from mammary glands representing the various phases of lactation. On the y-axis is the 
gene expression level expressed as a percentage of GAPDH expression and on the x-axis is 
the lactation phase of the ECM. Samples were either treated with insulin and cortisol (IF) or 
the hormone cocktail consisting of insulin, cortisol, prolactin, tri-iodothyronine and estradiol 
(IFPT3E2).  The asterisk denotes significant difference between IF and IFPT3E2. Samples were 
treated in duplicate and the experiment repeated twice. Standard error bars are shown. The y-
axis scale is unique for each of the proteins due to the significant difference in their 
expression levels. 
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Appendix 3 
Acini morphology and numbers after culturing early lactation WallMEC’s on ECM 
extracted from mammary glands representing the various phases of lactation.  A: 40x 
magnification images of acini after culturing cells for 13 days. PG, Early, Mid, Late and INV 
represent phases pregnant, early, mid and late lactation and involution respectively  B:  Effect 
of ECM phase on acini morphology. On the x-axis is the phase of lactation from which 
mammary ECM was isolated. On the y-axis is the number of each type of acini. Each 
treatment was performed in triplicate and the experiment repeated three times. Standard error 
bars are shown. M1-M6 represent the various acini types in order of decreasing size. 
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Appendix 4 
Milk protein gene expression after culturing early lactation WallMEC’s on ECM extracted 
from mammary glands representing the various phases of lactation. On the y-axis is the 
gene expression level expressed as a percentage of GAPDH and on the x-axis is the lactation 
phase of the ECM. Samples were either treated with IF or (IFPT3E2).  The asterisk denotes 
significant difference between IF and IFPT3E2. Samples were treated in duplicate and the 
experiment repeated twice. Standard error bars are shown. The y-axis scale is unique for each 
of the proteins due to the significant difference in their expression levels. 
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Appendix 5 
Quantitative PCR of MaeuCath1 using cDNA from P2A WallMECs. Cells were cultured on 
ECM from different phases of lactation in the presence or absence of IFPT3E2 and RNA 
isolated for cDNA synthesis and qPCR. Treatments were performed in triplicates and 
repeated twice. Representative results with their error bars are shown. 
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Appendix 6 
Cytokine-cytokine receptor interaction. Up-regulated in the P2B_NH versus P3_NH 
dataset (higher in P3_NH) are marked with a red star. 
IL-1 family
Hematopoietins
TNF family
